"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL739006";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5 mg/kg/day; 0/10";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL741835";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2.5 mg/kg/day; 0/10";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL817773";"B";"beta-Tubulin GTPase activity at 10 uM concentration.";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1134638";"11741473";"10.1021/jm010940+";"2001";"J Med Chem";"44";"4535";"4553";"";"";"";"";"";""
"CHEMBL739904";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 3.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL739001";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4 mg/kg/day; 0/10";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL741226";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2.7 mg/kg/day; 0/11";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL741075";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 0.33 mg/kg/day; 0/10";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL901939";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 3.16 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL913044";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 3.16 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL855046";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1964065";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ";"";"34103";"34374";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SR";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL886028";"F";"Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase after 24 hrs by flow cytometry";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1143713";"17533132";"10.1016/j.bmc.2007.05.030";"2007";"Bioorg Med Chem";"15";"5122";"5136";"";"";"";"";"";""
"CHEMBL1694087";"F";"Growth inhibition of pig LLC-PK1 cells";"Sus scrofa";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9823";"";"";"LLC-PK1";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1106834";"F";"Cytotoxicity against human HL60 cells after 48 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1154247";"19711971";"10.1021/np900365r";"2009";"J Nat Prod";"72";"1686";"1690";"";"";"";"";"";""
"CHEMBL901951";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 10 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1828322";"F";"Antiproliferative activity against MDR-1 overexpressing human 786-0 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"786-0";"";"CHEMBL1821642";"21774499";"10.1021/jm200454y";"2011";"J Med Chem";"54";"6014";"6027";"";"";"";"";"";""
"CHEMBL1908289";"A";"Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1743273";"A";"Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP3A4";"Homo sapiens";"118";"119";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1743201";"None";"None";"2008";"None";"None";"161";"304";"";"";"";"";"";""
"CHEMBL965578";"B";"Inhibition of mouse brain MAOA";"Mus musculus";"385";"391";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL890274";"F";"Cytotoxicity against multidrug resistant human KB-Vin cells by SRB microtiter plate assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145456";"17585747";"10.1021/jm061366a";"2007";"J Med Chem";"50";"3674";"3680";"";"";"";"";"";""
"CHEMBL866244";"F";"Cytotoxicity against human WRL68 cells by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WRL68";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL888947";"F";"Ratio of IC50 for KB8.5 cells to IC50 for KB V1 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB V1";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL965889";"F";"Cytotoxicity against human BGC823 cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"BGC-823";"";"CHEMBL1148213";"15387638";"10.1021/np030418l";"2004";"J Nat Prod";"67";"1441";"1444";"";"";"";"";"";""
"CHEMBL1827079";"F";"Cytotoxicity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL1020853";"A";"Cytotoxicity against bovine Bon-Fib cells after 48 hrs by MTT assay";"Bos taurus";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1159320";"11858754";"10.1021/np010206t";"2002";"J Nat Prod";"65";"189";"192";"";"";"";"";"";""
"CHEMBL886027";"F";"Antiproliferative activity against human MCF7 cells after 5 days";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1143713";"17533132";"10.1016/j.bmc.2007.05.030";"2007";"Bioorg Med Chem";"15";"5122";"5136";"";"";"";"";"";""
"CHEMBL790288";"F";"The capillary permeability of radioligand was measured in Rat brain";"Rattus norvegicus";"25";"25";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL1121459";"7392035";"10.1021/jm00180a022";"1980";"J Med Chem";"23";"682";"684";"";"";"";"";"";""
"CHEMBL901949";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1809625";"F";"Resistance factor, ratio of IC50 for drug-resistant MDR1-deficient human NCI/ADR cells expressing Pgp in absence of vinblastin to IC50 for drug-sensitive human MCF7 cells in presence of 50 nM vinblastin";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL1001108";"F";"Cytotoxicity against human MIAPaCa2 cells after 48 hrs by alamar blue assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MIA PaCa-2 ";"";"CHEMBL1140891";"19117761";"10.1016/j.bmc.2008.12.002";"2009";"Bioorg Med Chem";"17";"512";"522";"";"";"";"";"";""
"CHEMBL1820601";"F";"Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1697722";"A";"Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset";"";"530";"544";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1697692";"20553011";"10.1021/tx1000865";"2010";"Chem Res Toxicol";"23";"1215";"1222";"";"";"";"";"";""
"CHEMBL890773";"F";"Cytotoxicity against A549 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1146228";"17604394";"10.1021/np070069l";"2007";"J Nat Prod";"70";"1114";"1117";"";"";"";"";"";""
"CHEMBL910673";"F";"Antiproliferative activity against KB8.5 cells expressing MDR1";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL890270";"F";"Cytotoxicity against human A549 cells by SRB microtiter plate assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1145456";"17585747";"10.1021/jm061366a";"2007";"J Med Chem";"50";"3674";"3680";"";"";"";"";"";""
"CHEMBL890272";"F";"Cytotoxicity against human DU145 cells by SRB microtiter plate assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL1145456";"17585747";"10.1021/jm061366a";"2007";"J Med Chem";"50";"3674";"3680";"";"";"";"";"";""
"CHEMBL890775";"F";"Cytotoxicity against AGS cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"AGS";"";"CHEMBL1146228";"17604394";"10.1021/np070069l";"2007";"J Nat Prod";"70";"1114";"1117";"";"";"";"";"";""
"CHEMBL1794584";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]";"";"63980";"64461";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL958039";"F";"Antiproliferative activity against human MCF7 cells after 5 days by microplate assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1150769";"18513974";"10.1016/j.bmc.2008.04.071";"2008";"Bioorg Med Chem";"16";"6436";"6447";"";"";"";"";"";""
"CHEMBL1909184";"B";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855617";"F";"Antiproliferative activity against P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL890776";"F";"Cytotoxicity against HT29 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1146228";"17604394";"10.1021/np070069l";"2007";"J Nat Prod";"70";"1114";"1117";"";"";"";"";"";""
"CHEMBL1909097";"B";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"Sus scrofa";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9823";"CHEMBL3638187";"Heart";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL961498";"F";"Cytotoxicity against human KB cells by sulforhodamine B assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL855039";"F";"Anticancer activity against CNS cancer cell lines of NCI60 panel";"Homo sapiens";"10";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel CNS (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL944954";"F";"Induction of apoptosis in human HCT116 cells assessed as caspase activation after 24 hrs by HTS assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1140741";"18197614";"10.1021/jm7010657";"2008";"J Med Chem";"51";"417";"423";"";"";"";"";"";""
"CHEMBL997589";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997592";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 0.1 nM after 24 hrs by FACS analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997598";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 1 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997601";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 3.16 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL998460";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 31.6 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL1697779";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents";"Rodentia";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9989";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL888636";"F";"Growth inhibition of Pgp deficient MCF7 cells expressing MRP1";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1145421";"17567121";"10.1021/jm070194u";"2007";"J Med Chem";"50";"3290";"3301";"";"";"";"";"";""
"CHEMBL1614670";"A";"Volume of distribution at steady state in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1694088";"F";"Growth inhibition of pig L-MDR1 cells overexpressing human P-glycoprotein";"Sus scrofa";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9823";"";"";"L-MDR1";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1909130";"B";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909155";"B";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"5";"5 - Multiple direct protein targets may be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638246";"Spinal cord";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909156";"B";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900695";"F";"Cytotoxicity against human HeLa cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL900697";"F";"Cytotoxicity against human H295R cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"H295R";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909148";"B";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909206";"B";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909111";"B";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909089";"B";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1008918";"F";"Antitumor activity against human Melanoma cells after 48 hrs by SRB assay";"Homo sapiens";"16";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1909143";"B";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909214";"B";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909139";"B";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909162";"B";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909168";"B";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900703";"F";"Cytotoxicity against human PT45 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PT-45";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909188";"B";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909192";"B";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909137";"B";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900715";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at sub Go phase at 1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909112";"B";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909211";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909191";"B";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"Bos taurus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9913";"CHEMBL3638197";"Uterus";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909095";"B";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638191";"Lens of camera-type eye";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909215";"B";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909129";"B";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"1321-N1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909177";"B";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"IMR-32";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909181";"B";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909131";"B";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf21";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909132";"B";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909153";"B";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909166";"B";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL910672";"F";"Antiproliferative activity against KB cells expressing MDR1";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL1694085";"F";"Growth inhibition of dog MDCK2-MDR1 cells overexpressing human P-glycoprotein in presence of P-glycoprotein inhibitor LY335979";"Canis lupus familiaris";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9615";"";"";"MDCK-II";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL888486";"F";"Antitumor activity against NSCLC cells";"Homo sapiens";"15";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL853905";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 100 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL901962";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 100 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL899158";"F";"Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1137538";"17889544";"10.1016/j.bmc.2007.07.020";"2007";"Bioorg Med Chem";"15";"7355";"7360";"";"";"";"";"";""
"CHEMBL2166270";"B";"Inhibition of electric eel AChE at 2 mg/ml by Ellman's method";"Electrophorus electricus";"500";"501";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"8005";"";"";"";"";"CHEMBL2163249";"23062825";"10.1016/j.bmc.2012.09.040";"2012";"Bioorg Med Chem";"20";"6669";"6679";"";"";"";"";"";""
"CHEMBL1694090";"F";"Growth inhibition of pig L-MDR1 cells overexpressing human P-glycoprotein in presence of P-glycoprotein inhibitor LY335979";"Sus scrofa";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9823";"";"";"L-MDR1";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1694091";"F";"Ratio of GI50 for pig L-MDR1 cells overexpressing human P-glycoprotein to GI50 for pig LLC-PK1 cells";"Sus scrofa";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9823";"";"";"LLC-PK1";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1737902";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355]";"";"75513";"75614";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL901952";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 31.6 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1820602";"F";"Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1964062";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"13726";"13816";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DMS-273";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL888489";"F";"Antitumor activity against melanoma cells";"Homo sapiens";"15";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL1909185";"B";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909203";"B";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909183";"B";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"Mus musculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"ICR";"DrugMatrix";"10090";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900713";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 0.1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909124";"B";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909136";"B";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909121";"B";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909098";"B";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638251";"Adrenal gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909199";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909109";"B";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909127";"B";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909135";"B";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909141";"B";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909171";"B";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909208";"B";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand albino";"DrugMatrix";"9986";"CHEMBL3638205";"Urinary bladder";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909209";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909101";"B";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"T47D";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963889";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"13980";"14071";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"LXFL 529";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794580";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"130891";"131175";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL861042";"F";"Cytotoxicity against mouse 4T1 cells by MTT assay";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL861039";"F";"Cytotoxicity against human A549 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL900714";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL879379";"F";"Inhibitory activity against growth of HT-29 cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1131603";"9554885";"10.1021/jm970800t";"1998";"J Med Chem";"41";"1524";"1530";"";"";"";"";"";""
"CHEMBL1109129";"F";"Growth inhibition of human prostate cancer cell by NCI-CLS assay";"Homo sapiens";"18";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1109126";"F";"Growth inhibition of human melanoma cell by NCI-CLS assay";"Homo sapiens";"18";"51";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1109125";"F";"Growth inhibition of human CNS cancer cell by NCI-CLS assay";"Homo sapiens";"18";"49";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1218946";"F";"Growth inhibition of human renal cancer cells after 48 hrs";"Homo sapiens";"26";"74";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1218948";"F";"Growth inhibition of human breast cancer cells after 48 hrs";"Homo sapiens";"26";"74";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1218943";"F";"Growth inhibition of human CNS cancer cells after 48 hrs";"Homo sapiens";"26";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1109130";"F";"Growth inhibition of human breast cancer cell by NCI-CLS assay";"Homo sapiens";"18";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1963991";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"36454";"36745";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-92";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1267246";"F";"Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay";"Plasmodium falciparum 7G8";"572";"601";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"57266";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL2078581";"F";"TP_TRANSPORTER: drug resistance in MDR1-expressing MCF7 cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7";"";"CHEMBL2074080";"12608535";"10.1023/a:1022242607418";"2003";"Pharm Res";"20";"45";"50";"";"";"";"";"";""
"CHEMBL2076208";"F";"TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells";"";"28";"28";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1018153";"F";"Antiproliferative activity against human KB 8.5 cells after 3 days by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL855040";"F";"Anticancer activity against melanoma cancer cell lines of NCI60 panel";"Homo sapiens";"9";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel melanoma (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL1015235";"F";"Growth inhibition of human KB-7D cells overexpressing multidrug resistant associated protein after 72 hrs by methylene blue dye assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1151752";"19053773";"10.1021/jm8008635";"2008";"J Med Chem";"51";"8163";"8167";"";"";"";"";"";""
"CHEMBL628546";"A";"Statistical significance of IC 50 values; Expressed as R value";"";"14";"14";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1130080";"9207950";"10.1021/jm9700169";"1997";"J Med Chem";"40";"2102";"2106";"";"";"";"";"";""
"CHEMBL831553";"F";"Total growth inhibition of human Prostate cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Prostate cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL837115";"F";"Cytotoxic effect dissolved in DMSO against Leukemia cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL687851";"F";"Tested for cytotoxicity against HT-29 (wt)cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1145018";"12502374";"10.1021/jm0203027";"2003";"J Med Chem";"46";"194";"196";"";"";"";"";"";""
"CHEMBL1963990";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ";"";"40970";"41313";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UO-31";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1799244";"F";"Cell cycle arrest in human HCT116 cells assessed as accumulation at G0/G1 phase at 150 nM after 24 hrs by FACS analysis (Rvb = 76.5 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL1809627";"F";"Resistance factor, ratio of IC50 for Pgp-deficient human MCF7/VP cells expressing MRP1 in absence of vinblastin to IC50 for drug sensitive human MCF7 cells in presence of 50 nM vinblastin";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL903355";"F";"Cytotoxicity againt human A2780 cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1139110";"17239597";"10.1016/j.bmcl.2006.09.068";"2007";"Bioorg Med Chem Lett";"17";"1122";"1126";"";"";"";"";"";""
"CHEMBL1000971";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.032 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL901937";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1930891";"F";"Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1926616";"22119124";"10.1016/j.ejmech.2011.11.011";"2012";"Eur J Med Chem";"47";"424";"431";"";"";"";"";"";""
"CHEMBL987561";"F";"Cytotoxicity against rat C6 cells after 3 days treated 4 hrs before db-cAMP challenge by MTT assay";"Rattus norvegicus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL1018151";"F";"Antiproliferative activity against human COLO205 cells after 24 hrs by MTS assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 205";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL853895";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 10 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL853896";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 31.6 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL853903";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 10 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL1826865";"F";"Drug resistance index, ratio of IC50 for adriyamycin-resistant human MCF7 cells to IC50 for human MCF7 cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL983439";"F";"Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at G0/G1 phase at 1 uM by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1149784";"17573162";"10.1016/j.ejmech.2007.04.008";"2008";"Eur J Med Chem";"43";"429";"434";"";"";"";"";"";""
"CHEMBL861036";"F";"Cytotoxicity against human Ovcar3 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL705712";"F";"Inhibitory activity against growth of MCF-7 cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1131603";"9554885";"10.1021/jm970800t";"1998";"J Med Chem";"41";"1524";"1530";"";"";"";"";"";""
"CHEMBL751412";"F";"Cytotoxic effect on human non-small cell lung carcinoma cell lines";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL701391";"F";"Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1148410";"14761187";"10.1021/jm030918b";"2004";"J Med Chem";"47";"849";"858";"";"";"";"";"";""
"CHEMBL2343799";"F";"Cytotoxicity against human MES-SA/Dx5 cells after 72 hrs by Presto Blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL2331340";"23360284";"10.1021/jm301788a";"2013";"J Med Chem";"56";"1544";"1563";"";"";"";"";"";""
"CHEMBL1963961";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ";"";"39679";"40011";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"CCRF-CEM";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1267249";"F";"Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"567";"596";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"GB4";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267247";"F";"Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay";"Plasmodium falciparum D10";"426";"451";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"478861";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267248";"F";"Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"340";"365";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Dd2";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1826870";"F";"Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL837109";"F";"Cytotoxic effect dissolved in DMSO against Breast cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Breast carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL890273";"F";"Cytotoxicity against human ZR751cells by SRB microtiter plate assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ZR-75-1";"";"CHEMBL1145456";"17585747";"10.1021/jm061366a";"2007";"J Med Chem";"50";"3674";"3680";"";"";"";"";"";""
"CHEMBL1656794";"B";"Inhibition of tubulin polymerization after 60 mins";"";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1649061";"21126027";"10.1021/jm100659v";"2011";"J Med Chem";"54";"179";"200";"";"";"";"";"";""
"CHEMBL707011";"F";"Inhibitory concentration against proliferation of cultured lymphoid leukemia L1210 cells during 48 hrs.";"Mus musculus";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122127";"7131483";"10.1021/jm00351a008";"1982";"J Med Chem";"25";"1045";"1050";"";"";"";"";"";""
"CHEMBL833212";"F";"Cytotoxic activity against human tumor Aro cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ARO";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL1686191";"F";"Antiproliferative activity against human HCT8 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1692923";"F";"Antiproliferative activity against human HCT8 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL837301";"F";"Compound was tested for growth inhibition of human non-small cell lung cancer NCI-H460 cell line";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1138726";"15546733";"10.1016/j.bmcl.2004.09.069";"2004";"Bioorg Med Chem Lett";"14";"6075";"6078";"";"";"";"";"";""
"CHEMBL621654";"F";"Synergism with sulindac in A549 cells";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"A549";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL1029860";"F";"Cytotoxicity against human HeLa cells";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1136853";"19147348";"10.1016/j.bmcl.2008.12.077";"2009";"Bioorg Med Chem Lett";"19";"1245";"1249";"";"";"";"";"";""
"CHEMBL746011";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL737898";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2.7 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL701390";"F";"Antiproliferative activity against drug-resistant tumor cell line KBMDR.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1132294";"10411476";"10.1021/jm9806087";"1999";"J Med Chem";"42";"2561";"2568";"";"";"";"";"";""
"CHEMBL901942";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 10 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL901953";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 100 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL788350";"T";"Acute iv toxicity against rat after a dose of injection";"Rattus norvegicus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"";"";"";"";""
"CHEMBL1941682";"F";"Growth inhibition of human KB cells after 72 hrs by methylene blue assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1938387";"22060033";"10.1021/jm201031f";"2011";"J Med Chem";"54";"8517";"8525";"";"";"";"";"";""
"CHEMBL735923";"F";"Increase in life span at the highest nontoxic dose against P-388 tumor cell after 1 day at 2.7 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122127";"7131483";"10.1021/jm00351a008";"1982";"J Med Chem";"25";"1045";"1050";"standard_type:DOSE standard_relation:= standard_value:2.7 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2076066";"F";"TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) in MDR1-expressing MDCK cells";"";"9";"9";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2074370";"12134945";"10.1023/a:1016140429238";"2002";"Pharm Res";"19";"765";"772";"";"";"";"";"";""
"CHEMBL1005198";"B";"Inhibition of beta tubulin polymerization at 20 uM";"";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1150335";"18457382";"10.1021/jm070890u";"2008";"J Med Chem";"51";"3094";"3103";"";"";"";"";"";""
"CHEMBL997605";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 31.6 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL853898";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 316 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL1004852";"F";"Cytotoxicity against human MRP1 expressing hamster BHK21 cells after 72 hrs by MTT assay";"Mesocricetus auratus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL1156492";"17646169";"10.1074/jbc.m703964200";"2007";"J Biol Chem";"282";"31542";"31548";"";"";"";"";"";""
"CHEMBL1218945";"F";"Growth inhibition of human Ovarian cancer cells after 48 hrs";"Homo sapiens";"26";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1963945";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ";"";"26355";"26576";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"Hs-578T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL737974";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL746016";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 6.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1266174";"F";"Antiproliferative activity against mouse astrocyte cells by MTT assay";"Mus musculus";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL662314";"F";"Cytostatic effect on human colon tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel colon (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1963895";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ";"";"39421";"39735";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-OV-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL742637";"F";"Number of survivors on 30th day at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL866245";"F";"Cytotoxicity against human WRL68 cells by clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WRL68";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL855056";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL738762";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 4 mg/kg per day";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL738759";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 4.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL737255";"F";"Increase in life span at the highest nontoxic dose against P-388 tumor cell after 1-9 day at 0.33 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122127";"7131483";"10.1021/jm00351a008";"1982";"J Med Chem";"25";"1045";"1050";"standard_type:DOSE standard_relation:= standard_value:0.33 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL739572";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 2 mg/kg per day";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL837016";"F";"Cytotoxic effect dissolved in DMSO against CNS cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CNS cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL825197";"F";"Growth inhibitory concentration dissolved in DMSO against human Colon cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Colon cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL833357";"F";"Cytotoxic activity against human tumor A-172 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A 172";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL834631";"F";"Cytotoxic activity against human tumor PLC/PRF/5 cell line";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL664337";"F";"Synergism with sulindac in DLKP cells";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"DLKP cell line";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL765161";"F";"Cytotoxic effect on human prostate tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel prostate (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1028627";"F";"Cytotoxicity against human NCI-H292 cells after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H292";"";"CHEMBL1158358";"19027993";"10.1016/j.ejmech.2008.10.006";"2009";"Eur J Med Chem";"44";"2038";"2043";"";"";"";"";"";""
"CHEMBL1028628";"F";"Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEp-2";"";"CHEMBL1158358";"19027993";"10.1016/j.ejmech.2008.10.006";"2009";"Eur J Med Chem";"44";"2038";"2043";"";"";"";"";"";""
"CHEMBL1964099";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ";"";"25166";"25375";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"BT-549";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1247204";"F";"Cytotoxicity against human KB cells after 48 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1240517";"20724170";"10.1016/j.bmc.2010.07.055";"2010";"Bioorg Med Chem";"18";"6725";"6733";"";"";"";"";"";""
"CHEMBL1018155";"F";"Ratio of IC50 for human KB 8.5 cells to IC50 for human KB cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL1964009";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ";"";"36915";"37215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"RXF 393";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL831551";"F";"Total growth inhibition of human Ovarian cell line at 10E-3 M concentration ";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Ovarian carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL836257";"F";"Growth inhibitory concentration dissolved in DMSO against human MG-MID cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel NCI-60 (60 carcinoma cell lines)";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL831456";"F";"Total growth inhibition of human CNS cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CNS cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL658403";"F";"Cytotoxic effect on human CNS tumor cell lines";"";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"Panel CNS (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1114586";"F";"Antiproliferative activity against human K562/A02 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/A02";"";"CHEMBL1157101";"20353152";"10.1021/jm9014394";"2010";"J Med Chem";"53";"3048";"3064";"";"";"";"";"";""
"CHEMBL3750043";"B";"Inhibition of bovine MAP rich tubulin polymerization at 1 uM measured every 2 mins for 30 mins by UV-visible spectrophotometric analysis";"Bos taurus";"1";"1";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3745707";"26762835";"10.1016/j.bmc.2015.11.045";"2016";"Bioorg Med Chem";"24";"521";"544";"";"";"";"";"";""
"CHEMBL837025";"F";"Cytotoxic effect dissolved in DMSO against NSCLC cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL3998528";"F";"Cytotoxicity against human CCRF-CEM/VBL cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"CCRF-CEM/VBL";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL3998530";"F";"Cytotoxicity against human PC3 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL4686044";"F";"Antiproliferative activity against human KB cells incubated for 48 hrs by SRB assay";"Homo sapiens";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL879314";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 0.22 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1930894";"F";"Resistance index, ratio of IC50 for vincristine-selected multi drug-resistant human KB cells to IC50 for human KB cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1926616";"22119124";"10.1016/j.ejmech.2011.11.011";"2012";"Eur J Med Chem";"47";"424";"431";"";"";"";"";"";""
"CHEMBL1794345";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"170142";"170462";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964037";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ";"";"40395";"40740";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL983440";"F";"Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at S phase at 1 uM by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1149784";"17573162";"10.1016/j.ejmech.2007.04.008";"2008";"Eur J Med Chem";"43";"429";"434";"";"";"";"";"";""
"CHEMBL738074";"F";"Number of survivors on 60th day at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL741076";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 1 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL737900";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2 mg/kg/day; 0/11";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL991281";"F";"Antiproliferative activity against human SMMC7721 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL1143300";"19111465";"10.1016/j.bmcl.2008.12.020";"2009";"Bioorg Med Chem Lett";"19";"755";"758";"";"";"";"";"";""
"CHEMBL761423";"F";"Long-term survivors (LTS) for 60 days at optimal dose of 3.0 mg/kg for antitumor activity against P388 leukemia cells in 15 mice.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125276";"2066973";"10.1021/jm00111a012";"1991";"J Med Chem";"34";"1998";"2003";"standard_type:DOSE standard_relation:= standard_value:3.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1614065";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";"";"183";"183";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1692927";"F";"Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL1697798";"A";"FDA HLAED, alkaline phosphatase increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1678152";"F";"Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay";"Plasmodium falciparum";"94";"94";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"3D7";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1671701";"20547797";"10.1128/aac.00431-10";"2010";"Antimicrob Agents Chemother";"54";"3597";"3604";"";"";"";"";"";""
"CHEMBL1909122";"B";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909138";"B";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909170";"B";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909142";"B";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909119";"B";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HT-29";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909120";"B";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909105";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614682";"A";"Volume of distribution at steady state in human after iv administration";"Homo sapiens";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL932492";"F";"Cytotoxicity against human KB cells assessed as cell viability after 48 hrs by MTS assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1142402";"18295490";"10.1016/j.bmc.2008.02.012";"2008";"Bioorg Med Chem";"16";"3608";"3615";"";"";"";"";"";""
"CHEMBL998464";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 316 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997604";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 10 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL998462";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 100 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL3239653";"F";"Cytotoxicity against human melanoma cells after 48 hrs";"Homo sapiens";"18";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL1020850";"F";"Cytotoxicity against human Hep2 cells after 48 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEp-2";"";"CHEMBL1159320";"11858754";"10.1021/np010206t";"2002";"J Nat Prod";"65";"189";"192";"";"";"";"";"";""
"CHEMBL3231997";"F";"Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.02 ug/ml";"Cricetulus griseus";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"";"";"";"";"";""
"CHEMBL1018154";"F";"Antiproliferative activity against human KBV1 cells after 3 days by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-V1";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL4259354";"F";"Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4257520";"30109000";"10.1039/C8MD00125A";"2018";"Medchemcomm";"9";"1131";"1141";"";"";"";"";"";""
"CHEMBL853892";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 0.3 nM";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL1828332";"F";"Antiproliferative activity against MDR-1 overexpressing human 786-0 cells in presence of MDR1 inhibitor verapamil";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"786-0";"";"CHEMBL1821642";"21774499";"10.1021/jm200454y";"2011";"J Med Chem";"54";"6014";"6027";"";"";"";"";"";""
"CHEMBL1799255";"F";"Cell cycle arrest in human HCT116 cells assessed as increase of phosphorylated histone H3 at Ser10 level at 150 nM after 24 hrs by Western blotting";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL4259355";"F";"Antiproliferative activity against human WM9 cells after 48 hrs by MTT assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4257520";"30109000";"10.1039/C8MD00125A";"2018";"Medchemcomm";"9";"1131";"1141";"";"";"";"";"";""
"CHEMBL741227";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 2 mg/kg/day; 0/10";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1613836";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) ";"Homo sapiens";"31975";"32120";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137738";"T";"Comments (NB not yet translated). [column 'COMMENTAIRES' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137736";"T";"Animal toxicity known. [column 'TOXIC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL901944";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 100 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1686319";"F";"Antiproliferative activity against human KBVIN cells expressing P-glycoprotein after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KBVIN";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1738606";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398]";"Homo sapiens";"13828";"13960";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2032788";"F";"Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at G2 phase after 24 hrs by FACS analysis (Rvb = 26.1%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PLC-PRF-5";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL4482060";"F";"Cytotoxicity against human KB/S cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4480449";"30869890";"10.1021/acs.jnatprod.8b00919";"2019";"J Nat Prod";"82";"850";"858";"";"";"";"";"";""
"CHEMBL942828";"F";"Cytotoxicity against human KB/VJ300 cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL1141328";"17939738";"10.1021/np0703747";"2007";"J Nat Prod";"70";"1783";"1789";"";"";"";"";"";""
"CHEMBL1697778";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans";"Homo sapiens";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL824968";"F";"Inhibition of human non-small cell lung cancer A549 cell proliferation";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1138726";"15546733";"10.1016/j.bmcl.2004.09.069";"2004";"Bioorg Med Chem Lett";"14";"6075";"6078";"";"";"";"";"";""
"CHEMBL2428394";"F";"Cytotoxicity against taxol-resistant human MX1 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MX1";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL4155617";"A";"Cytotoxicity against human LO2 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL887777";"F";"Growth inhibition of human A2780 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1139973";"17490878";"10.1016/j.bmcl.2007.04.030";"2007";"Bioorg Med Chem Lett";"17";"3722";"3728";"";"";"";"";"";""
"CHEMBL900702";"F";"Cytotoxicity against human HT29 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL4310852";"F";"Potentiation of cisplatin-induced cytotoxicity against human A2780/CDDP cells assessed as cisplatin IC50 at 10 uM after 48 hrs by MTT assay (Rvb = 43.11 nM)";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL901950";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 3.16 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL987565";"B";"Inhibition of tubulin polymerization in rat C6 cells after 4 hrs";"Rattus norvegicus";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL4155623";"F";"Growth inhibition of human SMMC7721 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL989466";"F";"Cytotoxicity against human HO8910 cells by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HO8910";"";"CHEMBL1147261";"14695795";"10.1021/np030278f";"2003";"J Nat Prod";"66";"1554";"1557";"";"";"";"";"";""
"CHEMBL746663";"F";"Number of survivors on 60th day at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL2078493";"F";"TP_TRANSPORTER: drug resistance in BCRP-expressing MEF3.8 cells";"";"7";"7";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MEF3.8";"";"CHEMBL2074346";"12649196";"None";"2003";"Cancer Res";"63";"1339";"1344";"";"";"";"";"";""
"CHEMBL3137729";"T";"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3595576";"F";"Antiproliferative activity against human KB-S15 cells expressing P-gp170/MDR after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-S15";"";"CHEMBL3593220";"26160020";"10.1016/j.bmc.2015.06.043";"2015";"Bioorg Med Chem";"23";"4230";"4236";"";"";"";"";"";""
"CHEMBL1930890";"F";"Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1926616";"22119124";"10.1016/j.ejmech.2011.11.011";"2012";"Eur J Med Chem";"47";"424";"431";"";"";"";"";"";""
"CHEMBL3860277";"B";"Inhibition of bovine brain tubulin polymerization at 5 uM measured every minute for 1 hr by spectrophotometric method";"Bos taurus";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL3137727";"T";"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1008921";"F";"Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"44";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1008915";"F";"Antitumor activity against human NSCLC cells after 48 hrs by SRB assay";"Homo sapiens";"16";"51";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL3090245";"F";"Cytotoxicity against human NCI-H157 cells at 100 uM after 24 hrs by sulforhodamine B assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3085736";"24215819";"10.1016/j.ejmech.2013.10.053";"2013";"Eur J Med Chem";"70";"685";"691";"";"";"";"";"";""
"CHEMBL901943";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 31.6 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1008920";"F";"Antitumor activity against human renal cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1008919";"F";"Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"49";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1614456";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL961503";"F";"Cytotoxicity against human MCF7 cells by sulforhodamine B assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL3561978";"F";"PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"97";"98";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137731";"T";"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562146";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ";"";"1812";"1824";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2317045";"F";"Cell cycle arrest in human CAL33 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAL-33";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL1738442";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]";"Homo sapiens";"90360";"91293";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909176";"B";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"KAN-TS";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909161";"B";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909151";"B";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2216651";"F";"Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL1614678";"A";"Volume of distribution at steady state in dog after iv administration";"Canis lupus familiaris";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9615";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL4296190";"F";"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";"Cryptococcus neoformans";"6133";"6235";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 208821";"CO-ADD antimicrobial screening data";"5207";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL1014437";"F";"Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-VIN10 cells after 72 hrs by methylene blue dye assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1151752";"19053773";"10.1021/jm8008635";"2008";"J Med Chem";"51";"8163";"8167";"";"";"";"";"";""
"CHEMBL932493";"F";"Cytotoxicity against multidrug resistant P-gp expressing human KBV20C cells assessed as cell viability after 48 hrs by MTS assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KBV20C";"";"CHEMBL1142402";"18295490";"10.1016/j.bmc.2008.02.012";"2008";"Bioorg Med Chem";"16";"3608";"3615";"";"";"";"";"";""
"CHEMBL1909108";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909092";"B";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909172";"B";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909179";"B";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909198";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909102";"B";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909154";"B";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697802";"A";"FDA HLAED, gamma-glutamyl transferase (GGT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL900704";"F";"Cytotoxicity against human OE19 cells after 72 hrs by MTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OE19";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909194";"B";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076257";"F";"TP_TRANSPORTER: drug resistance in MRP1-expressing HEK293 cells";"";"5";"11";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"";"CHEMBL2074511";"12867490";"10.1124/dmd.31.8.1016";"2003";"Drug Metab Dispos";"31";"1016";"1026";"";"";"";"";"";""
"CHEMBL1909117";"B";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909096";"B";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909099";"B";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"Bacillus cereus";"871";"1742";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"1396";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909213";"B";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL991283";"F";"Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase at 0.1 uM after 12 hrs by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1143300";"19111465";"10.1016/j.bmcl.2008.12.020";"2009";"Bioorg Med Chem Lett";"19";"755";"758";"";"";"";"";"";""
"CHEMBL1963918";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ";"";"1001";"1008";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"P388/ADR";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL981353";"F";"Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL1799246";"F";"Cell cycle arrest in human HCT116 cells assessed as accumulation at S phase at 150 nM after 24 hrs by FACS analysis (Rvb = 8.5 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL1614421";"B";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"Homo sapiens";"49165";"49809";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2032767";"F";"Antiproliferative activity against human SNU475 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-475";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3562152";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ";"";"1822";"1837";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1004853";"F";"Cytotoxicity against hamster BHK21 cells after 72 hrs by MTT assay";"Mesocricetus auratus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL1156492";"17646169";"10.1074/jbc.m703964200";"2007";"J Biol Chem";"282";"31542";"31548";"";"";"";"";"";""
"CHEMBL2169430";"A";"Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL1908292";"B";"Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay";"Canis lupus familiaris";"60";"60";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL986545";"F";"Cytotoxicity against human colon cancer cells";"Homo sapiens";"14";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL986550";"F";"Cytotoxicity against human prostate cancer cells";"Homo sapiens";"14";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL1963976";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ";"";"27593";"27827";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-N";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964017";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ";"";"28020";"28262";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DU-145";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150100";"F";"Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150101";"F";"Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150102";"F";"Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150105";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150109";"F";"Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL708163";"F";"Cytotoxic effect on human leukemia tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel leukemia (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL819387";"F";"Cytotoxic effect on human breast tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel breast (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL3396261";"F";"Drug resistance index, ratio of IC50 for doxorubicin-resistant human MCF7 cells to IC50 for human MCF7 cells";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL1109128";"F";"Growth inhibition of human renal cancer cell by NCI-CLS assay";"Homo sapiens";"18";"51";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1109127";"F";"Growth inhibition of human ovarian cancer cell by NCI-CLS assay";"Homo sapiens";"18";"48";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1109122";"F";"Growth inhibition of human leukemia cell by NCI-CLS assay";"Homo sapiens";"18";"40";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1109124";"F";"Growth inhibition of human colon cancer cell by NCI-CLS assay";"Homo sapiens";"18";"50";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1218941";"F";"Growth inhibition of human NSCLC cells after 48 hrs";"Homo sapiens";"26";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL855605";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL746672";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as percent ratio of median survival time of treated mice to control mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1218944";"F";"Growth inhibition of human melanoma cells after 48 hrs";"Homo sapiens";"26";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1008922";"F";"Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"50";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1008917";"F";"Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"53";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL3529284";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL1964066";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ";"";"40373";"40696";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"TK-10";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL881118";"F";"Cytostatic effect on human breast tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel breast (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL756391";"F";"Compound was tested for % increase in life span of P388 tumor";"Mus musculus";"6";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL821657";"F";"The compound was evaluated in vitro for the inhibition of murine leukemia P388D1 cell proliferation.";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL2032734";"A";"Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 1 to 10 uM after 48 hrs by propidium iodide incorporation assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL901961";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 31.6 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1008916";"F";"Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay";"Homo sapiens";"16";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL910676";"F";"Ratio of IC50 for KBV1 cells to IC50 for KB cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KBV1";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL855610";"F";"Antiproliferative activity against adriamycin resistant P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL855055";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL853894";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 3.16 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL872809";"F";"The compound was evaluated in vitro for the inhibition of P388D1 cell colony formation.";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL4029349";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1613803";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855045";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL913042";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 0.3 nM";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL658402";"F";"Inhibition of proliferation in NCI human CNS tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel CNS (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL910675";"F";"Ratio of IC50 for KB8.5 cells to IC50 for KB cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL3856803";"F";"Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 18.8 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL853901";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 1 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL853902";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 3.16 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL1963953";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ";"";"40772";"41108";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"786-0";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1000969";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.8 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL981349";"F";"Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3282243";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL712027";"F";"Cytotoxicity against MCF-7/Adr cells.";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL1130080";"9207950";"10.1021/jm9700169";"1997";"J Med Chem";"40";"2102";"2106";"";"";"";"";"";""
"CHEMBL1697801";"A";"FDA HLAED, lactate dehydrogenase (LDH) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1692926";"F";"Antiproliferative activity against human DU145 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"44";"44";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL4142110";"A";"Cytotoxicity against golden hamster BHK21 cells at 100 uM after 48 hrs by sulforhodamine B assay";"Mesocricetus auratus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL846831";"F";"Chemosensitizing index is the ratio of IC50 (vincristine) to that of IC50 (vincristine+sinensetin)";"";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL3603699";"F";"Cytotoxicity against human PC3 cells after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3600380";"26270803";"10.1021/acs.jnatprod.5b00031";"2015";"J Nat Prod";"78";"2123";"2127";"";"";"";"";"";""
"CHEMBL2427015";"T";"Toxicity in KM mouse allografted with mouse H22 cells assessed as body weight at 0.5 mg/kg, ip administered on day 1 and 4 measured on day 8 (Rvb = 30 +/- 3.24 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"KM";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL703766";"F";"Concentration that causes a mitotic index (number of cells in mitosis divided by total cells) of 0.5 for cultured lymphoid leukemia L1210 cells during an exposure period of 12 h";"Mus musculus";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125562";"1479582";"10.1021/jm00104a005";"1992";"J Med Chem";"35";"4809";"4812";"";"";"";"";"";""
"CHEMBL1909307";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909315";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL4482061";"F";"Cytotoxicity against human KB/VJ300 cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL4480449";"30869890";"10.1021/acs.jnatprod.8b00919";"2019";"J Nat Prod";"82";"850";"858";"";"";"";"";"";""
"CHEMBL1614414";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) ";"Saccharomyces cerevisiae";"8343";"8361";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"4932";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL761079";"F";"Compound was evaluated for antitumor activity against mice implanted with lymphatic leukemia P388 cells (10e6 tumor cells) after intraperitoneal administration of 2 mg/kg per injection (1-5 days)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126221";"1433180";"10.1021/jm00098a014";"1992";"J Med Chem";"35";"3686";"3690";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL834614";"F";"Cytotoxic activity against human tumor NCI-H295 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H295";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL4259353";"F";"Antiproliferative activity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4257520";"30109000";"10.1039/C8MD00125A";"2018";"Medchemcomm";"9";"1131";"1141";"";"";"";"";"";""
"CHEMBL4252846";"F";"Cytotoxicity against mouse 4T1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Mus musculus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL3231914";"F";"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.6 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3231906";"F";"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/S";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.36 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3231910";"F";"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.6 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL1000968";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 4 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL1000970";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.16 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL981352";"F";"Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3239654";"F";"Cytotoxicity against human ovarian cancer cells after 48 hrs";"Homo sapiens";"18";"46";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL998463";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 100 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997595";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 0.3 nM after 24 hrs by FACS analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL888638";"F";"Growth inhibition of Pgp deficient MCF7/VP cells expressing MRP1";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7-VP";"";"CHEMBL1145421";"17567121";"10.1021/jm070194u";"2007";"J Med Chem";"50";"3290";"3301";"";"";"";"";"";""
"CHEMBL890774";"F";"Cytotoxicity against SMMC7721 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL1146228";"17604394";"10.1021/np070069l";"2007";"J Nat Prod";"70";"1114";"1117";"";"";"";"";"";""
"CHEMBL888487";"F";"Antitumor activity against colon tumor cells";"Homo sapiens";"15";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL988383";"F";"Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP";"Rattus norvegicus";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL998841";"F";"Cytotoxicity against vincristine sensitive human KB/S cells";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/S";"";"CHEMBL1156666";"18778099";"10.1021/np800435c";"2008";"J Nat Prod";"71";"1591";"1594";"";"";"";"";"";""
"CHEMBL1001109";"F";"Cytotoxicity against human SNU423 cells after 48 hrs by alamar blue assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-423";"";"CHEMBL1140891";"19117761";"10.1016/j.bmc.2008.12.002";"2009";"Bioorg Med Chem";"17";"512";"522";"";"";"";"";"";""
"CHEMBL1001107";"F";"Cytotoxicity against human MDA-MB-231 cells after 48 hrs by alamar blue assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1140891";"19117761";"10.1016/j.bmc.2008.12.002";"2009";"Bioorg Med Chem";"17";"512";"522";"";"";"";"";"";""
"CHEMBL3283011";"F";"Antitumor activity against mouse Gardner lymphosarcoma cell allografted in mouse at 0.1 to 0.2 mg/kg/day, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL739745";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 2.5 mg/kg per day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1000972";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.0064 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL1811488";"F";"Cytotoxic activity against drug-resistant MDR1-deficient human NCI/ADR cells expressing Pgp after 48 hrs by sulforhodamine B assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL703372";"F";"Concentration that inhibits proliferation of cultured lymphoid leukemia L1210 cells to 50% control growth during 48 h";"Mus musculus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125562";"1479582";"10.1021/jm00104a005";"1992";"J Med Chem";"35";"4809";"4812";"";"";"";"";"";""
"CHEMBL997593";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 0.3 nM after 24 hrs by FACS analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL1964047";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41644";"41993";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"U-251";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL702770";"F";"Fraction of cell population of cultured lymphoid leukemia L1210 cells in mitosis at a dose of 0.3 uM after 24 hr";"Mus musculus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122127";"7131483";"10.1021/jm00351a008";"1982";"J Med Chem";"25";"1045";"1050";"";"";"";"";"";""
"CHEMBL1964059";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41127";"41477";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-19";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL913041";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 0.1 nM";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL836253";"F";"Growth inhibitory concentration dissolved in DMSO against human Renal cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Renal cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL855038";"F";"Anticancer activity against colon cancer cell lines of NCI60 panel";"Homo sapiens";"9";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel colon (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL855041";"F";"Anticancer activity against ovarian cancer cell lines of NCI60 panel";"Homo sapiens";"10";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel ovarian (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL855037";"F";"Anticancer activity against NSCLC cancer cell lines of NCI60 panel";"Homo sapiens";"10";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL855044";"F";"Anticancer activity against breast cancer cell lines of NCI60 panel";"Homo sapiens";"10";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel breast (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL855043";"F";"Anticancer activity against prostate cancer cell lines of NCI60 panel";"Homo sapiens";"8";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel prostate (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL739569";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 1 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1820600";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1964055";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ";"";"251";"251";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900701";"F";"Cytotoxicity against human A549 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL901945";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 316 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL900700";"F";"Cytotoxicity against human Aro cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ARO";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1963860";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ";"";"37184";"37494";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCC 2998";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909134";"B";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909086";"B";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909118";"B";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HUVEC";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614673";"A";"Mean residence time in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1614674";"A";"Half life in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1614681";"A";"Clearance in human after iv administration";"Homo sapiens";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL4122015";"F";"Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4118137";"29678463";"10.1016/j.bmcl.2018.04.019";"2018";"Bioorg Med Chem Lett";"28";"1817";"1824";"";"";"";"";"";""
"CHEMBL1909190";"B";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909158";"B";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909114";"B";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909174";"B";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900717";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 0.1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909196";"B";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"Rheumatoid synovial fibroblasts";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909090";"B";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963885";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ";"";"28139";"28384";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"PC-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909128";"B";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL866242";"F";"Cytotoxicity against human MCF7 cells by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL887781";"F";"Growth inhibition of multidrug-resistant human 2780AD cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780 ADR";"";"CHEMBL1139973";"17490878";"10.1016/j.bmcl.2007.04.030";"2007";"Bioorg Med Chem Lett";"17";"3722";"3728";"";"";"";"";"";""
"CHEMBL703880";"F";"Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1148410";"14761187";"10.1021/jm030918b";"2004";"J Med Chem";"47";"849";"858";"";"";"";"";"";""
"CHEMBL1037456";"F";"Cytotoxicity against human HT-29 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1155979";"19679470";"10.1016/j.bmcl.2009.07.090";"2009";"Bioorg Med Chem Lett";"19";"5496";"5499";"";"";"";"";"";""
"CHEMBL1037457";"F";"Cytotoxicity against human A549 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1155979";"19679470";"10.1016/j.bmcl.2009.07.090";"2009";"Bioorg Med Chem Lett";"19";"5496";"5499";"";"";"";"";"";""
"CHEMBL1037459";"F";"Cytotoxicity against human MKN28 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MKN-28";"";"CHEMBL1155979";"19679470";"10.1016/j.bmcl.2009.07.090";"2009";"Bioorg Med Chem Lett";"19";"5496";"5499";"";"";"";"";"";""
"CHEMBL2032787";"F";"Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at G1 phase after 24 hrs by FACS analysis (Rvb = 66.8%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PLC-PRF-5";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL1694084";"F";"Growth inhibition of dog MDCK2 cells in presence of P-glycoprotein inhibitor LY335979";"Canis lupus familiaris";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9615";"";"";"MDCK-II";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1738317";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]";"Homo sapiens";"24903";"24918";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2032754";"F";"Antiproliferative activity against human Bel7402 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bel-7402";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3282234";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1964087";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40248";"40590";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H322M";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1114581";"F";"Antiproliferative activity against human K562 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1157101";"20353152";"10.1021/jm9014394";"2010";"J Med Chem";"53";"3048";"3064";"";"";"";"";"";""
"CHEMBL4028921";"A";"Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL1015234";"F";"Growth inhibition of human Pgp170 overexpressing multidrug resistant-KB-TAX50 cells after 72 hrs by methylene blue dye assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1151752";"19053773";"10.1021/jm8008635";"2008";"J Med Chem";"51";"8163";"8167";"";"";"";"";"";""
"CHEMBL986552";"F";"Cytotoxicity against human leukemia cells";"Homo sapiens";"17";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL744424";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4 mg/kg/day; 0/10";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1964007";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ";"";"40987";"41343";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-28";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1247689";"A";"Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay";"Chlorocebus sabaeus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL1240463";"20619938";"10.1016/j.ejmech.2010.06.029";"2010";"Eur J Med Chem";"45";"4403";"4408";"";"";"";"";"";""
"CHEMBL866247";"F";"Cytotoxicity against human KB cells by clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL3995438";"F";"Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay";"Homo sapiens";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL1964015";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ";"";"1040";"1047";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SN12K1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1218942";"F";"Growth inhibition of human colon cancer cells after 48 hrs";"Homo sapiens";"26";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL704656";"F";"Compound was evaluated for its cytotoxicity against vincristine-sensitive KB/S human oral epidermoid carcinoma cell lines.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1130866";"9873417";"10.1016/s0960-894x(98)00294-7";"1998";"Bioorg Med Chem Lett";"8";"1693";"1696";"";"";"";"";"";""
"CHEMBL3995440";"F";"Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL1267250";"F";"Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay";"Plasmodium falciparum HB3";"496";"521";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"137071";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL4412034";"F";"Antiproliferative activity against human taxol-resistant A549/TR cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549/TR";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL1060434";"F";"Cytotoxicity against multidrug-resistant human KB/VCR cells by SRB assay in presence of MDR reversing agent verapamil";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDR";"";"CHEMBL1151957";"19637874";"10.1021/jm900342g";"2009";"J Med Chem";"52";"5115";"5123";"";"";"";"";"";""
"CHEMBL888946";"F";"Ratio of IC50 for KB8.5 cells to IC50 for KB cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL1964006";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ";"";"41564";"41913";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HT-29";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL658404";"F";"Cytostatic effect on human CNS tumor cell lines";"";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"Panel CNS (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL823207";"F";"Cytotoxic effect on human ovarian tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel ovarian (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL708160";"F";"Inhibition of proliferation in NCI human leukemia tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel leukemia (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL832913";"F";"Growth inhibitory concentration dissolved in DMSO against human leukemia cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL831464";"F";"Total growth inhibition of human MG-MID cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel NCI-60 (60 carcinoma cell lines)";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL833941";"F";"Compound was tested for inhibition of tubulin polymerisation";"";"17";"17";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1138726";"15546733";"10.1016/j.bmcl.2004.09.069";"2004";"Bioorg Med Chem Lett";"14";"6075";"6078";"";"";"";"";"";""
"CHEMBL831460";"F";"Total growth inhibition of human NSCLC cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL755408";"F";"Increase in the life span of mice implanted with lymphocytic leukemia P388 at the highest nontoxic dose of 1.5 mg/kg given to the compound intraperitoneally";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124678";"2795608";"10.1021/jm00130a023";"1989";"J Med Chem";"32";"2363";"2367";"standard_type:DOSE standard_relation:= standard_value:1.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL833731";"F";"Growth inhibitory concentration dissolved in DMSO against human Melanoma cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL1964049";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ";"";"40562";"40898";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-5";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL687850";"F";"Tested for cytotoxicity against HT-29 (MDR)cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1145018";"12502374";"10.1021/jm0203027";"2003";"J Med Chem";"46";"194";"196";"";"";"";"";"";""
"CHEMBL1964021";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ";"";"40703";"41045";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-5";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL834653";"F";"Cytotoxic activity against human tumor Mia Paca 2 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Paca 2";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL739566";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia cells intraperitoneally at a dose of 0.22 mg/kg per day for 1-9 scheduled days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL901956";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 0.1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL900385";"F";"Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase at 0.01 uM after 24 hrs by flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1137541";"17889547";"10.1016/j.bmc.2007.07.046";"2007";"Bioorg Med Chem";"15";"7368";"7379";"";"";"";"";"";""
"CHEMBL1026803";"F";"Antitumor activity against mouse P388 cells xenografted mouse assessed as increase in life span relative to control";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1151404";"7161602";"10.1021/np50024a005";"1982";"J Nat Prod";"45";"679";"686";"";"";"";"";"";""
"CHEMBL1930892";"F";"Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1926616";"22119124";"10.1016/j.ejmech.2011.11.011";"2012";"Eur J Med Chem";"47";"424";"431";"";"";"";"";"";""
"CHEMBL1055751";"F";"Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL1055752";"F";"Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL958047";"F";"Effect on cell morphology in human U87 MG cells assessed as disruption of microtubule network at 10 nM by confocal fluorescence microscopy";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL1150769";"18513974";"10.1016/j.bmc.2008.04.071";"2008";"Bioorg Med Chem";"16";"6436";"6447";"";"";"";"";"";""
"CHEMBL1613838";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"21944";"21990";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1941685";"F";"Growth inhibition of human KB-VIN10 cells after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL1938387";"22060033";"10.1021/jm201031f";"2011";"J Med Chem";"54";"8517";"8525";"";"";"";"";"";""
"CHEMBL2078487";"F";"TP_TRANSPORTER: intracellular accumulation in Bsep-expressing LLC-PK1 cells";"";"7";"7";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074223";"10617675";"None";"2000";"Mol Pharmacol";"57";"24";"35";"";"";"";"";"";""
"CHEMBL1963935";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line. (Class of assay: confirmatory) ";"";"11325";"11391";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"RXF 631";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963929";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ";"";"41263";"41617";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"IGROV-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL703333";"F";"Cytotoxicity was evaluated against KB-C2 cells at 0.1 ug/mL; No cytotoxicity";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB 3-1";"";"CHEMBL1132809";"11086720";"10.1016/s0960-894x(00)00502-3";"2000";"Bioorg Med Chem Lett";"10";"2521";"2524";"";"";"";"";"";""
"CHEMBL833371";"F";"Cytotoxic activity against human tumor Hep G2 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL1963901";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40342";"40685";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H460";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL658288";"F";"Inhibition against CRFF-CEM-T-Cell leukemic cell line";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1124592";"2769688";"10.1021/jm00129a023";"1989";"J Med Chem";"32";"2158";"2162";"";"";"";"";"";""
"CHEMBL700544";"F";"Compound concentration required to reduce the cell proliferation of Wild type and drug-resistant KB subclones passaged in the presence of etoposide 7 uM by 50%";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1135654";"12431048";"10.1021/jm020913z";"2002";"J Med Chem";"45";"5205";"5216";"";"";"";"";"";""
"CHEMBL1211492";"F";"Cell cycle arrest in human KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by FACS analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1208684";"20537765";"10.1016/j.ejmech.2010.04.032";"2010";"Eur J Med Chem";"45";"3420";"3438";"";"";"";"";"";""
"CHEMBL735807";"F";"Percent increase in life span at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL742030";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1963911";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ";"";"38809";"39125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"CAKI-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL751414";"F";"Cytostatic effect on human non-small cell lung carcinoma tumor cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1941686";"F";"Growth inhibition of human KB-7d cells after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-7d";"";"CHEMBL1938387";"22060033";"10.1021/jm201031f";"2011";"J Med Chem";"54";"8517";"8525";"";"";"";"";"";""
"CHEMBL621653";"F";"Synergism with indomethacin in A549 cells";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"A549";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL744419";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL705970";"F";"Effect on the proliferation Wild -type and Drug- resistant KB subclones passaged in the presence of vincristine 0.02 uM";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1135654";"12431048";"10.1021/jm020913z";"2002";"J Med Chem";"45";"5205";"5216";"";"";"";"";"";""
"CHEMBL735806";"F";"Percent increase in life span at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1963954";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"13960";"14049";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-78";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL887766";"F";"Cytotoxicity against COLO205 cells";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 205";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL916633";"A";"Cytotoxicity against human SMMC7721 cells after 48 hrs";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL1139860";"17432904";"10.1021/np0700570";"2007";"J Nat Prod";"70";"830";"834";"";"";"";"";"";""
"CHEMBL2150110";"F";"Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1026800";"F";"Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 5 ug/disk after 12 days by potato disk assay";"Agrobacterium tumefaciens";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"B6";"Scientific Literature";"358";"";"";"";"";"CHEMBL1151404";"7161602";"10.1021/np50024a005";"1982";"J Nat Prod";"45";"679";"686";"";"";"";"";"";""
"CHEMBL998466";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G1 phase accumulation at 316 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL1799253";"F";"Induction of apoptosis in human HCT116 cells at 150 nM after 24 hrs using FITC-TUNEL staining by flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL756541";"F";"Compound was tested for % increase in life span of vincristine resistant P388 tumor";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL739814";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as in the presence of vincristine at 0.1 mg/kg as the ratio of median survival time of treated mice to control mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | NERVOUS SYSTEM";"Leukemia Oncology Models | Neoplasm Oncology Models | Central Analgesic Activity";"P388 Experimental Leukemia | Neoplasms | Chemotherapy Induced Pain for Peripheral Neuropathic Pain";"";""
"CHEMBL1109123";"F";"Growth inhibition of human NSCLC cell by NCI-CLS assay";"Homo sapiens";"18";"50";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1157784";"20395150";"10.1016/j.bmc.2010.03.063";"2010";"Bioorg Med Chem";"18";"3004";"3011";"";"";"";"";"";""
"CHEMBL1694086";"F";"Ratio of GI50 for dog MDCK2-MDR1 cells overexpressing human P-glycoprotein to GI50 for dog MDCK2 cells";"Canis lupus familiaris";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9615";"";"";"MDCK-II";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL742594";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1738184";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]";"Homo sapiens";"77876";"78260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697797";"A";"FDA HLAED, liver enzyme composite activity";"Homo sapiens";"486";"1470";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1697780";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents";"";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL900386";"F";"Cell cycle arrest in MDA-MB-231 cells by accumulation at G2/M phase at 0.1 uM after 24 hrs by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1137541";"17889547";"10.1016/j.bmc.2007.07.046";"2007";"Bioorg Med Chem";"15";"7368";"7379";"";"";"";"";"";""
"CHEMBL738769";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 6.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL742031";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1032705";"F";"Selectivity index, ratio of CC50 for african green monkey Vero cells to CC50 for human HeLa cells";"";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"Vero";"";"CHEMBL1158392";"19217699";"10.1016/j.ejmech.2009.01.014";"2009";"Eur J Med Chem";"44";"2468";"2472";"";"";"";"";"";""
"CHEMBL954125";"F";"Growth inhibition of human Jurkat cells";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Jurkat";"";"CHEMBL1139285";"19026536";"10.1016/j.bmcl.2008.10.111";"2009";"Bioorg Med Chem Lett";"19";"234";"236";"";"";"";"";"";""
"CHEMBL1026801";"F";"Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 2.5 ug/disk after 12 days by potato disk assay";"Agrobacterium tumefaciens";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"B6";"Scientific Literature";"358";"";"";"";"";"CHEMBL1151404";"7161602";"10.1021/np50024a005";"1982";"J Nat Prod";"45";"679";"686";"";"";"";"";"";""
"CHEMBL872416";"F";"Antiproliferative activity against drug-resistant tumor cell line KBwt.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1132294";"10411476";"10.1021/jm9806087";"1999";"J Med Chem";"42";"2561";"2568";"";"";"";"";"";""
"CHEMBL819386";"F";"Inhibition of proliferation in NCI human breast tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel breast (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL696195";"F";"Cytotoxicity tested against Hela C1 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1131902";"10612603";"10.1016/s0960-894x(99)00610-1";"1999";"Bioorg Med Chem Lett";"9";"3381";"3386";"";"";"";"";"";""
"CHEMBL986544";"F";"Cytotoxicity against human Non-small cell lung carcinoma cells";"Homo sapiens";"17";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL986546";"F";"Cytotoxicity against human central nervous system cancer cells";"Homo sapiens";"18";"41";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL986551";"F";"Cytotoxicity against human breast cancer cells";"Homo sapiens";"18";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL833359";"F";"Cytotoxic activity against human tumor HT-29 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL826399";"F";"Cytotoxic activity against human tumor SW 13 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SW 13";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL817771";"B";"beta-Tubulin GTPase activity at 1 uM concentration.";"";"4";"4";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1134638";"11741473";"10.1021/jm010940+";"2001";"J Med Chem";"44";"4535";"4553";"";"";"";"";"";""
"CHEMBL2114784";"F";"PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ";"Homo sapiens";"53812";"54032";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909087";"B";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL978157";"F";"Inhibition of Agrobacterium tumefaciens-induced tumor growth in potato tuber disk after 21 days";"Agrobacterium tumefaciens";"30";"30";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"358";"";"";"";"";"CHEMBL1155941";"18650096";"10.1016/j.bmc.2008.07.009";"2008";"Bioorg Med Chem";"16";"7691";"7697";"";"";"";"";"";""
"CHEMBL626815";"A";"Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.";"";"14";"14";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1130080";"9207950";"10.1021/jm9700169";"1997";"J Med Chem";"40";"2102";"2106";"";"";"";"";"";""
"CHEMBL1909160";"B";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909180";"B";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909100";"B";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614146";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) ";"Homo sapiens";"31975";"32120";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909106";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909200";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909104";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909197";"B";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909201";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614679";"A";"Clearance in monkey after iv administration";"Macaca";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9539";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL1614675";"A";"Clearance in rat after iv administration";"Rattus norvegicus";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL1614671";"A";"Clearance in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1614677";"A";"Clearance in dog after iv administration";"Canis lupus familiaris";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9615";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL1909210";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900696";"F";"Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL900699";"F";"Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909202";"B";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909150";"B";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa S3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909152";"B";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2089575";"B";"Inhibition of MAP rich tubulin polymerization in bovine brain at 1 uM after 5 mins by spectrophotometric analysis";"Bos taurus";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL2086284";"22587519";"10.1021/jm300176j";"2012";"J Med Chem";"55";"5174";"5187";"";"";"";"";"";""
"CHEMBL756539";"F";"Compound was tested for % increase in life span of adriamycin resistant P388 tumor";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL823208";"F";"Cytostatic effect on human ovarian tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel ovarian (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2066357";"F";"Cytotoxicity against human COLON cells after 48 hrs";"Homo sapiens";"22";"48";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL3368795";"F";"Cytotoxicity against human CCRF-CEM cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3995436";"F";"Antiproliferative activity against mouse 4T1 cells after 48 hrs by MTT assay";"Mus musculus";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL2169417";"A";"Selectivity index, ratio of IC50 for human liver OATP1B1 to IC50 for OATP1B3";"Homo sapiens";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL4689433";"F";"Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4680354";"33477020";"10.1016/j.bmc.2020.115960";"2021";"Bioorg Med Chem";"32";"115960";"115960";"";"";"";"";"";""
"CHEMBL702198";"F";"Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1148410";"14761187";"10.1021/jm030918b";"2004";"J Med Chem";"47";"849";"858";"";"";"";"";"";""
"CHEMBL901960";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 10 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL899159";"F";"Cytotoxicity against human multidrug resistant Lucena1 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1137538";"17889544";"10.1016/j.bmc.2007.07.020";"2007";"Bioorg Med Chem";"15";"7355";"7360";"";"";"";"";"";""
"CHEMBL900374";"F";"Antiproliferative activity against human MDA-MB-231 cells after 4 days by microplate assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1137541";"17889547";"10.1016/j.bmc.2007.07.046";"2007";"Bioorg Med Chem";"15";"7368";"7379";"";"";"";"";"";""
"CHEMBL900375";"F";"Antiproliferative activity against human MCF7 cells after 5 days by microplate assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1137541";"17889547";"10.1016/j.bmc.2007.07.046";"2007";"Bioorg Med Chem";"15";"7368";"7379";"";"";"";"";"";""
"CHEMBL2428395";"F";"Cytotoxicity against human MX1 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MX1";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL3214913";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ";"";"4591";"5133";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282227";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.2 mg/kg/day, ip after 1 day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562085";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL910671";"A";"Cytotoxicity against COLO205 cells";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 205";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL910674";"F";"Antiproliferative activity against KBV1 cells expressing MDR1";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-V1";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL3534613";"A";"Drug excretion in iv dosed human assessed as compound excreted into bile after 72 hrs by T-tube method";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL1738552";"F";"PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4155624";"F";"Growth inhibition of human SMMC7721 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3124558";"F";"Cytotoxicity against human MDA-MB-231 cells after 72 hrs by CellTitre-Blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3120073";"24437936";"10.1021/np4008014";"2014";"J Nat Prod";"77";"536";"542";"";"";"";"";"";""
"CHEMBL3529770";"A";"Unbound biliary clearance in iv dosed Sprague-Dawley rat";"Rattus norvegicus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL853889";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 100 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL853893";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 1 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL2321354";"F";"Cell cycle arrest in human HL60 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL1738369";"F";"PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"Jurkat";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150104";"F";"Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1909314";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3822010";"F";"Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL2032736";"A";"Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by propidium iodide incorporation assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL2150106";"F";"Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL3108431";"B";"Inhibition of tubulin polymerization (unknown origin) at 20 uM by spectrophotometric analysis";"Homo sapiens";"11";"11";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3102857";"24360827";"10.1016/j.bmc.2013.12.004";"2014";"Bioorg Med Chem";"22";"848";"855";"";"";"";"";"";""
"CHEMBL3108432";"F";"Antiproliferative activity against human HeLa cells after 72 hrs by SRB assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3102857";"24360827";"10.1016/j.bmc.2013.12.004";"2014";"Bioorg Med Chem";"22";"848";"855";"";"";"";"";"";""
"CHEMBL2024773";"F";"Ratio of GI50 for human vincristine-resistance KB cells to GI50 for wild type human KB cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2021899";"22465634";"10.1016/j.bmcl.2012.03.037";"2012";"Bioorg Med Chem Lett";"22";"3219";"3222";"";"";"";"";"";""
"CHEMBL2032753";"F";"Antiproliferative activity against human MHCC97H after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MHCC97H";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL742245";"F";"Number of survivors on 60th day at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL3239868";"F";"Anticancer activity against Syrian golden hamster BHK21 cells at 1 uM after 48 hrs by SRB assay";"Mesocricetus auratus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL3239869";"F";"Anticancer activity against Syrian golden hamster BHK21 cells at 0.1 uM after 48 hrs by SRB assay";"Mesocricetus auratus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL2422404";"B";"Inhibition of porcine brain tubulin polymerization at 1 uM measured every 30 seconds for 30 mins";"Sus scrofa";"2";"2";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL2417372";"23916255";"10.1016/j.bmcl.2013.06.083";"2013";"Bioorg Med Chem Lett";"23";"5223";"5227";"";"";"";"";"";""
"CHEMBL1964030";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ";"";"40735";"41067";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"K562";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3866637";"F";"Antiproliferative activity against human KB cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL1018156";"F";"Ratio of IC50 for human KBV1 cells to IC50 for human KB cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KBV1";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL997590";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 0.1 nM after 24 hrs by FACS analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997602";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 10 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997594";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 0.3 nM after 24 hrs by FACS analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL2216647";"F";"Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL2216650";"F";"Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL1963960";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ";"";"41287";"41632";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UACC-257";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2182531";"F";"Cytotoxicity against human HCT116 cells";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL2177037";"22247789";"10.1021/ml200236a";"2011";"ACS Med Chem Lett";"2";"948";"952";"";"";"";"";"";""
"CHEMBL834628";"F";"inhibitory concentration against human MDR KB/V cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB 3-1";"";"CHEMBL1137855";"15324905";"10.1016/j.bmcl.2004.06.089";"2004";"Bioorg Med Chem Lett";"14";"4767";"4770";"";"";"";"";"";""
"CHEMBL2169431";"A";"Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL856011";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL866250";"F";"Cytotoxicity against human Colo320DM cells by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 320DM";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL853890";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 316 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL833386";"F";"Cytotoxic activity against human tumor Ovcar-3 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL1909204";"B";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909147";"B";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909144";"B";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3748559";"B";"Displacement of [3H]-paclitaxel from biotinylated porcine tubulin after 25 mins by competitive binding assay";"Sus scrofa";"12";"12";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3745658";"26580420";"10.1021/acs.jmedchem.5b01312";"2015";"J Med Chem";"58";"9309";"9333";"";"";"";"";"";""
"CHEMBL888485";"F";"Antitumor activity against leukemia cells";"Homo sapiens";"15";"41";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL4155628";"A";"Growth inhibition of human LO2 cells at 0.1 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL1804783";"A";"Cytotoxicity against vincristine-sensitive human KB cells in presence of 0.1 ug/ml vincristine";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1799972";"21428274";"10.1021/np200008g";"2011";"J Nat Prod";"74";"1309";"1312";"";"";"";"";"";""
"CHEMBL961499";"F";"Cytotoxicity against human KB-VIN cells by sulforhodamine B assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL1963985";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"41631";"41977";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H23";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1799361";"B";"Inhibition of alpha-tubulin polymerization in human HT1080 cells assessed as disruption of microtubule structures at 100 nM after 4 hrs using Hoechst staining by fluorescence microscopic analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HT-1080";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL2032759";"F";"Antiproliferative activity against human JHH4 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3231475";"F";"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.20 mg/kg, ip administered daily for 8 to 10 days";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P1534";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1908285";"A";"Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1014436";"F";"Growth inhibition of human KB cells after 72 hrs by methylene blue dye assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1151752";"19053773";"10.1021/jm8008635";"2008";"J Med Chem";"51";"8163";"8167";"";"";"";"";"";""
"CHEMBL664817";"F";"Synergism with tolmedin in DLKP cells";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"DLKP cell line";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL739576";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 0.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL741231";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 0.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL739018";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intraperitoneally at a dose of 1 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL737412";"T";"Acute iv toxicity against mice after a dose of injection";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"";"";"";"";""
"CHEMBL1614550";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based HTS Dose Confirmation to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"184";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL989465";"F";"Cytotoxicity against human SMMC7721 cells by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL1147261";"14695795";"10.1021/np030278f";"2003";"J Nat Prod";"66";"1554";"1557";"";"";"";"";"";""
"CHEMBL1114585";"F";"Antiproliferative activity against human KB cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1157101";"20353152";"10.1021/jm9014394";"2010";"J Med Chem";"53";"3048";"3064";"";"";"";"";"";""
"CHEMBL1656795";"B";"Displacement of [3H]colchicine from tubulin at 30 uM";"";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1649061";"21126027";"10.1021/jm100659v";"2011";"J Med Chem";"54";"179";"200";"";"";"";"";"";""
"CHEMBL1738312";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]";"Homo sapiens";"55525";"55724";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1692930";"F";"Antiproliferative activity against human KBVIN cells after 3 days by sulforhodamine B assay";"Homo sapiens";"40";"40";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KBVIN";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL901959";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 3.16 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL3603697";"F";"Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL3600380";"26270803";"10.1021/acs.jnatprod.5b00031";"2015";"J Nat Prod";"78";"2123";"2127";"";"";"";"";"";""
"CHEMBL825195";"F";"Growth inhibitory concentration dissolved in DMSO against human CNS cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CNS cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL997596";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 1 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL997603";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 10 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL662299";"F";"Effect on cross resistance of chinese hamster cells resistant to Actinomycin D.";"Cricetulus griseus";"12";"12";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10029";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL1114587";"F";"Antiproliferative activity against human KB/VCR cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL1157101";"20353152";"10.1021/jm9014394";"2010";"J Med Chem";"53";"3048";"3064";"";"";"";"";"";""
"CHEMBL3529286";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL821746";"F";"Inhibition of proliferation in NCI human prostate tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel prostate (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL701387";"F";"Antiproliferative activity against drug-resistant tumor cell line KBCamp.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1132294";"10411476";"10.1021/jm9806087";"1999";"J Med Chem";"42";"2561";"2568";"";"";"";"";"";""
"CHEMBL1963844";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ";"";"38877";"39199";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL836259";"F";"Growth inhibitory concentration dissolved in DMSO against human Ovarian cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Ovarian carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL739002";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1964091";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ";"";"39577";"39897";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-4";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964095";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ";"";"1024";"1031";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"P388";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1029859";"F";"Cytotoxicity against human MCF7 cells";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1136853";"19147348";"10.1016/j.bmcl.2008.12.077";"2009";"Bioorg Med Chem Lett";"19";"1245";"1249";"";"";"";"";"";""
"CHEMBL738998";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1964048";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ";"";"41865";"42213";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-8";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964043";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40357";"40693";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-62";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL738763";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 5.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL744418";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 2 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL744421";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 4.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL998459";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 31.6 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL1008925";"F";"Cell cycle arrest in human HT-29 cells assessed as accumulation at G2/M phase at 30 nM after 24 hrs by flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL998461";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 100 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL991282";"F";"Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase at 3.2 uM after 12 hrs by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1143300";"19111465";"10.1016/j.bmcl.2008.12.020";"2009";"Bioorg Med Chem Lett";"19";"755";"758";"";"";"";"";"";""
"CHEMBL3739135";"F";"Cytotoxicity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3734715";"26522953";"10.1016/j.bmcl.2015.10.040";"2015";"Bioorg Med Chem Lett";"25";"5597";"5600";"";"";"";"";"";""
"CHEMBL3739138";"F";"Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3734715";"26522953";"10.1016/j.bmcl.2015.10.040";"2015";"Bioorg Med Chem Lett";"25";"5597";"5600";"";"";"";"";"";""
"CHEMBL1963887";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"14897";"14993";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DMS-114";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963882";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ";"";"28394";"28635";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MCF7";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231998";"F";"Mitotic arrest in CHO cells assessed as increase in cell accumulation at 0.002 ug/ml";"Cricetulus griseus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"";"";"";"";"";""
"CHEMBL1963868";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ";"";"41234";"41579";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCT-15";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1826867";"F";"Cytotoxicity against vincristine-resistant human KB cells over expressing P-glycoprotein after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL916635";"A";"Cytotoxicity against human L02 cells after 48 hrs";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL1139860";"17432904";"10.1021/np0700570";"2007";"J Nat Prod";"70";"830";"834";"";"";"";"";"";""
"CHEMBL3396161";"F";"Antiproliferative activity against human A2780 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3396166";"F";"Antiproliferative activity against doxorubicin-resistant human MCF7 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3128355";"B";"Competitive inhibition of dog brain tubulin using BODIPY FL-vinblastine as substrate at 10 uM incubated for 30 mins prior to substrate addition measured after 30 mins by fluorescence assay";"Canis lupus familiaris";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9615";"";"";"";"";"CHEMBL3124791";"24502232";"10.1021/jm4016526";"2014";"J Med Chem";"57";"1390";"1402";"";"";"";"";"";""
"CHEMBL2388148";"F";"Cytotoxicity against human CNS cancer cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL1908291";"B";"Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM";"Spodoptera frugiperda";"60";"60";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"7108";"";"";"Sf9";"Membrane";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL836255";"F";"Growth inhibitory concentration dissolved in DMSO against human Breast cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Breast carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL1964072";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ";"";"41891";"42241";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SW-620";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963994";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ";"";"37749";"38068";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HL-60";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL620275";"F";"In vitro inhibitory concentration required against human lung A549 carcinoma cells proliferation";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1134048";"11140731";"10.1016/s0960-894x(00)00578-3";"2001";"Bioorg Med Chem Lett";"11";"5";"8";"";"";"";"";"";""
"CHEMBL702225";"F";"Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant KB subclones passaged in the presence of doxorubicin 0.09 uM by 50%";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1135654";"12431048";"10.1021/jm020913z";"2002";"J Med Chem";"45";"5205";"5216";"";"";"";"";"";""
"CHEMBL888492";"F";"Antitumor activity against ovarian tumor cells";"Homo sapiens";"15";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL888490";"F";"Antitumor activity against renal tumor cells";"Homo sapiens";"15";"43";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL888491";"F";"Antitumor activity against prostate tumor cells";"Homo sapiens";"15";"40";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL888637";"F";"Growth inhibition of NCI/ADR cells expressing Pgp/MRP1";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR";"";"CHEMBL1145421";"17567121";"10.1021/jm070194u";"2007";"J Med Chem";"50";"3290";"3301";"";"";"";"";"";""
"CHEMBL900716";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at sub Go phase at 0.1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL831469";"F";"Total growth inhibition of human Leukemia cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL2032751";"F";"Antiproliferative activity against human PLC/PRF/5 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PLC-PRF-5";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2032762";"F";"Antiproliferative activity against human SNU182 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-182";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2032764";"F";"Antiproliferative activity against human SNU398 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2032785";"F";"Cell cycle arrest in human SNU398 cells assessed as accumulation at G2 phase after 24 hrs by FACS analysis (Rvb = 38.2%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL961505";"F";"Cytotoxicity against human PC3 cells by sulforhodamine B assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL1964081";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ";"";"1025";"1028";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1768335";"B";"Inhibition of pig tubulin polymerization at 3 uM";"Sus scrofa";"1";"1";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL1764957";"21459004";"10.1016/j.bmc.2011.03.005";"2011";"Bioorg Med Chem";"19";"2659";"2665";"";"";"";"";"";""
"CHEMBL1963876";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41148";"41498";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-268";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963866";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"38557";"38887";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-75";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963880";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40605";"40938";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"EKVX ";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1247690";"F";"Cytotoxicity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1240463";"20619938";"10.1016/j.ejmech.2010.06.029";"2010";"Eur J Med Chem";"45";"4403";"4408";"";"";"";"";"";""
"CHEMBL986549";"F";"Cytotoxicity against human renal cancer cells";"Homo sapiens";"18";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL1799357";"F";"Induction of apoptosis in human HCT116 cells at 150 nM after 48 hrs using FITC-TUNEL staining by flow cytometry (Rvb = 7.3 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL1006005";"B";"Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control";"Homo sapiens";"189";"189";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL1150338";"18457386";"10.1021/jm7015683";"2008";"J Med Chem";"51";"3275";"3287";"";"";"";"";"";""
"CHEMBL2428521";"F";"Cytotoxicity against human BxPC3 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"BXPC-3";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL1020849";"F";"Cytotoxicity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1159320";"11858754";"10.1021/np010206t";"2002";"J Nat Prod";"65";"189";"192";"";"";"";"";"";""
"CHEMBL861041";"F";"Cytotoxicity against human PT45 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PT-45";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL1964075";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"37652";"37966";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H522";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL991280";"F";"Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1143300";"19111465";"10.1016/j.bmcl.2008.12.020";"2009";"Bioorg Med Chem Lett";"19";"755";"758";"";"";"";"";"";""
"CHEMBL3529281";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL942827";"F";"Cytotoxicity against human KB cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1141328";"17939738";"10.1021/np0703747";"2007";"J Nat Prod";"70";"1783";"1789";"";"";"";"";"";""
"CHEMBL2032752";"F";"Antiproliferative activity against human SMMC7721 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2032756";"F";"Antiproliferative activity against human HepG2 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3603698";"F";"Cytotoxicity against human HeLa cells after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3600380";"26270803";"10.1021/acs.jnatprod.5b00031";"2015";"J Nat Prod";"78";"2123";"2127";"";"";"";"";"";""
"CHEMBL2032760";"F";"Antiproliferative activity against human JHH7 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL1816742";"F";"Cell cycle arrest in human KB/HeLa cells assessed as accumulation of cells at G2/M phase after 24 hrs by flow cytometry";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1811833";"21705223";"10.1016/j.bmc.2011.06.010";"2011";"Bioorg Med Chem";"19";"4183";"4191";"";"";"";"";"";""
"CHEMBL903354";"F";"Cytotoxicity againt multidrug-resistant human 2780AD cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780 ADR";"";"CHEMBL1139110";"17239597";"10.1016/j.bmcl.2006.09.068";"2007";"Bioorg Med Chem Lett";"17";"1122";"1126";"";"";"";"";"";""
"CHEMBL3998527";"F";"Cytotoxicity against human CCRF-CEM cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL954127";"F";"Cytotoxicity against human Jurkat cells in presence and relative to TRAIL";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Jurkat";"";"CHEMBL1139285";"19026536";"10.1016/j.bmcl.2008.10.111";"2009";"Bioorg Med Chem Lett";"19";"234";"236";"";"";"";"";"";""
"CHEMBL1001110";"F";"Cytotoxicity against human UCI101 cells after 48 hrs by alamar blue assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UCI101";"";"CHEMBL1140891";"19117761";"10.1016/j.bmc.2008.12.002";"2009";"Bioorg Med Chem";"17";"512";"522";"";"";"";"";"";""
"CHEMBL664818";"F";"Drug interaction towards DLKP cell line was determined in terms of combination index in presence of Indomethacin; Not available";"";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"DLKP cell line";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL1008914";"F";"Antitumor activity against human Leukemia cells after 48 hrs by SRB assay";"Homo sapiens";"16";"49";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL858445";"P";"Partition coefficient (logP)";"";"25";"25";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1121459";"7392035";"10.1021/jm00180a022";"1980";"J Med Chem";"23";"682";"684";"";"";"";"";"";""
"CHEMBL900698";"F";"Cytotoxicity against human Ovcar3 cells after 72 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1614544";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"36150";"36356";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL703879";"F";"Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1148410";"14761187";"10.1021/jm030918b";"2004";"J Med Chem";"47";"849";"858";"";"";"";"";"";""
"CHEMBL1909116";"B";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909140";"B";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909207";"B";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614076";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]";"Homo sapiens";"10028";"10069";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909189";"B";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HIT-T15";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL866248";"F";"Cytotoxicity against human PA1 cells by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PA-1";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL866251";"F";"Cytotoxicity against human Colo320DM cells by clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"COLO 320DM";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL822051";"F";"Cytostatic effect on human melanoma tumor cell lines";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel melanoma (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL873221";"F";"Antiproliferative activity against drug-resistant tumor cell line KBV20C.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1132294";"10411476";"10.1021/jm9806087";"1999";"J Med Chem";"42";"2561";"2568";"";"";"";"";"";""
"CHEMBL822046";"F";"Inhibition of proliferation in NCI human melanoma tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel melanoma (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1794424";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771]";"";"30566";"30997";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1037458";"F";"Cytotoxicity against human HepG2 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1155979";"19679470";"10.1016/j.bmcl.2009.07.090";"2009";"Bioorg Med Chem Lett";"19";"5496";"5499";"";"";"";"";"";""
"CHEMBL831549";"F";"Total growth inhibition of human Melanoma cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL1694089";"F";"Growth inhibition of pig LLC-PK1 cells in presence of P-glycoprotein inhibitor LY335979";"Sus scrofa";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9823";"";"";"LLC-PK1";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL3239650";"F";"Cytotoxicity against human leukemia cells after 48 hrs";"Homo sapiens";"18";"43";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL998378";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 100 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL1000973";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 0.00128 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL3239871";"F";"Anticancer activity against human NCI-H157 cells at 10 uM after 48 hrs by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL3239872";"F";"Anticancer activity against human NCI-H157 cells at 1 uM after 48 hrs by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL2439156";"F";"Antitrypanosomal activity against bloodstream form of Trypanosoma brucei brucei 427 after 3 days by Alamar Blue assay";"Trypanosoma brucei brucei";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"427";"Scientific Literature";"5702";"";"";"";"";"CHEMBL2434842";"23927763";"10.1021/jm4004279";"2013";"J Med Chem";"56";"7727";"7740";"";"";"";"";"";""
"CHEMBL1811487";"F";"Cytotoxic activity against drug-sensitive Pgp-, MRP1-deficient human MCF7 cells after 48 hrs by sulforhodamine B assay in presence of 50 nM vinblastin";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL2166271";"B";"Inhibition of horse BChE at 2 mg/ml by Ellman's method";"Equus caballus";"500";"501";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9796";"";"";"";"";"CHEMBL2163249";"23062825";"10.1016/j.bmc.2012.09.040";"2012";"Bioorg Med Chem";"20";"6669";"6679";"";"";"";"";"";""
"CHEMBL1218947";"F";"Growth inhibition of human prostate cancer cells after 48 hrs";"Homo sapiens";"26";"70";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1697730";"A";"Human drug-induced liver injury (DILI) modelling dataset from Ekins et al";"Homo sapiens";"529";"532";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697723";"20843939";"10.1124/dmd.110.035113";"2010";"Drug Metab Dispos";"38";"2302";"2308";"";"";"";"";"";""
"CHEMBL861038";"F";"Cytotoxicity against human Aro cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"ARO";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL861034";"F";"Cytotoxicity against human HepG2 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL861035";"F";"Cytotoxicity against human H295R cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H295R";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL861043";"F";"Cytotoxicity against mouse BNL cells by MTT assay";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"BNL";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL1909091";"B";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1026802";"F";"Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 1.5 ug/disk after 12 days by potato disk assay";"Agrobacterium tumefaciens";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"B6";"Scientific Literature";"358";"";"";"";"";"CHEMBL1151404";"7161602";"10.1021/np50024a005";"1982";"J Nat Prod";"45";"679";"686";"";"";"";"";"";""
"CHEMBL1697799";"A";"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909187";"B";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1032703";"F";"Cytotoxicity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1158392";"19217699";"10.1016/j.ejmech.2009.01.014";"2009";"Eur J Med Chem";"44";"2468";"2472";"";"";"";"";"";""
"CHEMBL1909103";"B";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909123";"B";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Erythrocyte";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909157";"B";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695208";"F";"In vitro cytotoxic activity against colon adenocarcinoma (HT-29) cells assayed by inhibition of [3H]-labeled thymidine incorporation";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1134309";"11728191";"10.1021/jm010974h";"2001";"J Med Chem";"44";"4462";"4467";"";"";"";"";"";""
"CHEMBL991279";"F";"Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bel-7402";"";"CHEMBL1143300";"19111465";"10.1016/j.bmcl.2008.12.020";"2009";"Bioorg Med Chem Lett";"19";"755";"758";"";"";"";"";"";""
"CHEMBL900710";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909167";"B";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900712";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL900711";"F";"Cell cycle arrest in human A549 cells assessed as accumulation at G1 phase at 0.1 uM after 24 hrs";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909175";"B";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"SK-N-MC";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1809630";"B";"Effect on bovine brain microtubule depolymerization assessed as decrease in absorbance at wavelength 340 nm after 15 mins";"Bos taurus";"14";"14";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL667652";"F";"In vitro cytotoxic activity against prostate carcinoma (DU-145) cells assayed by inhibition of [3H]-labeled thymidine incorporation";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL1134309";"11728191";"10.1021/jm010974h";"2001";"J Med Chem";"44";"4462";"4467";"";"";"";"";"";""
"CHEMBL998842";"F";"Cytotoxicity against vincristine resistant human KB/VJ300 cells";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL1156666";"18778099";"10.1021/np800435c";"2008";"J Nat Prod";"71";"1591";"1594";"";"";"";"";"";""
"CHEMBL958552";"F";"Cytotoxicity against human CCRF-CEM cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1158863";"9392881";"10.1021/np970226o";"1997";"J Nat Prod";"60";"1125";"1129";"";"";"";"";"";""
"CHEMBL1826866";"F";"Drug resistance index, ratio of IC50 for vincristine-resistant human KB cells to IC50 for human KB cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL704902";"F";"Concentration required to inhibit proliferation of cultured lymphoid leukemia L1210 cells to 50% growth over 48 hours";"Mus musculus";"43";"43";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126221";"1433180";"10.1021/jm00098a014";"1992";"J Med Chem";"35";"3686";"3690";"";"";"";"";"";""
"CHEMBL2078578";"F";"TP_TRANSPORTER: intracellular accumulation in MDR1-expressing LLC-PK1 cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074223";"10617675";"None";"2000";"Mol Pharmacol";"57";"24";"35";"";"";"";"";"";""
"CHEMBL1614342";"F";"PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"18552";"18602";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL888943";"F";"Antiproliferative activity against KB cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL2076219";"F";"TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells";"";"22";"22";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Sf9";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL890271";"F";"Cytotoxicity against human KB cells by SRB microtiter plate assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1145456";"17585747";"10.1021/jm061366a";"2007";"J Med Chem";"50";"3674";"3680";"";"";"";"";"";""
"CHEMBL700543";"F";"Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1135654";"12431048";"10.1021/jm020913z";"2002";"J Med Chem";"45";"5205";"5216";"";"";"";"";"";""
"CHEMBL855609";"F";"Antiproliferative activity against MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL836381";"F";"Compound was tested for growth inhibition of human colon carcinoma HCT116 cell line";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1138726";"15546733";"10.1016/j.bmcl.2004.09.069";"2004";"Bioorg Med Chem Lett";"14";"6075";"6078";"";"";"";"";"";""
"CHEMBL704718";"F";"Tested for the inhibition of L1210 cell proliferation.";"Mus musculus";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125276";"2066973";"10.1021/jm00111a012";"1991";"J Med Chem";"34";"1998";"2003";"";"";"";"";"";""
"CHEMBL2182532";"F";"Cytotoxicity against mouse L1210 cells";"Mus musculus";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL2177037";"22247789";"10.1021/ml200236a";"2011";"ACS Med Chem Lett";"2";"948";"952";"";"";"";"";"";""
"CHEMBL1686192";"F";"Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL3998531";"F";"Cytotoxicity against human NCI-H460 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL3995434";"F";"Antiproliferative activity against human A549 cells after 48 hrs by MTT assay";"Homo sapiens";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL742246";"F";"Number of survivors on 60th day at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL826249";"F";"Compound was tested for inhibition of tubulin polymerisation at 1 uM";"";"3";"3";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1138726";"15546733";"10.1016/j.bmcl.2004.09.069";"2004";"Bioorg Med Chem Lett";"14";"6075";"6078";"";"";"";"";"";""
"CHEMBL947537";"B";"Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method";"Saccharomyces cerevisiae";"26";"26";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1150198";"1812211";"10.1021/np50078a006";"1991";"J Nat Prod";"54";"1522";"1530";"";"";"";"";"";""
"CHEMBL4029350";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1909310";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909316";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909320";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909311";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909313";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL983441";"F";"Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at G2/M phase at 1 uM by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1149784";"17573162";"10.1016/j.ejmech.2007.04.008";"2008";"Eur J Med Chem";"43";"429";"434";"";"";"";"";"";""
"CHEMBL983438";"F";"Cell cycle arrest in human OVCAR-3 cells assessed as accumulation at subG0 phase at 1 uM by flow cytometry";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1149784";"17573162";"10.1016/j.ejmech.2007.04.008";"2008";"Eur J Med Chem";"43";"429";"434";"";"";"";"";"";""
"CHEMBL4028922";"A";"Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"Homo sapiens";"598";"598";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL4028923";"A";"Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL901947";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 0.1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL901957";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 0.3 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL1909319";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL2428397";"F";"Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL3239870";"F";"Anticancer activity against human NCI-H157 cells at 100 uM after 48 hrs by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL3384910";"F";"Cytotoxicity against human NCI-H157 cells by sulforhodamine B assay";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3352388";"25257911";"10.1016/j.bmc.2014.08.026";"2014";"Bioorg Med Chem";"22";"6163";"6173";"";"";"";"";"";""
"CHEMBL888493";"F";"Antitumor activity against breast tumor cells";"Homo sapiens";"15";"43";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL961504";"F";"Cytotoxicity against human HCT8 cells by sulforhodamine B assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL997591";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 0.1 nM after 24 hrs by FACS analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL1108963";"P";"Octanol-water partition coefficient, log P of the compound";"";"55";"55";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1157036";"20106561";"10.1016/j.ejmech.2009.12.043";"2010";"Eur J Med Chem";"45";"1639";"1647";"";"";"";"";"";""
"CHEMBL1964086";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"12281";"12354";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"XF498";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964077";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ";"";"41347";"41698";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"KM12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL853899";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 0.1 nM";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL759423";"F";"Compound was tested for T/C range at optimal dose of 3.0 mg/kg for antitumor activity against P388 leukemia cells in mice; value ranges from 165-181";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1125276";"2066973";"10.1021/jm00111a012";"1991";"J Med Chem";"34";"1998";"2003";"standard_type:DOSE standard_relation:= standard_value:3.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1964092";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ";"";"38953";"39286";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"LOX IMVI ";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL862161";"F";"Cytotoxicity against human HeLa cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL1614087";"F";"PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ";"Mus musculus";"51951";"52238";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10090";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614090";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5&apos;UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";"";"2071";"2071";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL944955";"F";"Induction of apoptosis in human SNU398 cells assessed as caspase activation after 24 hrs by HTS assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL1140741";"18197614";"10.1021/jm7010657";"2008";"J Med Chem";"51";"417";"423";"";"";"";"";"";""
"CHEMBL1963848";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ";"";"14290";"14389";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"KM-20L2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2343800";"F";"Cytotoxicity against human KB-VIN10 cells after 72 hrs by SRB assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL2331340";"23360284";"10.1021/jm301788a";"2013";"J Med Chem";"56";"1544";"1563";"";"";"";"";"";""
"CHEMBL750707";"F";"In vitro cytotoxic activity against nonsmall cell lung carcinoma (NCI-H460) cells assayed by inhibition of [3H]-labeled thymidine incorporation";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1134309";"11728191";"10.1021/jm010974h";"2001";"J Med Chem";"44";"4462";"4467";"";"";"";"";"";""
"CHEMBL3822011";"F";"Cytotoxicity against human A2780 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL1020852";"A";"Cytotoxicity against CHO cells after 48 hrs by MTT assay";"Cricetulus griseus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL1159320";"11858754";"10.1021/np010206t";"2002";"J Nat Prod";"65";"189";"192";"";"";"";"";"";""
"CHEMBL1799243";"F";"Cell cycle arrest in human HCT116 cells assessed as accumulation at sub-G1 phase at 150 nM after 24 hrs by FACS analysis (Rvb = 6.2 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL1799245";"F";"Cell cycle arrest in human HCT116 cells assessed as accumulation at G2/M phase at 150 nM after 24 hrs by FACS analysis (Rvb = 10.9 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL2024772";"F";"Cytotoxicity against human KB cells at 4 uM after 48 hrs by SRB assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2021899";"22465634";"10.1016/j.bmcl.2012.03.037";"2012";"Bioorg Med Chem Lett";"22";"3219";"3222";"";"";"";"";"";""
"CHEMBL1018093";"B";"Inhibition of HIV1 RT";"Human immunodeficiency virus 1";"152";"153";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL1137798";"1710653";"10.1021/np50073a012";"1991";"J Nat Prod";"54";"143";"154";"";"";"";"";"";""
"CHEMBL958038";"F";"Antiproliferative activity against human MDA-MB-231 cells after 4 days by microplate assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1150769";"18513974";"10.1016/j.bmc.2008.04.071";"2008";"Bioorg Med Chem";"16";"6436";"6447";"";"";"";"";"";""
"CHEMBL961501";"F";"Selectivity index, ratio of ED50 for human KB cells to ED50 for vincristine-resistant human KB-VIN cells";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL961502";"F";"Cytotoxicity against human A549 cells by sulforhodamine B assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1150376";"18473435";"10.1021/jm701208v";"2008";"J Med Chem";"51";"3297";"3303";"";"";"";"";"";""
"CHEMBL888488";"F";"Antitumor activity against CNS tumor cells";"Homo sapiens";"15";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CNS tumor";"";"CHEMBL1145408";"17559205";"10.1021/jm070235m";"2007";"J Med Chem";"50";"3167";"3172";"";"";"";"";"";""
"CHEMBL1686316";"F";"Antiproliferative activity against human PC3 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1686318";"F";"Antiproliferative activity against human KB cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL704659";"F";"Compound was evaluated for its cytotoxicity against vincristine-resistant KB/VJ300 human oral epidermoid carcinoma cell lines.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1130866";"9873417";"10.1016/s0960-894x(98)00294-7";"1998";"Bioorg Med Chem Lett";"8";"1693";"1696";"";"";"";"";"";""
"CHEMBL3562088";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562092";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, green channel.   (Class of assay: confirmatory) ";"";"29";"29";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562096";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 ratio channel.   (Class of assay: confirmatory) ";"";"29";"29";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562112";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL901954";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 316 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL699927";"F";"Cytotoxicity was evaluated against KB CV-60 cells at 0.1 ug/mL; No cytotoxicity";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB 3-1";"";"CHEMBL1132809";"11086720";"10.1016/s0960-894x(00)00502-3";"2000";"Bioorg Med Chem Lett";"10";"2521";"2524";"";"";"";"";"";""
"CHEMBL2428396";"F";"Cytotoxicity against vincristine-resistant human KB cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL861037";"F";"Cytotoxicity against human MCF7 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL997599";"F";"Cell cycle arrest in human KB/HeLa cells assessed as S phase accumulation at 3.16 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL3562133";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529276";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3603695";"F";"Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3600380";"26270803";"10.1021/acs.jnatprod.5b00031";"2015";"J Nat Prod";"78";"2123";"2127";"";"";"";"";"";""
"CHEMBL1908286";"A";"Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL3871123";"T";"Cytotoxicity against human Chang cells by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Chang";"";"CHEMBL3870355";"28105271";"10.1021/acsmedchemlett.6b00313";"2017";"ACS Med Chem Lett";"8";"32";"37";"";"";"";"";"";""
"CHEMBL1032704";"A";"Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay";"Chlorocebus sabaeus";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL1158392";"19217699";"10.1016/j.ejmech.2009.01.014";"2009";"Eur J Med Chem";"44";"2468";"2472";"";"";"";"";"";""
"CHEMBL3529272";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3231994";"F";"Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as increase in host lifespan at 1.5 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3562049";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, blue channel.   (Class of assay: confirmatory) ";"";"30";"30";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL742720";"F";"Number of survivors on 30th day at dose 1.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL886026";"F";"Antiproliferative activity against human MDA-MB-231 cells after 4 days";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1143713";"17533132";"10.1016/j.bmc.2007.05.030";"2007";"Bioorg Med Chem";"15";"5122";"5136";"";"";"";"";"";""
"CHEMBL1909133";"B";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909085";"B";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3987361";"Submaxillary gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614680";"A";"Volume of distribution at steady state in monkey after iv administration";"Macaca";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9539";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL1909205";"B";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL965580";"B";"Inhibition of mouse brain MAOB";"Mus musculus";"241";"244";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1909186";"B";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL926279";"F";"Cytotoxicity against human KB/VJ300 cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL1140639";"17608533";"10.1021/np0701778";"2007";"J Nat Prod";"70";"1380";"1383";"";"";"";"";"";""
"CHEMBL1614137";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of of 5&apos;UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1827 (Project Summary), 1813 (Primary HTS)]";"";"2104";"2104";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2422400";"B";"Inhibition of tubulin polymerization in human NCI-H522 cells assessed as beta-tubulin accumulation in cytoskeletal fraction at 100 nM after 24 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"NCI-H522";"";"CHEMBL2417372";"23916255";"10.1016/j.bmcl.2013.06.083";"2013";"Bioorg Med Chem Lett";"23";"5223";"5227";"";"";"";"";"";""
"CHEMBL635404";"P";"Micelle/water partition coefficient (Pmic) of the compound was determined";"";"14";"14";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129683";"8691461";"10.1021/jm960068i";"1996";"J Med Chem";"39";"2621";"2624";"";"";"";"";"";""
"CHEMBL2169433";"A";"Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake incubated for 5 mins by scintillation counting";"Homo sapiens";"12";"24";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL1909318";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909312";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909317";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909308";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3995435";"F";"Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL1909309";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1250979";"F";"Anticancer activity against vincristine-resistant human Hep3B cells after 3 days by SRB assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Hep 3B2";"";"CHEMBL1250520";"20735140";"10.1021/jm100846r";"2010";"J Med Chem";"53";"6699";"6705";"";"";"";"";"";""
"CHEMBL739577";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 1.5 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL922492";"F";"Cell cycle arrest in human K562 cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by flow cytometry";"Homo sapiens";"59";"60";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1144837";"18293907";"10.1021/jm0708331";"2008";"J Med Chem";"51";"2307";"2310";"";"";"";"";"";""
"CHEMBL1686315";"F";"Antiproliferative activity against human 1A9 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"1A9";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1686190";"F";"Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1686317";"F";"Antiproliferative activity against human HepG2 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1681672";"21296579";"10.1016/j.bmc.2011.01.001";"2011";"Bioorg Med Chem";"19";"1816";"1822";"";"";"";"";"";""
"CHEMBL1692928";"F";"Antiproliferative activity against human HepG2 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL1692929";"F";"Antiproliferative activity against human KB cells after 3 days by sulforhodamine B assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL1694083";"F";"Growth inhibition of dog MDCK2-MDR1 cells overexpressing human P-glycoprotein";"Canis lupus familiaris";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9615";"";"";"MDCK-II";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL1692924";"F";"Antiproliferative activity against human PC3 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL1697800";"A";"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL738768";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 5 mg/kg per day";"Mus musculus";"4";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL3748554";"B";"Displacement of [3H]-colchicine from biotinylated porcine tubulin after 2 hrs by competitive binding assay";"Sus scrofa";"9";"9";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3745658";"26580420";"10.1021/acs.jmedchem.5b01312";"2015";"J Med Chem";"58";"9309";"9333";"";"";"";"";"";""
"CHEMBL705357";"F";"Mitotic index (fraction of cells in mitosis divided by total cells ) for cultured lymphoid leukemia L1210 cells";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124678";"2795608";"10.1021/jm00130a023";"1989";"J Med Chem";"32";"2363";"2367";"";"";"";"";"";""
"CHEMBL1694082";"F";"Growth inhibition of dog MDCK2 cells";"Canis lupus familiaris";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9615";"";"";"MDCK-II";"";"CHEMBL1687930";"21344920";"10.1021/jm100991m";"2011";"J Med Chem";"54";"1576";"1586";"";"";"";"";"";""
"CHEMBL703878";"F";"Antiproliferative activity against drug-resistant tumor cell line KB7D.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1132294";"10411476";"10.1021/jm9806087";"1999";"J Med Chem";"42";"2561";"2568";"";"";"";"";"";""
"CHEMBL853906";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 316 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL3282244";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL658287";"F";"Inhibitory concentration against human T-cell leukemic cell line (CRFF-CEM) in vitro";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1124428";"2918516";"10.1021/jm00123a030";"1989";"J Med Chem";"32";"674";"679";"";"";"";"";"";""
"CHEMBL2446774";"F";"Cytotoxicity against human KB-VIN10 cells overexpressing P-gp170/MDR assessed as growth inhibition after 72 hrs by methylene blue staining-based assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL2440102";"24106982";"10.1021/jm4011115";"2013";"J Med Chem";"56";"8008";"8018";"";"";"";"";"";""
"CHEMBL943165";"F";"Cytotoxicity against human A172 cells after 6 days";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A 172";"";"CHEMBL1141436";"18044843";"10.1021/np070270w";"2007";"J Nat Prod";"70";"1854";"1858";"";"";"";"";"";""
"CHEMBL855036";"F";"Anticancer activity against leukemia cancer cell lines of NCI60 panel";"Homo sapiens";"10";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel leukemia (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL2427180";"F";"Antitumor activity against mouse H22 cells allografted in KM mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered on day 1 and 4 measured on day 8 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2428522";"F";"Cytotoxicity against human HT-29 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL738393";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as range.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1963854";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"41955";"42298";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"A549";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL833385";"F";"Cytotoxic activity against human tumor Igrov-1 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"IGROV-1";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL853888";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 31.6 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL944953";"F";"Induction of apoptosis in human T47D cells assessed as caspase activation after 24 hrs by HTS assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"T47D";"";"CHEMBL1140741";"18197614";"10.1021/jm7010657";"2008";"J Med Chem";"51";"417";"423";"";"";"";"";"";""
"CHEMBL1964025";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ";"";"38812";"39141";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"Malme-3M";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909193";"B";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909173";"B";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL900705";"F";"Cytotoxicity against human OE33 cells after 72 hrs by MTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OE33";"";"CHEMBL1137570";"17915851";"10.1021/jm070534b";"2007";"J Med Chem";"50";"5509";"5513";"";"";"";"";"";""
"CHEMBL1909182";"B";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909107";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638255";"Striatum";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909084";"B";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909088";"B";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909115";"B";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"Escherichia coli";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1008926";"B";"Inhibition of ornithine decarboxylase in human HT-29 cells assessed as release of radioactive CO2 from [14C-carboxyl] ornithine";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1140214";"19006285";"10.1021/jm800827q";"2008";"J Med Chem";"51";"7508";"7513";"";"";"";"";"";""
"CHEMBL1909126";"B";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909146";"B";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909164";"B";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909110";"B";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Jurkat";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909113";"B";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909094";"B";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"MDCK";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909149";"B";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL913043";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 1 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL1737912";"F";"PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614672";"A";"Fraction unbound in human after iv administration";"Homo sapiens";"554";"554";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1964088";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ";"";"38535";"38847";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"RPMI-8226";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738494";"F";"PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964018";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"38940";"39248";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-539";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964063";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ";"";"27642";"27872";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-MB-231";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909178";"B";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638233";"Cerebellum";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909145";"B";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909159";"B";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4296187";"F";"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";"Pseudomonas aeruginosa";"24161";"24267";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 27853";"CO-ADD antimicrobial screening data";"287";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3384911";"A";"Cytotoxicity against African green monkey Vero cells by sulforhodamine B assay";"Chlorocebus sabaeus";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL3352388";"25257911";"10.1016/j.bmc.2014.08.026";"2014";"Bioorg Med Chem";"22";"6163";"6173";"";"";"";"";"";""
"CHEMBL4624687";"F";"Antiproliferative activity against human HL60 cells incubated for 2 days by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4622912";"32527555";"10.1016/j.bmcl.2020.127256";"2020";"Bioorg Med Chem Lett";"30";"127256";"127256";"";"";"";"";"";""
"CHEMBL878922";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3 mg/kg/day; 0/10";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1804782";"A";"Cytotoxicity in vincristine-resistant human KB/VJ300 cells in presence of 0.1 ug/ml vincristine";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL1799972";"21428274";"10.1021/np200008g";"2011";"J Nat Prod";"74";"1309";"1312";"";"";"";"";"";""
"CHEMBL739521";"F";"Percent increase in life span at dose 2 mg/kg/day in 10 mice implanted with P388 leukemia cell line";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL913045";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at S phase at 10 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL855054";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL2343798";"F";"Resistance factor, ratio of IC50 for human KB-VIN10 cells to IC50 for human KB cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL2331340";"23360284";"10.1021/jm301788a";"2013";"J Med Chem";"56";"1544";"1563";"";"";"";"";"";""
"CHEMBL1963921";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ";"";"28183";"28420";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-MB-435";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1114575";"F";"Antiproliferative activity against human MCF7 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1157101";"20353152";"10.1021/jm9014394";"2010";"J Med Chem";"53";"3048";"3064";"";"";"";"";"";""
"CHEMBL855042";"F";"Anticancer activity against renal cancer cell lines of NCI60 panel";"Homo sapiens";"10";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel renal (Carcinoma cell lines)";"";"CHEMBL1137368";"17154522";"10.1021/jm0607808";"2006";"J Med Chem";"49";"6922";"6924";"";"";"";"";"";""
"CHEMBL855052";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL2321355";"F";"Cell cycle arrest in human HT-29 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL1692925";"F";"Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1687889";"21284385";"10.1021/jm1011947";"2011";"J Med Chem";"54";"1244";"1255";"";"";"";"";"";""
"CHEMBL1024044";"F";"Antitumor activity against vincristine-resistant mouse P388 cells implanted in CDF1 mouse at 0.2 mg/kg assessed as median survival time relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1138436";"14987066";"10.1021/np030346y";"2004";"J Nat Prod";"67";"245";"256";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | NERVOUS SYSTEM";"Leukemia Oncology Models | Neoplasm Oncology Models | Central Analgesic Activity";"P388 Experimental Leukemia | Neoplasms | Chemotherapy Induced Pain for Peripheral Neuropathic Pain";"";""
"CHEMBL4346911";"A";"Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4346655";"30852384";"10.1016/j.ejmech.2019.02.071";"2019";"Eur J Med Chem";"169";"21";"28";"";"";"";"";"";""
"CHEMBL853897";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 100 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL861040";"F";"Cytotoxicity against human HT29 cells by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL823454";"F";"Cytotoxic effect on human colon tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel colon (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL888944";"F";"Antiproliferative activity against KB8.5 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL901940";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 0.3 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL901941";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL998465";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 316 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL619526";"F";"Drug interaction towards A549 cell line was determined in terms of combination index in presence of Tometin; Not available";"";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"A549";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL947536";"B";"Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method";"Bos taurus";"26";"26";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1150198";"1812211";"10.1021/np50078a006";"1991";"J Nat Prod";"54";"1522";"1530";"";"";"";"";"";""
"CHEMBL2032765";"F";"Antiproliferative activity against human SNU423 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-423";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL1247230";"F";"Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as down-regulation of Bcl-2 expression at 0.2 uM after 48 hrs by Western blotting";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL1240517";"20724170";"10.1016/j.bmc.2010.07.055";"2010";"Bioorg Med Chem";"18";"6725";"6733";"";"";"";"";"";""
"CHEMBL705548";"F";"Inhibitory activity against growth of L1210 cell line";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1131603";"9554885";"10.1021/jm970800t";"1998";"J Med Chem";"41";"1524";"1530";"";"";"";"";"";""
"CHEMBL1024045";"F";"Antitumor activity against vincristine-resistant mouse P388 cells implanted in CDF1 mouse at 0.1 mg/kg assessed as median survival time relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1138436";"14987066";"10.1021/np030346y";"2004";"J Nat Prod";"67";"245";"256";"standard_type:DOSE standard_relation:= standard_value:0.1 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | NERVOUS SYSTEM";"Leukemia Oncology Models | Neoplasm Oncology Models | Central Analgesic Activity";"P388 Experimental Leukemia | Neoplasms | Chemotherapy Induced Pain for Peripheral Neuropathic Pain";"";""
"CHEMBL2032763";"F";"Antiproliferative activity against human SNU387 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-387";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL739744";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 1 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2114780";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ";"Homo sapiens";"58729";"58906";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"SW480";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL759723";"F";"Compound was evaluated for in vitro growth inhibition activity against sensitive PC-6 cell line.";"Rattus norvegicus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"PC-6";"";"CHEMBL1130905";"9873473";"10.1016/s0960-894x(98)00344-8";"1998";"Bioorg Med Chem Lett";"8";"1997";"2000";"";"";"";"";"";""
"CHEMBL746024";"F";"Number of survivors on 30th day at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL739007";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 6.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2077634";"F";"TP_TRANSPORTER: intracellular accumulation in MRP2-expressing LLC PK1 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2073997";"10570049";"10.1124/mol.56.6.1219";"1999";"Mol Pharmacol";"56";"1219";"1228";"";"";"";"";"";""
"CHEMBL2076285";"F";"TP_TRANSPORTER: drug resistance in KB-VIN10 cells";"";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"KB-VIN10";"";"CHEMBL2074333";"15231674";"10.1158/0008-5472.can-03-3474";"2004";"Cancer Res";"64";"4621";"4628";"";"";"";"";"";""
"CHEMBL1963963";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ";"";"14626";"14722";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DLD-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1250978";"F";"Anticancer activity against human Hep3B cells after 3 days by SRB assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Hep 3B2";"";"CHEMBL1250520";"20735140";"10.1021/jm100846r";"2010";"J Med Chem";"53";"6699";"6705";"";"";"";"";"";""
"CHEMBL712288";"F";"Inhibition of proliferation in NCI 60 human tumor cell line panel, MG-MID represents mean value";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL831458";"F";"Total growth inhibition of human Colon cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Colon cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL867647";"F";"Microtubule disassembly in Ovcar3 cells at 5 uM";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1138193";"16539377";"10.1021/jm0510676";"2006";"J Med Chem";"49";"1910";"1915";"";"";"";"";"";""
"CHEMBL836251";"F";"Growth inhibitory concentration dissolved in DMSO against human NSCLC cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL912484";"F";"Induction of apoptosis in HeLa cells assessed as effect on sub-G1 population";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1139851";"17228873";"10.1021/jm060717i";"2007";"J Med Chem";"50";"319";"327";"";"";"";"";"";""
"CHEMBL722088";"F";"Compound was evaluated in vivo for antileukemic activity by calculating Percent increase in life span at dose of 2 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1125562";"1479582";"10.1021/jm00104a005";"1992";"J Med Chem";"35";"4809";"4812";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"General Leukemia";"";""
"CHEMBL746025";"F";"Number of survivors on 30th day at dose 1 mg/kg/day in 10 mice implanted with P388 leukemia cell line; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL2169432";"A";"Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake by scintillation counting";"Homo sapiens";"12";"24";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL1964012";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ";"";"41240";"41578";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"COLO 205";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL746015";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 5 mg/kg/day; 0/10";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2032755";"F";"Antiproliferative activity against human Hep3B after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Hep 3B2";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2317046";"F";"Cell cycle arrest in human HL60 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL2114843";"F";"PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"68426";"68635";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL833360";"F";"Cytotoxic activity against human tumor MCF-7 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL833370";"F";"Cytotoxic activity against human tumor Hep 3B cell line";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL743073";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3 mg/kg/day; 0/10";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL3283015";"T";"Acute toxicity in ip dosed mouse";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL3282231";"T";"Toxicity in ip dosed mouse allografted with mouse p388 cells administered from day 1 to day 9";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL3285622";"T";"Neurotoxicity in iv dosed monkey assessed as leukopenia";"Macaca mulatta";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9544";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL735158";"F";"Percent increase in life span at dose 0.5 mg/kg/day in 10 mice implanted with P388 leukemia cell line";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1909165";"B";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"";"";"Reticulocytes";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909212";"B";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909125";"B";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909163";"B";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"Cavia porcellus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10141";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909169";"B";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909195";"B";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909093";"B";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614676";"A";"Volume of distribution at steady state in rat after iv administration";"Rattus norvegicus";"103";"103";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1614629";"15920768";"10.1002/jps.20373";"2005";"J Pharm Sci";"94";"1467";"1483";"";"";"";"";"";""
"CHEMBL2066608";"F";"Cytotoxicity against human melanoma cells after 48 hrs";"Homo sapiens";"22";"48";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL2066611";"F";"Cytotoxicity against human prostate cancer cells after 48 hrs";"Homo sapiens";"20";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL981345";"F";"Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981347";"F";"Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981348";"F";"Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL758077";"F";"In vitro inhibitory concentration required against murine P388 leukemic cells proliferation";"Mus musculus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1134048";"11140731";"10.1016/s0960-894x(00)00578-3";"2001";"Bioorg Med Chem Lett";"11";"5";"8";"";"";"";"";"";""
"CHEMBL986547";"F";"Cytotoxicity against human melanoma cells";"Homo sapiens";"18";"40";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL986548";"F";"Cytotoxicity against human ovarian cancer cells";"Homo sapiens";"17";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1155808";"18598018";"10.1021/jm800194k";"2008";"J Med Chem";"51";"4563";"4570";"";"";"";"";"";""
"CHEMBL1826868";"F";"Cytotoxicity against adriyamycin-resistant human MCF7 cells over expressing P-glycoprotein after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1821706";"21761866";"10.1021/jm200511x";"2011";"J Med Chem";"54";"5796";"5810";"";"";"";"";"";""
"CHEMBL1963989";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ";"";"41040";"41374";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"ACHN";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1930893";"F";"Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1926616";"22119124";"10.1016/j.ejmech.2011.11.011";"2012";"Eur J Med Chem";"47";"424";"431";"";"";"";"";"";""
"CHEMBL1613871";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response to Identify Inhibitors of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"183";"183";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964034";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ";"";"35810";"36111";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"A498";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964085";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ";"";"40966";"41294";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"M14";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964040";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ";"";"41083";"41427";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MOLT-4";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1941687";"F";"Growth inhibition of human KB-S15 cells after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-S15";"";"CHEMBL1938387";"22060033";"10.1021/jm201031f";"2011";"J Med Chem";"54";"8517";"8525";"";"";"";"";"";""
"CHEMBL1964045";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ";"";"28471";"28705";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI/ADR-RES";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL818983";"B";"In vitro inhibition of tubulin polymerization measured as turbidity formed by centrifugation";"Bos taurus";"5";"5";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1131603";"9554885";"10.1021/jm970800t";"1998";"J Med Chem";"41";"1524";"1530";"";"";"";"";"";""
"CHEMBL845710";"F";"Cytotoxic effect on 60 human tumor cell line panel, MG-MID represents mean value";"";"3";"3";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL708164";"F";"Cytostatic effect on human leukemia tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel leukemia (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1247691";"F";"Selectivity index, ratio of IC50 for green monkey Vero cells over IC50 for human HeLa cells";"";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"Vero";"";"CHEMBL1240463";"20619938";"10.1016/j.ejmech.2010.06.029";"2010";"Eur J Med Chem";"45";"4403";"4408";"";"";"";"";"";""
"CHEMBL741232";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1613918";"F";"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]";"Homo sapiens";"18608";"18631";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL833220";"F";"Cytotoxic activity against human tumor PT45 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PT45";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL1218940";"F";"Growth inhibition of human leukemia cells after 48 hrs";"Homo sapiens";"26";"70";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL1212917";"20684599";"10.1021/jm1007165";"2010";"J Med Chem";"53";"5567";"5575";"";"";"";"";"";""
"CHEMBL1055755";"F";"Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL635477";"P";"Partition coefficient (logD7.4)";"";"61";"66";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL1247229";"F";"Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as morphological changes using DAPI staining at 0.2 uM after 48 hrs by fluorescence microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL1240517";"20724170";"10.1016/j.bmc.2010.07.055";"2010";"Bioorg Med Chem";"18";"6725";"6733";"";"";"";"";"";""
"CHEMBL888945";"F";"Antiproliferative activity against KBV1cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-V1";"";"CHEMBL1144649";"17416524";"10.1016/j.bmcl.2007.03.070";"2007";"Bioorg Med Chem Lett";"17";"3003";"3005";"";"";"";"";"";""
"CHEMBL997600";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 3.16 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL816889";"F";"The compound was evaluated in vitro for the mammalian brain tubulin polymerization using standard assay.";"";"2";"2";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL853904";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 31.6 nM";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL866243";"F";"Cytotoxicity against human MCF7 cells by clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL712289";"F";"Cytostatic effect on 60 human tumor cell line panel, MG-MID represents mean value";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL1963900";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ";"";"26413";"26627";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"T47D";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL866246";"F";"Cytotoxicity against human KB cells by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL866249";"F";"Cytotoxicity against human PA1 cells by clonogenic assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PA-1";"";"CHEMBL1146977";"16480866";"10.1016/j.bmcl.2006.01.077";"2006";"Bioorg Med Chem Lett";"16";"2446";"2449";"";"";"";"";"";""
"CHEMBL3377414";"F";"Cell cycle arrest in human RD cells assessed as rounded cells at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL2216649";"F";"Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LNCaP";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL4412030";"F";"Antiproliferative activity against human A549 cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL4431646";"F";"Growth inhibition of human KB/VJ300 cells after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL4431302";"26918761";"10.1021/acs.jnatprod.5b01117";"2016";"J Nat Prod";"79";"1048";"1055";"";"";"";"";"";""
"CHEMBL2075733";"F";"TP_TRANSPORTER: uptake in membrane vesicles from GLC4/ADR cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"GLC-4/ADR";"Membrane vesicle";"CHEMBL2074451";"10188979";"10.1038/sj.bjp.0702360";"1999";"Br J Pharmacol";"126";"681";"688";"";"";"";"";"";""
"CHEMBL3866635";"F";"Antiproliferative activity against human K562 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL3866636";"F";"Antiproliferative activity against human K562/A02 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/A02";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL2354311";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ";"";"31581";"31649";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3369012";"F";"Cytotoxicity against human PC3 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3822025";"F";"Cytotoxicity against human A549/CDDP cells assessed as growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3369017";"F";"Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL4412023";"F";"Antiproliferative activity against human K562 cells after 72 hrs by MTT assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL4412026";"F";"Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL4273763";"B";"Inhibition of tubulin (unknown origin) polymerization assessed as polymerized tubulin level at 5 to 25 uM by fluorescence assay";"Homo sapiens";"3";"3";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4270577";"30055463";"10.1016/j.ejmech.2018.07.024";"2018";"Eur J Med Chem";"156";"774";"789";"";"";"";"";"";""
"CHEMBL3215270";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"22759";"22913";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1266173";"F";"Antiproliferative activity against mouse neural precursor cells by MTT assay";"Mus musculus";"37";"37";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL1267251";"F";"Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"655";"685";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"W2";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267245";"F";"Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"534";"559";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"3D7";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1259840";"F";"Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay";"Homo sapiens";"9";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1255528";"20732809";"10.1016/j.bmcl.2010.07.100";"2010";"Bioorg Med Chem Lett";"20";"5859";"5863";"";"";"";"";"";""
"CHEMBL3739137";"F";"Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3734715";"26522953";"10.1016/j.bmcl.2015.10.040";"2015";"Bioorg Med Chem Lett";"25";"5597";"5600";"";"";"";"";"";""
"CHEMBL3995439";"F";"Antiproliferative activity against human HGC27 cells after 48 hrs by MTT assay";"Homo sapiens";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HGC-27";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL3377419";"F";"Cell cycle arrest in human HepG2 cells at 500 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL1964074";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ";"";"15163";"15267";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"M19-MEL";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613869";"F";"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1813 (Primary HTS), 1827 (Project Summary)]";"";"2032";"2032";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL738758";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 3 mg/kg per day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL743071";"F";"Number of survivors of DBA2 mice on 30th day after inoculation with L1210 leukemia cell line intravenously at a dose of 3.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1000967";"F";"Antimitotic activity in rat ASK cells assessed as reversal of astrocyte formation at 20 ug/mL";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"ASK";"";"CHEMBL1147382";"8277312";"10.1021/np50100a011";"1993";"J Nat Prod";"56";"1728";"1736";"";"";"";"";"";""
"CHEMBL981350";"F";"Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL981351";"F";"Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method";"Mus musculus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1147285";"2778449";"10.1021/np50063a010";"1989";"J Nat Prod";"52";"522";"527";"";"";"";"";"";""
"CHEMBL3411294";"A";"Inhibition of human OATP1B3-mediated [3H]CCK-8 after 5 mins by Dixon plot method";"Homo sapiens";"6";"12";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL3137739";"T";"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1266185";"F";"Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay";"Mus musculus";"1252";"1259";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL1259839";"F";"Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay";"Homo sapiens";"9";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LNCaP";"";"CHEMBL1255528";"20732809";"10.1016/j.bmcl.2010.07.100";"2010";"Bioorg Med Chem Lett";"20";"5859";"5863";"";"";"";"";"";""
"CHEMBL1026799";"F";"Antitumor activity against Agrobacterium tumefaciens B6-induced tumor formation at 10 ug/disk after 12 days by potato disk assay";"Agrobacterium tumefaciens";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"B6";"Scientific Literature";"358";"";"";"";"";"CHEMBL1151404";"7161602";"10.1021/np50024a005";"1982";"J Nat Prod";"45";"679";"686";"";"";"";"";"";""
"CHEMBL1964004";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"38197";"38507";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H226";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963903";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ";"";"40754";"41090";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UACC-62";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1809626";"F";"Cytotoxic activity against Pgp-deficient human MCF7/VP cells expressing MRP1 after 48 hrs by sulforhodamine B assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7-VP";"";"CHEMBL1806466";"21680190";"10.1016/j.bmc.2011.05.030";"2011";"Bioorg Med Chem";"19";"4355";"4365";"";"";"";"";"";""
"CHEMBL1963981";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ";"";"41327";"41678";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SN12C";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963922";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41592";"41947";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-295";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4009497";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 62.61%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL1963874";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ";"";"41314";"41656";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCT-116";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL916634";"A";"Cytotoxicity against human HL60 cells after 48 hrs";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1139860";"17432904";"10.1021/np0700570";"2007";"J Nat Prod";"70";"830";"834";"";"";"";"";"";""
"CHEMBL4296189";"F";"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";"Candida albicans";"6134";"6236";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 90028";"CO-ADD antimicrobial screening data";"5476";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2078149";"F";"TP_TRANSPORTER: inhibition of Verapamil binding in membranes from Vinblastine-induced Caco-2 cells";"";"4";"8";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Caco-2";"Membrane";"CHEMBL2074241";"9862789";"None";"1999";"J Pharmacol Exp Ther";"288";"348";"357";"";"";"";"";"";""
"CHEMBL4196284";"B";"Inhibition of tubulin (unknown origin) polymerization assessed as tubulin assembly rate by fluorescence assay";"Homo sapiens";"8";"8";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4196002";"29407956";"10.1016/j.ejmech.2018.01.042";"2018";"Eur J Med Chem";"146";"260";"273";"";"";"";"";"";""
"CHEMBL3561981";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ";"";"168";"168";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3602455";"B";"Inhibition of porcine tubulin polymerization at 10 uM measured every min for 30 mins by spectrophotometric analysis";"Sus scrofa";"1";"1";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3600297";"26241032";"10.1021/acs.jmedchem.5b00659";"2015";"J Med Chem";"58";"6549";"6558";"";"";"";"";"";""
"CHEMBL2389646";"F";"Cytotoxicity against human renal cancer cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL2389648";"F";"Cytotoxicity against human ovarian cancer cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL2389647";"F";"Cytotoxicity against human melanoma cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL2388147";"F";"Cytotoxicity against human colon cancer cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL2032766";"F";"Antiproliferative activity against human SNU449 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-449";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3529279";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529278";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529274";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3243457";"F";"Cytotoxicity against human VP16-resistant KB-7d cells overexpressing MRP after 72 hrs by methylene blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-7d";"";"CHEMBL3232864";"24657567";"10.1016/j.ejmech.2014.02.061";"2014";"Eur J Med Chem";"77";"306";"314";"";"";"";"";"";""
"CHEMBL4362737";"B";"Binding affinity to tubulin (unknown origin) assessed as reduction in alpha-C fragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4362744";"F";"Selectivity index, ratio of IC50 for human CCRF-CEM/VBL cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL3862061";"F";"Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 24 hrs by MTT assay";"Homo sapiens";"3";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3861942";"None";"10.1039/C6MD00178E";"2016";"Medchemcomm";"7";"1429";"1435";"";"";"";"";"";""
"CHEMBL3562119";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ";"";"2170";"2186";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3830510";"F";"Growth inhibition of human NCI-H157 cells at 100 uM after 48 hrs by SRB assay";"Homo sapiens";"39";"39";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3826920";"27480030";"10.1016/j.bmc.2016.07.042";"2016";"Bioorg Med Chem";"24";"4452";"4463";"";"";"";"";"";""
"CHEMBL2317047";"F";"Cell cycle arrest in human HT-29 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL2317044";"F";"Cell cycle arrest in human HT-29 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL2317048";"F";"Cell cycle arrest in human CAL33 cells assessed as accumulation at sub-G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAL-33";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL2216646";"A";"Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NFF";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL2388150";"F";"Cytotoxicity against human NSCLC cells after 48 hrs";"Homo sapiens";"13";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL3534590";"A";"Drug excretion in iv dosed Sprague-Dawley rat assessed as compound excreted into bile";"Rattus norvegicus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL3369016";"F";"Cytotoxicity against human H1299 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3866645";"B";"Inhibition of alpha tubulin polymerization in human A549 cells at 50 nM by Hoechst 33258 staining based fluorescent microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL2410476";"F";"Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay";"Homo sapiens";"12";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2406939";"23855338";"10.1021/np400297p";"2013";"J Nat Prod";"76";"1337";"1342";"";"";"";"";"";""
"CHEMBL3562121";"F";"PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"96";"97";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3857838";"F";"Cytotoxicity against human MCF7 cells assessed as inhibition of cell survival rate after 48 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856213";"27240278";"10.1016/j.ejmech.2016.05.045";"2016";"Eur J Med Chem";"121";"238";"249";"";"";"";"";"";""
"CHEMBL739571";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intraperitoneally at a dose of 2.7 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL741834";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 1 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL3411292";"A";"Inhibition of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control";"Homo sapiens";"11";"11";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL997597";"F";"Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation at 1 nM after 24 hrs by FACS analysis";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140930";"19220018";"10.1021/jm801338r";"2009";"J Med Chem";"52";"1284";"1294";"";"";"";"";"";""
"CHEMBL955283";"F";"Cytotoxicity against human KB cells";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1148992";"7130986";"10.1021/np50022a010";"1982";"J Nat Prod";"45";"418";"426";"";"";"";"";"";""
"CHEMBL1931156";"F";"Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay";"Homo sapiens";"45";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1926673";"22119129";"10.1016/j.ejmech.2011.11.007";"2012";"Eur J Med Chem";"47";"387";"398";"";"";"";"";"";""
"CHEMBL1931157";"F";"Cytotoxicity against human MDA-MB-231 cells after 48 hrs by SRB assay";"Homo sapiens";"45";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1926673";"22119129";"10.1016/j.ejmech.2011.11.007";"2012";"Eur J Med Chem";"47";"387";"398";"";"";"";"";"";""
"CHEMBL815200";"F";"The compound tested for the inhibition of tubulin polymerization.";"";"16";"16";"BAO_0000019";"assay format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1125276";"2066973";"10.1021/jm00111a012";"1991";"J Med Chem";"34";"1998";"2003";"";"";"";"";"";""
"CHEMBL901958";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL4689432";"F";"Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4680354";"33477020";"10.1016/j.bmc.2020.115960";"2021";"Bioorg Med Chem";"32";"115960";"115960";"";"";"";"";"";""
"CHEMBL3285623";"T";"Neurotoxicity in iv dosed monkey assessed as peripheral neuropathy";"Macaca mulatta";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9544";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL3285630";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 0.22 mg/kg/day administered from day 1 to day 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3239656";"F";"Cytotoxicity against human prostate cancer cells after 48 hrs";"Homo sapiens";"18";"43";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL1018152";"F";"Antiproliferative activity against human KB cells after 3 days by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1139312";"19041247";"10.1016/j.bmc.2008.11.016";"2009";"Bioorg Med Chem";"17";"111";"118";"";"";"";"";"";""
"CHEMBL3285620";"T";"Acute toxicity in rat";"Rattus norvegicus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL3239655";"F";"Cytotoxicity against human renal cancer cells after 48 hrs";"Homo sapiens";"18";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL758683";"F";"The compound was evaluated in vitro for the P388 cell spindle disruption.; 0.02-0.04";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1126349";"None";"10.1016/S0960-894X(00)80225-5";"1992";"Bioorg Med Chem Lett";"2";"1257";"1262";"";"";"";"";"";""
"CHEMBL901963";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G1 phase at 316 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL845556";"F";"Relative resistance is the ratio of IC50 values of drug with JTV-519 to that without the reversing agent";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL831466";"F";"Total growth inhibition of human Breast cell line at 10E-3 M concentration ";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Breast carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL837111";"F";"Cytotoxic effect dissolved in DMSO against MG-MID cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel NCI-60 (60 carcinoma cell lines)";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL4201258";"F";"Cell cycle arrest in human PANC1 cells assessed as accumulation at G1 phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 70.7%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PANC-1";"";"CHEMBL4196179";"30156410";"10.1021/acs.jmedchem.8b00986";"2018";"J Med Chem";"61";"8444";"8456";"";"";"";"";"";""
"CHEMBL746673";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg in the presence of vincristine at 0.1 mg/kg as percent ratio of median survival time of treated mice to control mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | NERVOUS SYSTEM";"Leukemia Oncology Models | Neoplasm Oncology Models | Central Analgesic Activity";"P388 Experimental Leukemia | Neoplasms | Chemotherapy Induced Pain for Peripheral Neuropathic Pain";"";""
"CHEMBL837119";"F";"Cytotoxic effect dissolved in DMSO against Prostate cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Prostate cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL4009499";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 12.93%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL3390169";"F";"Cytotoxicity against vincristine-sensitive human KB cells";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3352798";"25333996";"10.1021/np500589u";"2014";"J Nat Prod";"77";"2504";"2512";"";"";"";"";"";""
"CHEMBL3239866";"F";"Anticancer activity against Syrian golden hamster BHK21 cells at 100 uM after 48 hrs by SRB assay";"Mesocricetus auratus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL3282241";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2032757";"F";"Antiproliferative activity against human HuH7 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Huh-7 ";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL2077586";"F";"TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.05 uM) in membrane vesicle from MRP1-expressing HeLa cells";"";"4";"4";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HeLa";"Membrane vesicle";"CHEMBL2074383";"8621644";"10.1074/jbc.271.16.9683";"1996";"J Biol Chem";"271";"9683";"9689";"";"";"";"";"";""
"CHEMBL3282253";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2066610";"F";"Cytotoxicity against human renal cancer cells after 48 hrs";"Homo sapiens";"23";"51";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL5143969";"F";"Antiproliferative activity against human HCT-8 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL5143510";"34649064";"10.1016/j.ejmech.2021.113897";"2022";"Eur J Med Chem";"227";"113897";"113897";"";"";"";"";"";""
"CHEMBL3822023";"F";"Cytotoxicity against human HCT8/VCT cells assessed as growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT8/VCT";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3822022";"F";"Resistance index, ratio of IC50 for human A2780/TAX cells to IC50 for human A2780 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3822024";"F";"Resistance index, ratio of IC50 for human HCT8/VCT cells to IC50 for human HCT8 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3822026";"F";"Resistance index, ratio of IC50 for human A549/CDDP cells to IC50 for human A549 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL738394";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg in the presence of vincristine at 0.1 mg/kg as range.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | NERVOUS SYSTEM";"Leukemia Oncology Models | Neoplasm Oncology Models | Central Analgesic Activity";"P388 Experimental Leukemia | Neoplasms | Chemotherapy Induced Pain for Peripheral Neuropathic Pain";"";""
"CHEMBL3285360";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL711532";"F";"In vitro cytotoxic activity against uterine sarcoma (MES-SA) cells assayed by inhibition of [3H]-labeled thymidine incorporation";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1134309";"11728191";"10.1021/jm010974h";"2001";"J Med Chem";"44";"4462";"4467";"";"";"";"";"";""
"CHEMBL2354292";"F";"PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1. (Class of assay: confirmatory) ";"";"249";"249";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL751411";"F";"Inhibition of proliferation in NCI human non-small cell lung tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2077373";"F";"TP_TRANSPORTER: increase in brain concentration in mdr1a(-/-) mouse";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"9";"9 - Direct single protein target assigned";"mdr1a(-/-)";"TP-search Transporter Database";"10090";"CHEMBL3638188";"Brain";"";"";"CHEMBL2074408";"8667431";"10.1093/jnci/88.14.994";"1996";"J Natl Cancer Inst";"88";"994";"999";"";"";"";"";"";""
"CHEMBL3239873";"F";"Anticancer activity against human NCI-H157 cells at 0.1 uM after 48 hrs by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL3282226";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 1.8 mg/kg/day, ip after 1 day";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3562026";"F";"PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ";"";"180";"181";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562064";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ";"";"1996";"2013";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4686067";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved PARP expression at 0.1 uM measured after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL2354254";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ";"";"153871";"156311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3370643";"F";"Antiproliferative activity against human KB cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3351617";"25059503";"10.1016/j.bmc.2014.06.042";"2014";"Bioorg Med Chem";"22";"4917";"4923";"";"";"";"";"";""
"CHEMBL4362666";"F";"Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by MTS assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL3231912";"F";"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3784809";"F";"Cytotoxicity against human HeLa cells after 3 days by SRB assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3779888";"26927488";"10.1016/j.ejmech.2016.02.004";"2016";"Eur J Med Chem";"112";"367";"372";"";"";"";"";"";""
"CHEMBL3124374";"F";"Induction of apoptosis in human CCRF-CEM VCR/R cells at 1 uM after 48 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"CCRF-CEM VCR/R";"";"CHEMBL3120073";"24437936";"10.1021/np4008014";"2014";"J Nat Prod";"77";"536";"542";"";"";"";"";"";""
"CHEMBL2066609";"F";"Cytotoxicity against human ovarian cancer cells after 48 hrs";"Homo sapiens";"22";"48";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL5161604";"F";"Resistance index, ratio of IC50 for antiproliferative activity against human vincristine-resistant HCT-8/VCR cells to IC50 for antiproliferative activity against HCT-8 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL5155650";"F";"Antiproliferative activity against human K562/Adr cells measured after 72 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/Adr";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL3137733";"T";"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137728";"T";"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137724";"T";"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1247203";"F";"Cytotoxicity against human KB/VCR cells expressing Pgp after 48 hrs by MTT assay";"Homo sapiens";"5";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL1240517";"20724170";"10.1016/j.bmc.2010.07.055";"2010";"Bioorg Med Chem";"18";"6725";"6733";"";"";"";"";"";""
"CHEMBL2077476";"F";"TP_TRANSPORTER: efflux in Mrp1-expressing HEK293 cells";"";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"";"CHEMBL2073844";"9281595";"10.1124/mol.52.3.344";"1997";"Mol Pharmacol";"52";"344";"353";"";"";"";"";"";""
"CHEMBL655021";"F";"Effect on cross resistance of CCRF-CEM cells resistant to vincristine.";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1124835";"2362268";"10.1021/jm00169a014";"1990";"J Med Chem";"33";"1914";"1919";"";"";"";"";"";""
"CHEMBL3137722";"T";"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL897535";"B";"Inhibition of tubulin polymerization at 20 uM";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1148871";"17482458";"10.1016/j.bmcl.2007.04.048";"2007";"Bioorg Med Chem Lett";"17";"3613";"3617";"";"";"";"";"";""
"CHEMBL4686066";"F";"Cell cycle arrest in human KB-VIN cells assessed as increase in accumulation at sub-G1 phase at 0.01 to 0.1 uM measured after 24 hrs by propidium iodide staining based flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3241350";"F";"Antiproliferative activity against human NCI-H157 cells at 100 uM after 48 hrs by SRB assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3232752";"24675179";"10.1016/j.ejmech.2014.03.015";"2014";"Eur J Med Chem";"78";"43";"53";"";"";"";"";"";""
"CHEMBL2150108";"F";"Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150111";"F";"Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL848065";"F";"Cytostatic effect on human renal tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel renal (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2169429";"A";"Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL3137723";"T";"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137734";"T";"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2343639";"F";"Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL2331272";"23489291";"10.1021/np300648d";"2013";"J Nat Prod";"76";"516";"523";"";"";"";"";"";""
"CHEMBL3860268";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at G2/M phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 9.17%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL3396260";"F";"Drug resistance index, ratio of IC50 for cis-platinum-resistant human A549 cells to IC50 for human A549 cells";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3281980";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3282242";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3562033";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2400152";"B";"Competitive binding affinity to pig brain tubulin vinblastine binding site at 0.1 to 100 uM after 1 hr by mass spectrophotometric analysis in presence of vinblastine";"Sus scrofa";"2";"2";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL2396655";"23750455";"10.1021/jm400575x";"2013";"J Med Chem";"56";"5562";"5586";"";"";"";"";"";""
"CHEMBL3243455";"F";"Cytotoxicity against human vincristine/paclitaxel-resistant KB-VIN10 cells overexpressing P-gp170 after 72 hrs by methylene blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL3232864";"24657567";"10.1016/j.ejmech.2014.02.061";"2014";"Eur J Med Chem";"77";"306";"314";"";"";"";"";"";""
"CHEMBL4686094";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved PARP expression at 0.1 uM measured after 48 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3860264";"F";"Cytotoxicity against human HCC1428 cells assessed as decrease in cell viability at 1 uM after 60 hrs by xCELLigence system";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL3856800";"F";"Cell cycle arrest in human MCF7 cells assessed as accumulation at sub-G0 phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.4 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL4310854";"F";"Reversal ratio of IC50 for paclitaxel-induced cytotoxicity against human A2780/TAX cells in absence of compound to IC50 paclitaxel-induced cytotoxicity against human A2780/TAX cells in presence of compound";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780/Taxol";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL4310855";"F";"Reversal ratio of IC50 for cisplatin-induced cytotoxicity against human A2780/CDDP cells in absence of compound to IC50 for cisplatin-induced cytotoxicity against human A2780/CDDP cells in presence of compound";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL4155629";"A";"Growth inhibition of human LO2 cells at 0.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4686073";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-9 expression at 0.1 uM measured after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL2075740";"F";"TP_TRANSPORTER: intracellular accumulation in KB-3-1 and C-A120 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"KB-3-1; C-A120";"";"CHEMBL2074493";"9058594";"None";"1997";"Mol Pharmacol";"51";"399";"405";"";"";"";"";"";""
"CHEMBL2075060";"F";"TP_TRANSPORTER: inhibition of LTC4 uptake (LTC4: 0.01 uM, Vincristine: 100 uM) in liver plasma membrane vesicles of Wistar rat";"Rattus norvegicus";"1";"1";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"TP-search Transporter Database";"10116";"CHEMBL3559723";"Liver";"";"Plasma membrane vesicle";"CHEMBL2074429";"2172249";"10.1016/s0021-9258(17)30655-5";"1990";"J Biol Chem";"265";"19279";"19286";"";"";"";"";"";""
"CHEMBL3370647";"F";"Antiproliferative activity against human KB-S15 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-S15";"";"CHEMBL3351617";"25059503";"10.1016/j.bmc.2014.06.042";"2014";"Bioorg Med Chem";"22";"4917";"4923";"";"";"";"";"";""
"CHEMBL876008";"F";"Cytotoxic effect dissolved in DMSO against Renal cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Renal cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL4142108";"F";"Cytotoxicity against human NCI-H157 cells at 1 uM after 48 hrs by sulforhodamine B assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL3239657";"F";"Cytotoxicity against human breast cancer cells after 48 hrs";"Homo sapiens";"18";"44";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL3243452";"F";"Cytotoxicity against human KB cells after 72 hrs by methylene blue assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3232864";"24657567";"10.1016/j.ejmech.2014.02.061";"2014";"Eur J Med Chem";"77";"306";"314";"";"";"";"";"";""
"CHEMBL3562075";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 green channel.   (Class of assay: confirmatory) ";"";"28";"28";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3856793";"F";"Selectivity index, ratio of IC50 for African green monkey Vero cells to IC50 for human MCF7 cells";"";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL3636021";"F";"Cytotoxicity against human KB cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3632476";"26318055";"10.1016/j.ejmech.2015.08.035";"2015";"Eur J Med Chem";"103";"17";"28";"";"";"";"";"";""
"CHEMBL3370648";"F";"Antiproliferative activity against human KB-7d cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-7d";"";"CHEMBL3351617";"25059503";"10.1016/j.bmc.2014.06.042";"2014";"Bioorg Med Chem";"22";"4917";"4923";"";"";"";"";"";""
"CHEMBL3871121";"F";"Cytotoxicity against human SiHa cells by MTT assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SiHa";"";"CHEMBL3870355";"28105271";"10.1021/acsmedchemlett.6b00313";"2017";"ACS Med Chem Lett";"8";"32";"37";"";"";"";"";"";""
"CHEMBL3871122";"F";"Cytotoxicity against mouse B16F10 cells by MTT assay";"Mus musculus";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16-F10";"";"CHEMBL3870355";"28105271";"10.1021/acsmedchemlett.6b00313";"2017";"ACS Med Chem Lett";"8";"32";"37";"";"";"";"";"";""
"CHEMBL3636023";"F";"Cytotoxicity against human A549 cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3632476";"26318055";"10.1016/j.ejmech.2015.08.035";"2015";"Eur J Med Chem";"103";"17";"28";"";"";"";"";"";""
"CHEMBL3529292";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529291";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3231575";"T";"Toxicity in iv dosed mouse assessed as lethality";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"";"";"";"";"";""
"CHEMBL2066356";"F";"Cytotoxicity against human NSCLC cells after 48 hrs";"Homo sapiens";"22";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL3283007";"F";"Antitumor activity against mouse Ridgeway osteogenic sarcoma cells allografted in mouse at 0.1 to 0.2 mg/kg/day, ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"sarcoma";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3283291";"T";"Toxicity in ip dosed mouse allografted with mouse P1534(J) cells administered from day 1 to day 9";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL3282225";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 2.7 mg/kg/day, ip after 1 day";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4155627";"A";"Growth inhibition of human LO2 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL4142113";"A";"Cytotoxicity against golden hamster BHK21 cells at 0.1 uM after 48 hrs by sulforhodamine B assay";"Mesocricetus auratus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL3885882";"F";"In vitro activity on S. mansoni schistosomula at 50 uM";"Schistosoma mansoni";"654";"247666";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Puerto Rican";"DrugMatrix";"6183";"";"";"";"";"CHEMBL3885881";"None";"10.6019/CHEMBL3885881";"None";"None";"None";"None";"None";"standard_type:AGE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:GENDER standard_relation:None standard_value:None standard_units:None comments:None | standard_type:REGIMEN standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4271209";"F";"Cytotoxicity in human KB cells assessed as reduction in cell viability";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4270497";"28760313";"10.1016/j.ejmech.2017.07.033";"2017";"Eur J Med Chem";"142";"179";"212";"";"";"";"";"";""
"CHEMBL4045304";"B";"Inhibition of bovine brain tubulin polymerization";"Bos taurus";"8";"14";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL4043145";"28780159";"10.1016/j.bmcl.2017.07.063";"2017";"Bioorg Med Chem Lett";"27";"3992";"4000";"";"";"";"";"";""
"CHEMBL4310860";"F";"Resistance ratio of IC50 for human KBV cells to IC50 for human KB cells";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL4412033";"F";"Drug resistance index, ratio of IC50 for taxol-resistant human HCT8/T cells to IC50 for human HCT8 cells";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL3231911";"F";"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.36 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL4252844";"F";"Cytotoxicity against human DU145 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL3231909";"F";"Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL4296783";"F";"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";"Escherichia coli";"1581";"1582";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 25922";"CO-ADD antimicrobial screening data";"562";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL3529541";"A";"Total biliary clearance in iv dosed human after 72 hrs by T-tube method";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL3370646";"F";"Antiproliferative activity against human KB-VIN10 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL3351617";"25059503";"10.1016/j.bmc.2014.06.042";"2014";"Bioorg Med Chem";"22";"4917";"4923";"";"";"";"";"";""
"CHEMBL4155626";"F";"Growth inhibition of human SMMC7721 cells at 5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3862060";"F";"Cytotoxicity against human A549 cells assessed as decrease in cell viability after 24 hrs by MTT assay";"Homo sapiens";"3";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3861942";"None";"10.1039/C6MD00178E";"2016";"Medchemcomm";"7";"1429";"1435";"";"";"";"";"";""
"CHEMBL5161633";"F";"Resistance index, ratio of IC50 for antiproliferative activity against human adriamycin-resistant A549/ADR cells to IC50 for antiproliferative activity against human A549 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL4155630";"A";"Growth inhibition of human LO2 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL5143979";"F";"Antiproliferative activity against vincristine resistant human HCT-8/VCR cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCT-8/VCR";"";"CHEMBL5143510";"34649064";"10.1016/j.ejmech.2021.113897";"2022";"Eur J Med Chem";"227";"113897";"113897";"";"";"";"";"";""
"CHEMBL5161634";"F";"Antiproliferative activity against human vincristine-resistant HCT-8/VCR cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL4009496";"F";"Antiproliferative activity against human HCC1428 cells at 1 uM up to 60 hrs by RTCA";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL4155631";"A";"Growth inhibition of human LO2 cells at 5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3822027";"F";"Cytotoxicity against human MCF7/DX cells assessed as growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7/DX";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3822021";"F";"Cytotoxicity against human A2780/TAX cells assessed as growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780/TAX";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL2317180";"F";"Cell cycle arrest in human HT-29 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL4705354";"B";"Binding affinity to beta-tubulin in mouse 518T2 cells at 0.1 to 50 uM measured after 1.5 hrs using Alexa Fluor 532 dye by copper-mediated click reaction based SDS PAGE analysis";"Mus musculus";"10";"10";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"518T2";"";"CHEMBL4699638";"33180487";"10.1021/acs.jmedchem.0c01482";"2020";"J Med Chem";"63";"14054";"14066";"";"";"";"";"";""
"CHEMBL3856802";"F";"Cell cycle arrest in human MCF7 cells assessed as accumulation at S phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 8.5 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL4845253";"B";"Inhibition of EBI binding to beta tubulin in human A2780S cells at 5 to 25 uM preincubated for 2 hrs followed by addition of EBI and measured after 2 hrs by western blot assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"A2780S";"";"CHEMBL4842387";"34648295";"10.1021/acs.jmedchem.1c01451";"2021";"J Med Chem";"64";"15379";"15401";"";"";"";"";"";""
"CHEMBL2389644";"F";"Cytotoxicity against human prostate cancer cells after 48 hrs";"Homo sapiens";"13";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL4201256";"F";"Cell cycle arrest in human PANC1 cells assessed as increase in accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PANC-1";"";"CHEMBL4196179";"30156410";"10.1021/acs.jmedchem.8b00986";"2018";"J Med Chem";"61";"8444";"8456";"";"";"";"";"";""
"CHEMBL3856801";"F";"Cell cycle arrest in human MCF7 cells assessed as accumulation at G0/G1 phase at 0.5 uM after 18 to 24 hrs by propidium iodide staining based flow cytometry (Rvb = 67 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL3856791";"F";"Cytotoxicity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"13";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL3998534";"F";"Resistance factor, ratio of IC50 for human CCRF-CEM/VBL cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL3562136";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ";"";"1968";"1982";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3636022";"F";"Cytotoxicity against human KB/VCR cells assessed as inhibition of cell proliferation after 72 hrs by SRB assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL3632476";"26318055";"10.1016/j.ejmech.2015.08.035";"2015";"Eur J Med Chem";"103";"17";"28";"";"";"";"";"";""
"CHEMBL4686045";"F";"Antiproliferative activity against human KB-VIN cells incubated for 48 hrs by SRB assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4028924";"A";"Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay";"Homo sapiens";"629";"629";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028801";"23956101";"10.1093/toxsci/kft176";"2013";"Toxicol Sci";"136";"216";"241";"";"";"";"";"";""
"CHEMBL4686072";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-8 expression at 0.1 uM measured after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4362741";"F";"Antiproliferative activity against human KB/VCR cells assessed as reduction in cell viability after 72 hrs by MTS assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL3281983";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4142106";"F";"Cytotoxicity against human NCI-H157 cells at 100 uM after 48 hrs by sulforhodamine B assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4142109";"F";"Cytotoxicity against human NCI-H157 cells at 0.1 uM after 48 hrs by sulforhodamine B assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4155625";"F";"Growth inhibition of human SMMC7721 cells at 2.5 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3390170";"F";"Cytotoxicity against vincristine-resistant human KB/VJ300 cells";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL3352798";"25333996";"10.1021/np500589u";"2014";"J Nat Prod";"77";"2504";"2512";"";"";"";"";"";""
"CHEMBL4705782";"B";"Inhibition of N,N'-Ethylenebis(iodoacetamide) binding to beta-tubulin in human HepG2 cells assessed as reduction in EBI/beta-tubulin adduct formation at 5 uM preincubated for 2 hrs followed by EBI addition and measured after 1.5 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4699650";"33201714";"10.1021/acs.jmedchem.0c01345";"2020";"J Med Chem";"63";"14840";"14866";"";"";"";"";"";""
"CHEMBL3231922";"F";"Antitumor activity against mouse P388/VCR/I/63 cells allografted in Dublin-CDF1 mouse assessed as day of host death at 1.5 mg/kg, ip administered on days 1, 5 and 9 (Rvb = 10 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4817019";"B";"Inhibition of P-glycoprotein in human MCF7/ADR cells assessed as reversal fold by measuring reduction in vincristine IC50 at 5 uM incubated for 48 hrs by CCK-8 assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL4813991";"33725657";"10.1016/j.ejmech.2021.113336";"2021";"Eur J Med Chem";"216";"113336";"113336";"";"";"";"";"";""
"CHEMBL4738990";"F";"Cytotoxicity against human L02 cells assessed as cell viability after 24 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"L02";"";"CHEMBL4732241";"33636536";"10.1016/j.ejmech.2021.113295";"2021";"Eur J Med Chem";"215";"113295";"113295";"";"";"";"";"";""
"CHEMBL4362735";"B";"Binding affinity to tubulin (unknown origin) assessed as reduction in Beta-colfragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4050895";"F";"Antiproliferative activity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL2427179";"F";"Antitumor activity against mouse H22 cells allografted in KM mouse assessed as tumor growth inhibition at 0.5 mg/kg, ip administered on day 1 and 4 measured on day 8 relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4689436";"F";"Antiproliferative activity against human cells MCF-7 assessed as reduction in cell viability incubated for 24 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4680354";"33477020";"10.1016/j.bmc.2020.115960";"2021";"Bioorg Med Chem";"32";"115960";"115960";"";"";"";"";"";""
"CHEMBL4201259";"F";"Cell cycle arrest in human PANC1 cells assessed as accumulation at S phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 11.1%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PANC-1";"";"CHEMBL4196179";"30156410";"10.1021/acs.jmedchem.8b00986";"2018";"J Med Chem";"61";"8444";"8456";"";"";"";"";"";""
"CHEMBL2427174";"T";"Toxicity in KM mouse allografted with mouse H22 cells assessed as body weight at 0.25 mg/kg, ip administered on day 1 and 4 measured on day 8 (Rvb = 30 +/- 3.24 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"KM";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4231285";"B";"Inhibition of porcine brain tubulin polymerization assessed as tubulin polymerization level by measuring arbitary units at 3 uM by fluorescence analysis";"Sus scrofa";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL4229351";"29549841";"10.1016/j.ejmech.2018.03.001";"2018";"Eur J Med Chem";"150";"567";"578";"";"";"";"";"";""
"CHEMBL2343637";"F";"Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL2331272";"23489291";"10.1021/np300648d";"2013";"J Nat Prod";"76";"516";"523";"";"";"";"";"";""
"CHEMBL4686107";"B";"Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 0.01 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4686110";"B";"Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 0.01 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB7D";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3396290";"B";"Displacement of (E)-3-(4-(Dimethylamino)phenyl)-1-(4'-fluoro[1,1'-biphenyl]-2-yl)prop-2-en-1-one from tubulin (unknown origin) by fluorescence assay";"Homo sapiens";"2";"2";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3231903";"F";"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.67 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/S";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.67 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL4142159";"F";"Antitumor activity against Agrobacterium tumefaciens-induced tumor after 21 days by potato disc bioassay technique";"Agrobacterium tumefaciens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"358";"";"";"";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL2354222";"F";"PubChem BioAssay. Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay. (Class of assay: confirmatory) ";"";"249";"249";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4150000";"F";"Resistance ratio of IC50 for human KBV cells to IC50 for human KB cells";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4145601";"29795767";"10.1021/acsmedchemlett.8b00125";"2018";"ACS Med Chem Lett";"9";"502";"506";"";"";"";"";"";""
"CHEMBL2447314";"F";"Cytotoxicity against human KB cells assessed as growth inhibition after 72 hrs by methylene blue staining-based assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2440102";"24106982";"10.1021/jm4011115";"2013";"J Med Chem";"56";"8008";"8018";"";"";"";"";"";""
"CHEMBL2354221";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ";"";"172535";"175189";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3282251";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4037381";"F";"Antiproliferative activity against human KB cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"39";"39";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4033782";"29294282";"10.1021/acs.jmedchem.7b01259";"2018";"J Med Chem";"61";"760";"776";"";"";"";"";"";""
"CHEMBL4431655";"F";"Cytotoxicity against mouse B16 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"Mus musculus";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL4431303";"26934105";"10.1021/acs.jnatprod.5b01073";"2016";"J Nat Prod";"79";"1005";"1011";"";"";"";"";"";""
"CHEMBL823206";"F";"Inhibition of proliferation in NCI human ovarian tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel ovarian (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2354211";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ";"";"35070";"35135";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL823453";"F";"Inhibition of proliferation in NCI human colon tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel colon (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2032789";"F";"Cell cycle arrest in human PLC/PRF/5 cells assessed as accumulation at sub-G1 phase after 24 hrs by FACS analysis (Rvb = 1.4%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PLC-PRF-5";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL4252842";"F";"Cytotoxicity against human HGC27 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HGC-27";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL3369018";"F";"Resistance factor, ratio of IC50 for vinblastine-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3282250";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285621";"A";"Neurotoxicity in iv dosed chicken assessed as neuromuscular disturbance by measuring loss of balance";"Gallus gallus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9031";"";"";"";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"";"";"";"";""
"CHEMBL3411290";"A";"Inhibition of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL4296193";"F";"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";"Acinetobacter baumannii";"1581";"1582";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 19606";"CO-ADD antimicrobial screening data";"470";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2032728";"F";"Antiproliferative activity against rat C6 cells at 0.1 to 10 uM after 48 hrs by neutral red incorporation assay";"Rattus norvegicus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL2410475";"F";"Antiproliferative activity against temperature-sensitive rat lymphatic endothelial cells after 48 hrs by MTS assay";"Rattus norvegicus";"12";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"Endothelial cell";"";"CHEMBL2406939";"23855338";"10.1021/np400297p";"2013";"J Nat Prod";"76";"1337";"1342";"";"";"";"";"";""
"CHEMBL2032737";"A";"Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by Hoechst 33342 staining";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL2077557";"F";"TP_TRANSPORTER: inhibition of EGCG in MRP2-expressing MDCKII cells";"";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL2074563";"14511674";"10.1016/j.bbrc.2003.09.007";"2003";"Biochem Biophys Res Commun";"310";"222";"227";"";"";"";"";"";""
"CHEMBL2428524";"F";"Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL2076177";"F";"TP_TRANSPORTER: inhibition of MTX uptake (MTX: 1 uM, Vincristine: 300 uM) in membrane vesicle from MRP3-expessing HEK 293 cell";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"Membrane vesicle";"CHEMBL2073963";"11585759";"None";"2001";"Cancer Res";"61";"7225";"7232";"";"";"";"";"";""
"CHEMBL5161632";"F";"Antiproliferative activity against human adriamycin-resistant A549/ADR cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL5162749";"B";"Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as decrease of adduct formation by measuring gray value measured at 25 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL5154820";"35339837";"10.1016/j.ejmech.2022.114271";"2022";"Eur J Med Chem";"235";"114271";"114271";"";"";"";"";"";""
"CHEMBL5155649";"F";"Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL2078574";"F";"TP_TRANSPORTER: drug resistance in MRP1-expressing PEAKSTABEL cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"PEAKSTABLE";"";"CHEMBL2074335";"12657726";"None";"2003";"Mol Cancer Ther";"2";"307";"316";"";"";"";"";"";""
"CHEMBL4686096";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-8 expression at 0.1 uM measured after 48 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4149476";"F";"Growth inhibition of human KB/VJ300 cells after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL4145571";"29746134";"10.1021/acs.jnatprod.8b00170";"2018";"J Nat Prod";"81";"1266";"1277";"";"";"";"";"";""
"CHEMBL3562024";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ";"";"369";"370";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4686104";"B";"Induction of microtubule disruption in human KB7D cells at 1 uM measured after 24 hrs by DAPI staining based deconvolution fluorescence microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB7D";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3782351";"F";"Cytotoxicity against human vincristine-sensitive KB cells assessed as cell viability after 72 hrs by MTT assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3779857";"26717050";"10.1021/acs.jnatprod.5b00992";"2016";"J Nat Prod";"79";"230";"239";"";"";"";"";"";""
"CHEMBL3782352";"F";"Cytotoxicity against human KB/VJ300 cells assessed as cell viability after 72 hrs by MTT assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL3779857";"26717050";"10.1021/acs.jnatprod.5b00992";"2016";"J Nat Prod";"79";"230";"239";"";"";"";"";"";""
"CHEMBL4431656";"F";"Cytotoxicity against human HaCaT cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HaCaT";"";"CHEMBL4431303";"26934105";"10.1021/acs.jnatprod.5b01073";"2016";"J Nat Prod";"79";"1005";"1011";"";"";"";"";"";""
"CHEMBL2076286";"F";"TP_TRANSPORTER: drug resistance in KB-TAX50 cells";"";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"KB-TAX50";"";"CHEMBL2074333";"15231674";"10.1158/0008-5472.can-03-3474";"2004";"Cancer Res";"64";"4621";"4628";"";"";"";"";"";""
"CHEMBL5161609";"F";"Antiproliferative activity against human A549 cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL5161611";"F";"Antiproliferative activity against human A2780 cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL4362740";"F";"Selectivity index, ratio of IC50 for human KBtax cells to IC50 for human KB cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4149997";"F";"Antiproliferative activity against human KBV cells after 48 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4145601";"29795767";"10.1021/acsmedchemlett.8b00125";"2018";"ACS Med Chem Lett";"9";"502";"506";"";"";"";"";"";""
"CHEMBL3239651";"F";"Cytotoxicity against human NSCLC cells after 48 hrs";"Homo sapiens";"18";"46";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NSCLC";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL3231476";"F";"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.25 mg/kg, ip administered daily for 8 to 10 days";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P1534";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3231917";"T";"Toxicity in CD2F1 mouse allografted with mouse P388/VCR cells at 1.67 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"CD2F1";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.67 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL4686112";"B";"Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB7D";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4037382";"F";"Antiproliferative activity against human KB/VCR cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"39";"39";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL4033782";"29294282";"10.1021/acs.jmedchem.7b01259";"2018";"J Med Chem";"61";"760";"776";"";"";"";"";"";""
"CHEMBL4310859";"F";"Cytotoxicity against human KB cells after 48 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL4362719";"B";"Inhibition of porcine tubulin at 5 uM in presence of GTP measured every minute for 1 hr by microplate reader analysis";"Sus scrofa";"4";"4";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL5162904";"B";"Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as decrease of adduct formation by measuring gray value measured at 5 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL5154820";"35339837";"10.1016/j.ejmech.2022.114271";"2022";"Eur J Med Chem";"235";"114271";"114271";"";"";"";"";"";""
"CHEMBL4412036";"F";"Antiproliferative activity against human VCR-resistant K562/VCR cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/VCR";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL3748560";"B";"Displacement of [3H]-vinblastine from biotinylated porcine tubulin after 15 mins by competitive binding assay";"Sus scrofa";"12";"12";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3745658";"26580420";"10.1021/acs.jmedchem.5b01312";"2015";"J Med Chem";"58";"9309";"9333";"";"";"";"";"";""
"CHEMBL3377416";"F";"Cell cycle arrest in human PC3 cells at 500 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL4042129";"F";"Cytotoxicity against human KB/S cells assessed as reduction in cell viability after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/S";"";"CHEMBL4041503";"27759387";"10.1021/acs.jnatprod.6b00674";"2016";"J Nat Prod";"79";"2709";"2717";"";"";"";"";"";""
"CHEMBL3377418";"F";"Cell cycle arrest in human RD cells at 500 nM incubated for 24 hrs followed by compound washout measured after 24 hrs";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL5155645";"F";"Antiproliferative activity against human KB/VCR cells measured after 72 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL3231474";"F";"Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.10 mg/kg, ip administered daily for 8 to 10 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P1534";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.1 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL5143982";"F";"Resistance index, ratio of IC50 for antiproliferative activity against vincristine resistant human HCT-8/VCR cells to IC50 for antiproliferative activity against human HCT-8 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5143510";"34649064";"10.1016/j.ejmech.2021.113897";"2022";"Eur J Med Chem";"227";"113897";"113897";"";"";"";"";"";""
"CHEMBL3285361";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3124375";"F";"Induction of apoptosis in human CCRF-CEM cells at 1 to 100 nM after 48 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL3120073";"24437936";"10.1021/np4008014";"2014";"J Nat Prod";"77";"536";"542";"";"";"";"";"";""
"CHEMBL4050954";"F";"Antiproliferative activity against human KB/VCR cells after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL4412039";"F";"Antiproliferative activity against human ADR-resistant Bel7402/ADR cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL2075689";"F";"TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Vincristine: 200 uM) in MDR1-expressing NIH-3T3 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"NIH3T3";"";"CHEMBL2074246";"14985103";"10.1016/j.bbrc.2004.01.156";"2004";"Biochem Biophys Res Commun";"315";"942";"949";"";"";"";"";"";""
"CHEMBL901938";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at S phase at 0.1 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL3739136";"F";"Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Lu1";"";"CHEMBL3734715";"26522953";"10.1016/j.bmcl.2015.10.040";"2015";"Bioorg Med Chem Lett";"25";"5597";"5600";"";"";"";"";"";""
"CHEMBL2389645";"F";"Cytotoxicity against human breast cancer cells after 48 hrs";"Homo sapiens";"13";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL3821857";"A";"Antiproliferative activity against African green monkey Vero cells assessed as reduction in cell viability at 100 uM after 48 hrs by SRB assay";"Chlorocebus sabaeus";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL3817741";"None";"10.1039/C5MD00529A";"2016";"Medchemcomm";"7";"914";"923";"";"";"";"";"";""
"CHEMBL3529538";"A";"Total biliary clearance in iv dosed Sprague-Dawley rat";"Rattus norvegicus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL3396776";"F";"Cytotoxicity against human KB/VCR cells after 72 hrs by SRB method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL3393024";"25597010";"10.1016/j.bmcl.2014.12.083";"2015";"Bioorg Med Chem Lett";"25";"795";"798";"";"";"";"";"";""
"CHEMBL3529737";"A";"Unbound biliary clearance in iv dosed human after 72 hrs by T-tube method";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638228";"Bile";"";"";"CHEMBL3526096";"23139379";"10.1124/dmd.112.049312";"2013";"Drug Metab Dispos";"41";"372";"378";"";"";"";"";"";""
"CHEMBL3239652";"F";"Cytotoxicity against human colon cancer cells after 48 hrs";"Homo sapiens";"18";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL3866638";"F";"Antiproliferative activity against human KB/VCR cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL3602457";"B";"Induction of microtubule destabilization in human A549 cells at 1 uM after 24 hrs by DAPI staining-based immunofluorescence confocal microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3600297";"26241032";"10.1021/acs.jmedchem.5b00659";"2015";"J Med Chem";"58";"6549";"6558";"";"";"";"";"";""
"CHEMBL4416667";"F";"Antiproliferative activity against human KB/S cells assessed as reduction in cell growth after 72 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4414629";"31642315";"10.1021/acs.jnatprod.9b00712";"2019";"J Nat Prod";"82";"3121";"3132";"";"";"";"";"";""
"CHEMBL3363568";"F";"Antitumor activity against Agrobacterium tumefaciens -induced tumor at 10 ug/ml after 21 days by potato disc bioassay technique";"Agrobacterium tumefaciens";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"358";"";"";"";"";"CHEMBL3352265";"25036793";"10.1016/j.ejmech.2014.07.028";"2014";"Eur J Med Chem";"84";"343";"363";"";"";"";"";"";""
"CHEMBL3856804";"F";"Induction of apoptosis in human MCF7 cells assessed as viable cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 72.30 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL3281984";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.33 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2428525";"F";"Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL3995433";"F";"Antiproliferative activity against human BT549 cells after 48 hrs by MTT assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"BT-549";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL3995437";"F";"Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3994605";"28038323";"10.1016/j.ejmech.2016.12.043";"2017";"Eur J Med Chem";"127";"100";"114";"";"";"";"";"";""
"CHEMBL4252841";"F";"Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL4686068";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-3 expression at 0.1 uM measured after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4362736";"B";"Binding affinity to tubulin (unknown origin) assessed as reduction in alpha-N fragment production at 100 uM after 30 mins by coomassie brilliant blue staining based trypsin proteolysis assay";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL3377410";"F";"Cell cycle arrest in human PC3 cells assessed as accumulation at G2/M phase at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL4252845";"F";"Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL3285362";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.36 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2076524";"F";"TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 1 uM, Vincristine: 30 uM) in membrane vesicles from MRP7-expressing HEK293 cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"HEK293";"Membrane vesicle";"CHEMBL2074568";"12527806";"10.1124/mol.63.2.351";"2003";"Mol Pharmacol";"63";"351";"358";"";"";"";"";"";""
"CHEMBL4412037";"F";"Drug resistance index, ratio of IC50 for VCR-resistant human K562/VCR cells to IC50 for human K562 cells";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL3998529";"F";"Cytotoxicity against human HCT116 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL3866639";"F";"Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3865815";"27423028";"10.1016/j.ejmech.2016.07.002";"2016";"Eur J Med Chem";"122";"488";"496";"";"";"";"";"";""
"CHEMBL3377413";"F";"Cell cycle arrest in human PC3 cells assessed as rounded cells at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL3998532";"F";"Cytotoxicity against human NCI-H526 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H526";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL4346910";"F";"Cytotoxicity against human SMMC7721 cells incubated for 72 hrs by MTT assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4346655";"30852384";"10.1016/j.ejmech.2019.02.071";"2019";"Eur J Med Chem";"169";"21";"28";"";"";"";"";"";""
"CHEMBL4009488";"B";"Inhibition of bovine brain tubulin polymerization at 5 uM measured every 1 min for 1 hr by spectrophotometric method";"Bos taurus";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL4819423";"F";"Cytotoxicity against human KBV cells by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KBV";"";"CHEMBL4818987";"32992133";"10.1016/j.ejmech.2020.112830";"2020";"Eur J Med Chem";"208";"112830";"112830";"";"";"";"";"";""
"CHEMBL4416668";"F";"Antiproliferative activity against human KB/VJ300 cells assessed as reduction in cell growth after 72 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL4414629";"31642315";"10.1021/acs.jnatprod.9b00712";"2019";"J Nat Prod";"82";"3121";"3132";"";"";"";"";"";""
"CHEMBL4837728";"F";"Cytotoxicity against human vincristine-resistant KB cells assessed as cell growth inhibition measured after 72 hrs by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4837192";"33872002";"10.1021/acs.jnatprod.1c00013";"2021";"J Nat Prod";"84";"1524";"1533";"";"";"";"";"";""
"CHEMBL2422401";"B";"Inhibition of tubulin polymerization in human NCI-H522 cells assessed as alpha-tubulin accumulation in cytoskeletal fraction at 100 nM after 24 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"NCI-H522";"";"CHEMBL2417372";"23916255";"10.1016/j.bmcl.2013.06.083";"2013";"Bioorg Med Chem Lett";"23";"5223";"5227";"";"";"";"";"";""
"CHEMBL4686095";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-3 expression at 0.1 uM measured after 48 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4686097";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in cleaved caspase-9 expression at 0.1 uM measured after 48 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3856807";"F";"Induction of apoptosis in human MCF7 cells assessed as necrotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 6.75 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL4362658";"F";"Antiproliferative activity against human KB cells assessed as reduction in cell viability after 72 hrs by MTS assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4362743";"F";"Antiproliferative activity against human CCRF-CEM/VBL cells assessed as reduction in cell viability after 72 hrs by MTS assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4817009";"F";"Antiproliferative activity against human MCF7/ADR cells incubated for 48 hrs by CCK-8 assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI/ADR-RES";"";"CHEMBL4813991";"33725657";"10.1016/j.ejmech.2021.113336";"2021";"Eur J Med Chem";"216";"113336";"113336";"";"";"";"";"";""
"CHEMBL3282233";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.36 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3998533";"F";"Cytotoxicity against human NCI-H211 cells assessed as decrease in cell proliferation after 72 hrs by Alamar blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H211";"";"CHEMBL3997781";"28064078";"10.1016/j.ejmech.2016.12.046";"2017";"Eur J Med Chem";"127";"235";"249";"";"";"";"";"";""
"CHEMBL4820215";"F";"Cytotoxicity against human MCF-T cells assessed as cell survival measured after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MCF-T";"";"CHEMBL4819015";"33360797";"10.1016/j.ejmech.2020.113107";"2021";"Eur J Med Chem";"211";"113107";"113107";"";"";"";"";"";""
"CHEMBL4819386";"F";"Antiproliferative activity against human K562/VCR cells incubated for 72 hrs by CCK8 method";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/VCR";"";"CHEMBL4818987";"32992133";"10.1016/j.ejmech.2020.112830";"2020";"Eur J Med Chem";"208";"112830";"112830";"";"";"";"";"";""
"CHEMBL4009498";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at S phase at 1 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 24.46%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL5155644";"F";"Antiproliferative activity against human KB cells measured after 72 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL5155646";"F";"Resistant index, ratio IC50 for KB/VCR cells over IC50 for KB cells";"";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"KB ";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL5155648";"F";"Resistant index, ratio IC50 for KB-V1 cells over IC50 for KB cells";"";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"KB ";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL5161636";"F";"Resistance index, ratio of IC50 for antiproliferative activity against human paclitaxel-resistant A2780/TAX cells to IC50 for antiproliferative activity against human A2780 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL4686109";"B";"Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4201260";"F";"Cell cycle arrest in human PANC1 cells assessed as accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis (Rvb = 13.7%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PANC-1";"";"CHEMBL4196179";"30156410";"10.1021/acs.jmedchem.8b00986";"2018";"J Med Chem";"61";"8444";"8456";"";"";"";"";"";""
"CHEMBL3856805";"F";"Induction of apoptosis in human MCF7 cells assessed as early apoptotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 4.90 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL5162765";"B";"Binding affinity to beta-tubulin colchicine binding site in human HeLa cells assessed as inhibition of EBI-beta-tubulin adduct formation measured at 5 to 25 uM incubated for 2 hrs followed by addition of EBI measured after 1.5 hrs by EBI competition based Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL5154820";"35339837";"10.1016/j.ejmech.2022.114271";"2022";"Eur J Med Chem";"235";"114271";"114271";"";"";"";"";"";""
"CHEMBL837117";"F";"Cytotoxic effect dissolved in DMSO against Melanoma cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Melanoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL4837727";"F";"Cytotoxicity against human vincristine-sensitive KB cells assessed as cell growth inhibition measured after 72 hrs by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4837192";"33872002";"10.1021/acs.jnatprod.1c00013";"2021";"J Nat Prod";"84";"1524";"1533";"";"";"";"";"";""
"CHEMBL848064";"F";"Cytotoxic effect on human renal tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel renal (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL2114821";"F";"PubChem BioAssay. qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen. (Class of assay: confirmatory) ";"";"945";"946";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4669271";"B";"Inhibition of tubulin polymerization in human MOLM-13 cells assessed as disruption of microtubule network at 200 nM after 18 hrs by FITC-staining based flow cytometry analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"MOLM-13";"";"CHEMBL4665719";"32736077";"10.1016/j.bmcl.2020.127453";"2020";"Bioorg Med Chem Lett";"30";"127453";"127453";"";"";"";"";"";""
"CHEMBL3561991";"F";"PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ";"";"181";"182";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL833358";"F";"Cytotoxic activity against human tumor C8305 cell line";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"C8305";"";"CHEMBL1144427";"15857148";"10.1021/jm049387x";"2005";"J Med Chem";"48";"3417";"3427";"";"";"";"";"";""
"CHEMBL837023";"F";"Cytotoxic effect dissolved in DMSO against Colon cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Colon cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL3231999";"B";"Displacement of [3H]VLB from tubulin in pig brain by competitive assay";"Sus scrofa";"12";"12";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"";"";"";"";"";""
"CHEMBL2343803";"F";"Cytotoxicity against human KB cells after 72 hrs by SRB assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2331340";"23360284";"10.1021/jm301788a";"2013";"J Med Chem";"56";"1544";"1563";"";"";"";"";"";""
"CHEMBL4009489";"B";"Inhibition of alpha-tubulin polymerization in human HCC1428 cells at 1 uM after 24 hrs by confocal microscopic method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4007433";"28222318";"10.1016/j.ejmech.2017.02.021";"2017";"Eur J Med Chem";"129";"186";"208";"";"";"";"";"";""
"CHEMBL2317178";"F";"Cell cycle arrest in human CAL33 cells assessed as accumulation at G2 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAL-33";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL738059";"F";"Number of survivors of DBA2 mice on 60th day after inoculation with L1210 leukemia cell line intravenously at a dose of 0.5 mg/kg/day; 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2032784";"F";"Cell cycle arrest in human SNU398 cells assessed as accumulation at G1 phase after 24 hrs by FACS analysis (Rvb = 55.8%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3603696";"F";"Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL3600380";"26270803";"10.1021/acs.jnatprod.5b00031";"2015";"J Nat Prod";"78";"2123";"2127";"";"";"";"";"";""
"CHEMBL3562035";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 3 blue channel.   (Class of assay: confirmatory) ";"";"29";"29";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562135";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1247232";"F";"Induction of apoptosis in human KB/VCR cells expressing Pgp assessed as up-regulation of Bax expression at 0.2 uM after 48 hrs by Western blotting";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB/VCR";"";"CHEMBL1240517";"20724170";"10.1016/j.bmc.2010.07.055";"2010";"Bioorg Med Chem";"18";"6725";"6733";"";"";"";"";"";""
"CHEMBL3281986";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 0.22 mg/kg/day, ip administered from day 1 to day 9 relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529285";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3562144";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3595577";"F";"Antiproliferative activity against human KB-7d cells expressing MRP after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-7d";"";"CHEMBL3593220";"26160020";"10.1016/j.bmc.2015.06.043";"2015";"Bioorg Med Chem";"23";"4230";"4236";"";"";"";"";"";""
"CHEMBL2317043";"F";"Cell cycle arrest in human HL60 cells assessed as accumulation at G1 phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL853891";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase at 0.1 nM";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL853900";"F";"Cell cycle arrest in KB/HeLa cells by accumulation at G1 phase at 0.3 nM";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138222";"17181164";"10.1021/jm0605031";"2006";"J Med Chem";"49";"7816";"7825";"";"";"";"";"";""
"CHEMBL4259356";"F";"Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL4257520";"30109000";"10.1039/C8MD00125A";"2018";"Medchemcomm";"9";"1131";"1141";"";"";"";"";"";""
"CHEMBL4252843";"F";"Cytotoxicity against human NCI-H460 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL848063";"F";"Inhibition of proliferation in NCI human renal tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel renal (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL3282252";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.60 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4296192";"F";"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media using NBS plates, by Resazurin F(560/590)";"Staphylococcus aureus subsp. aureus";"1581";"1582";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 43300";"CO-ADD antimicrobial screening data";"46170";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL886032";"F";"Effect on cell morphology in human U87 cells assessed as disruption of microtubule network and loss of function at 10 nM after 3 hrs";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"U-87MG ATCC";"";"CHEMBL1143713";"17533132";"10.1016/j.bmc.2007.05.030";"2007";"Bioorg Med Chem";"15";"5122";"5136";"";"";"";"";"";""
"CHEMBL901948";"F";"Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2M phase at 0.3 nM after 24 hrs by flow cytometric analysis";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1138290";"17973361";"10.1021/jm0708984";"2007";"J Med Chem";"50";"6059";"6066";"";"";"";"";"";""
"CHEMBL3377417";"F";"Cell cycle arrest in human RD cells at 1000 to 2000 nM incubated for 24 hrs followed by compound washout measured after 24 hrs";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL2317179";"F";"Cell cycle arrest in human HL60 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL2317042";"F";"Cell cycle arrest in human CAL33 cells assessed as accumulation at S phase at 0.5 uM after 24 hrs flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CAL-33";"";"CHEMBL2311499";"23202849";"10.1016/j.ejmech.2012.10.051";"2013";"Eur J Med Chem";"59";"39";"47";"";"";"";"";"";""
"CHEMBL3396165";"F";"Antiproliferative activity against cis-platinum-resistant human A549 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL4252847";"A";"Cytotoxicity against human RWPE1 cells assessed as inhibition of cell viability after 48 hrs by MTT assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RWPE-1";"";"CHEMBL4251576";"29174816";"10.1016/j.ejmech.2017.11.010";"2018";"Eur J Med Chem";"143";"216";"231";"";"";"";"";"";""
"CHEMBL4259352";"F";"Antiproliferative activity against HEL cells after 48 hrs by MTT assay";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEL";"";"CHEMBL4257520";"30109000";"10.1039/C8MD00125A";"2018";"Medchemcomm";"9";"1131";"1141";"";"";"";"";"";""
"CHEMBL4819385";"F";"Antiproliferative activity against human K562 cells incubated for 72 hrs by CCK8 method";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4818987";"32992133";"10.1016/j.ejmech.2020.112830";"2020";"Eur J Med Chem";"208";"112830";"112830";"";"";"";"";"";""
"CHEMBL2066358";"F";"Cytotoxicity against human CNS cancer cells after 48 hrs";"Homo sapiens";"23";"53";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL2078561";"F";"TP_TRANSPORTER: inhibition of Vinblastine transepithelial transport (basal to apical) in MRP2-expressing MDCK cells";"";"6";"6";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK";"";"CHEMBL2073914";"12134946";"10.1023/a:1016192413308";"2002";"Pharm Res";"19";"773";"779";"";"";"";"";"";""
"CHEMBL2032786";"F";"Cell cycle arrest in human SNU398 cells assessed as accumulation at sub-G1 phase after 24 hrs by FACS analysis (Rvb = 1.2%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL4034795";"B";"Inhibition of tubulin (unknown origin) polymerization by fluorescence assay";"Homo sapiens";"14";"14";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4033650";"28431353";"10.1016/j.ejmech.2017.04.025";"2017";"Eur J Med Chem";"135";"34";"48";"";"";"";"";"";""
"CHEMBL3860276";"B";"Induction of microtubule depolymerization in human HCC1428 cells at 1 uM after 24 hrs by DAPI staining-based confocal microscopic method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL2343634";"F";"Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NFF";"";"CHEMBL2331272";"23489291";"10.1021/np300648d";"2013";"J Nat Prod";"76";"516";"523";"";"";"";"";"";""
"CHEMBL3856792";"T";"Cytotoxicity against African green monkey Vero cells assessed as cell growth inhibition after 48 hrs by MTT assay";"Chlorocebus sabaeus";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"60711";"";"";"Vero";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL3239867";"F";"Anticancer activity against Syrian golden hamster BHK21 cells at 10 uM after 48 hrs by SRB assay";"Mesocricetus auratus";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL3232838";"24681981";"10.1016/j.ejmech.2014.03.046";"2014";"Eur J Med Chem";"78";"167";"177";"";"";"";"";"";""
"CHEMBL2428523";"F";"Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL2424644";"23981529";"10.1016/j.ejmech.2013.08.006";"2013";"Eur J Med Chem";"68";"222";"232";"";"";"";"";"";""
"CHEMBL2066355";"F";"Cytotoxicity against human leukemia cells after 48 hrs";"Homo sapiens";"22";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL3529293";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3821856";"F";"Antiproliferative activity against human NCI-H157 cells assessed as cell growth inhibition after 48 hrs by SRB assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL3817741";"None";"10.1039/C5MD00529A";"2016";"Medchemcomm";"7";"914";"923";"";"";"";"";"";""
"CHEMBL2150107";"F";"Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL4142107";"F";"Cytotoxicity against human NCI-H157 cells at 10 uM after 48 hrs by sulforhodamine B assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4362742";"F";"Selectivity index, ratio of IC50 for human KB/VCR cells to IC50 for human KB cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4142111";"A";"Cytotoxicity against golden hamsterBHK21 cells at 10 uM after 48 hrs by sulforhodamine B assay";"Mesocricetus auratus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4122014";"F";"Antiproliferative activity against human K562/VCR cells after 72 hrs by CCK8 assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562/VCR";"";"CHEMBL4118137";"29678463";"10.1016/j.bmcl.2018.04.019";"2018";"Bioorg Med Chem Lett";"28";"1817";"1824";"";"";"";"";"";""
"CHEMBL4050955";"F";"Resistance factor, ratio of IC50 for human KB/VCR cells to IC50 for human KB cells";"Homo sapiens";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL2032758";"F";"Antiproliferative activity against human JHH2 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL4142112";"A";"Cytotoxicity against golden hamster BHK21 cells at 1 uM after 48 hrs by sulforhodamine B assay";"Mesocricetus auratus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4142204";"F";"Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4138179";"29133061";"10.1016/j.ejmech.2017.11.004";"2018";"Eur J Med Chem";"143";"1942";"1958";"";"";"";"";"";""
"CHEMBL3377411";"F";"Cell cycle arrest in human RD cells assessed as accumulation at G2/M phase at 500 nM after 24 hrs by propidium iodide staining-based flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RD";"";"CHEMBL3351435";"25025991";"10.1021/jm500561a";"2014";"J Med Chem";"57";"6531";"6552";"";"";"";"";"";""
"CHEMBL5155647";"F";"Antiproliferative activity against human KB-V1 cells measured after 72 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-V1";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL4303810";"F";"Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)";"Homo sapiens";"1629";"1637";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"HRCE";"";"CHEMBL4303122";"None";"10.1101/2020.04.21.054387";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2216648";"A";"Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2203019";"23215348";"10.1021/np3006474";"2012";"J Nat Prod";"75";"2200";"2208";"";"";"";"";"";""
"CHEMBL2446773";"F";"Cytotoxicity against human KB-S15 cells overexpressing P-gp170/MDR assessed as growth inhibition after 72 hrs by methylene blue staining-based assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-S15";"";"CHEMBL2440102";"24106982";"10.1021/jm4011115";"2013";"J Med Chem";"56";"8008";"8018";"";"";"";"";"";""
"CHEMBL3215017";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"26950";"27095";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1799257";"F";"Cell cycle arrest in human HCT116 cells assessed as increase of phosphorylated histone H3 at Ser10 level at 150 nM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 1.4 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1795243";"21664138";"10.1016/j.bmc.2011.05.031";"2011";"Bioorg Med Chem";"19";"3995";"4003";"";"";"";"";"";""
"CHEMBL4142158";"F";"Cytotoxicity against human HepG2 cells by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL2032733";"A";"Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 1 to 10 uM after 48 hrs by neutral red incorporation assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL2150103";"F";"Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL4412040";"F";"Drug resistance index, ratio of IC50 for ADR-resistant human Bel7402/ADR cells to IC50 for human Bel7402 cells";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL700818";"F";"The compound was tested in vitro for growth of inhibitory activity against lymphoid leukemia L1210 cells";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124678";"2795608";"10.1021/jm00130a023";"1989";"J Med Chem";"32";"2363";"2367";"";"";"";"";"";""
"CHEMBL3282224";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in life span at 4 mg/kg/day, ip after 1 day";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3282232";"T";"Toxicity in ip dosed mouse allografted with mouse p388 cells after 1 day";"Mus musculus";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL3281982";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 1 mg/kg/day, ip administered on day 1, 5 and 9 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3285363";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4375932";"A";"Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 48 hrs by SRB assay";"Mesocricetus auratus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4373717";"31404864";"10.1016/j.ejmech.2019.111587";"2019";"Eur J Med Chem";"181";"111587";"111587";"";"";"";"";"";""
"CHEMBL4375930";"F";"Cytotoxicity against human NCI-H157 cells assessed as reduction in cell viability after 48 hrs by SRB assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4373717";"31404864";"10.1016/j.ejmech.2019.111587";"2019";"Eur J Med Chem";"181";"111587";"111587";"";"";"";"";"";""
"CHEMBL4155616";"F";"Cytotoxicity against human SMMC7721 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3283295";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.2 mg/kg/day after 1 day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3282477";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 5, 9 and 13 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3595574";"F";"Antiproliferative activity against human KB cells after 72 hrs by methylene blue assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL3593220";"26160020";"10.1016/j.bmc.2015.06.043";"2015";"Bioorg Med Chem";"23";"4230";"4236";"";"";"";"";"";""
"CHEMBL3562011";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 3, ratio channel.   (Class of assay: confirmatory) ";"";"30";"30";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2388149";"F";"Cytotoxicity against human leukemia cells after 48 hrs";"Homo sapiens";"13";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Leukemia cell";"";"CHEMBL2385029";"23685944";"10.1016/j.ejmech.2013.03.033";"2013";"Eur J Med Chem";"64";"603";"612";"";"";"";"";"";""
"CHEMBL831462";"F";"Total growth inhibition of human Renal cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Renal cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL3137732";"T";"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137726";"T";"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2032761";"F";"Antiproliferative activity against human PLC/PRF/5 after 72 hrs by CellTiter Glo assay";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PLC-PRF-5";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL4412031";"F";"Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bel-7402";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL4671791";"A";"Cytotoxicity against human PBL assessed as reduction in cell viability in presence of mitogenic stimulus phytohaemagglutinin incubated for 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PBL";"";"CHEMBL4665839";"32986419";"10.1021/acs.jmedchem.0c01315";"2020";"J Med Chem";"63";"12023";"12042";"";"";"";"";"";""
"CHEMBL4412035";"F";"Drug resistance index, ratio of IC50 for taxol-resistant human A549/TR cells to IC50 for human A549 cells";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL3396163";"F";"Antiproliferative activity against human HCT8 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3396164";"F";"Antiproliferative activity against vincristine-resistant human HCT8 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL3822007";"F";"Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3363566";"F";"Antitumor activity against Agrobacterium tumefaciens -induced tumor at 1000 ug/ml after 21 days by potato disc bioassay technique";"Agrobacterium tumefaciens";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"358";"";"";"";"";"CHEMBL3352265";"25036793";"10.1016/j.ejmech.2014.07.028";"2014";"Eur J Med Chem";"84";"343";"363";"";"";"";"";"";""
"CHEMBL3369011";"F";"Cytotoxicity against vinblastine-resistant human CCRF-CEM cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3369015";"F";"Cytotoxicity against human H460 cells assessed as growth inhibition after 72 hrs by Alamar Blue assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL3351946";"24583355";"10.1016/j.ejmech.2014.02.018";"2014";"Eur J Med Chem";"76";"155";"169";"";"";"";"";"";""
"CHEMBL3529273";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3243456";"F";"Cytotoxicity against human vincristine/paclitaxel-resistant KB-S15 cells overexpressing P-gp170 after 72 hrs by methylene blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-S15";"";"CHEMBL3232864";"24657567";"10.1016/j.ejmech.2014.02.061";"2014";"Eur J Med Chem";"77";"306";"314";"";"";"";"";"";""
"CHEMBL3231913";"F";"Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.90 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/VCR";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.9 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL3562043";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ";"";"368";"369";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3396162";"F";"Antiproliferative activity against taxol-resistant human A2780 cells after 48 hrs by SRB method";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL3393048";"25061803";"10.1021/jm500024v";"2014";"J Med Chem";"57";"6364";"6382";"";"";"";"";"";""
"CHEMBL4296186";"F";"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";"Klebsiella pneumoniae";"6160";"6262";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"ATCC 700603";"CO-ADD antimicrobial screening data";"573";"";"";"";"";"CHEMBL4296181";"None";"10.6019/CHEMBL4296181";"None";"None";"None";"None";"None";"standard_type:ASSAY_TEST standard_relation:None standard_value:None standard_units:None comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEDIA standard_relation:None standard_value:None standard_units:None comments:None | standard_type:PLATE_TYPE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:TIME standard_relation:= standard_value:18.0 standard_units:hr comments:None";"";"";"";"";""
"CHEMBL2032735";"A";"Cytotoxicity against mouse astrocytes assessed as decrease in cell viability at 0.1 uM after 48 hrs by neutral red incorporation assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"Astrocyte";"";"CHEMBL2029220";"22268526";"10.1021/jm201428a";"2012";"J Med Chem";"55";"2196";"2211";"";"";"";"";"";""
"CHEMBL3137735";"T";"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137740";"T";"Proposed mechanism(s) of liver damage. [column 'MEC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137730";"T";"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137737";"T";"Presence of at least one case with successful reintroduction. [column 'REINT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137725";"T";"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3595573";"F";"Antiproliferative activity against human KB-VIN10 cells expressing P-gp170/MDR after 72 hrs by methylene blue assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-VIN10";"";"CHEMBL3593220";"26160020";"10.1016/j.bmc.2015.06.043";"2015";"Bioorg Med Chem";"23";"4230";"4236";"";"";"";"";"";""
"CHEMBL4667298";"F";"Antiproliferative activity against human A2780 cells incubated for 72 hrs by ATPlite reagent based assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL4665649";"31047749";"10.1016/j.bmcl.2019.04.035";"2019";"Bioorg Med Chem Lett";"29";"1647";"1653";"";"";"";"";"";""
"CHEMBL4667299";"F";"Antiproliferative activity against D4-9-31 resistance human A2780 cells incubated for 72 hrs by ATPlite reagent based assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL4665649";"31047749";"10.1016/j.bmcl.2019.04.035";"2019";"Bioorg Med Chem Lett";"29";"1647";"1653";"";"";"";"";"";""
"CHEMBL4362739";"F";"Antiproliferative activity against human KBtax cells assessed as reduction in cell viability after 72 hrs by MTS assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359883";"31419740";"10.1016/j.ejmech.2019.111584";"2019";"Eur J Med Chem";"181";"111584";"111584";"";"";"";"";"";""
"CHEMBL4343140";"B";"Inhibition of bovine brain microtubule polymerization incubated for 60 mins by spectrophotometric method";"Bos taurus";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL4342416";"31536895";"10.1016/j.ejmech.2019.111691";"2019";"Eur J Med Chem";"183";"111691";"111691";"";"";"";"";"";""
"CHEMBL2343801";"F";"Cytotoxicity against human MES-SA cells after 72 hrs by Presto Blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL2331340";"23360284";"10.1021/jm301788a";"2013";"J Med Chem";"56";"1544";"1563";"";"";"";"";"";""
"CHEMBL3822012";"F";"Cytotoxicity against human HCT8 cells assessed as cell viability after 48 hrs by MTT assay";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3822028";"F";"Resistance index, ratio of IC50 for human MCF7/DX cells to IC50 for human MCF7 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3817728";"27149641";"10.1021/acs.jmedchem.6b00021";"2016";"J Med Chem";"59";"5264";"5283";"";"";"";"";"";""
"CHEMBL3529280";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4149991";"F";"Antiproliferative activity against human KB cells after 48 hrs by MTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL4145601";"29795767";"10.1021/acsmedchemlett.8b00125";"2018";"ACS Med Chem Lett";"9";"502";"506";"";"";"";"";"";""
"CHEMBL3856806";"F";"Induction of apoptosis in human MCF7 cells assessed as late apoptotic cells after 24 to 48 hrs by Annexin V/7-AAD staining based flow cytometry (Rvb = 16.05 %)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3856194";"27187865";"10.1016/j.ejmech.2016.05.010";"2016";"Eur J Med Chem";"120";"134";"147";"";"";"";"";"";""
"CHEMBL4201254";"F";"Cell cycle arrest in human MCF7 cells assessed as increase in accumulation at G2/M phase at 100 nM after 18 hrs by Hoechst 33342 staining based FACS analysis relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4196179";"30156410";"10.1021/acs.jmedchem.8b00986";"2018";"J Med Chem";"61";"8444";"8456";"";"";"";"";"";""
"CHEMBL4155622";"F";"Growth inhibition of human SMMC7721 cells at 0.01 ug/ml after 72 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4152291";"29886320";"10.1016/j.ejmech.2018.05.056";"2018";"Eur J Med Chem";"155";"165";"170";"";"";"";"";"";""
"CHEMBL3562120";"F";"PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3232002";"A";"Cytotoxicity against CHO cells at 0.02 ug/ml";"Cricetulus griseus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"";"";"";"";"";""
"CHEMBL3529277";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4310851";"F";"Potentiation of paclitaxel-induced cytotoxicity against human A2780/TAX cells assessed as paclitaxel IC50 at 10 uM after 48 hrs by MTT assay (Rvb = 3970 nM)";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780/Taxol";"";"CHEMBL4308879";"30455148";"10.1016/j.bmcl.2018.11.023";"2019";"Bioorg Med Chem Lett";"29";"28";"31";"";"";"";"";"";""
"CHEMBL4142157";"A";"Cytotoxicity against golden hamster BHK21 cells after 48 hrs by sulforhodamine B assay";"Mesocricetus auratus";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10036";"";"";"BHK-21";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL4042130";"F";"Cytotoxicity against human KB/VJ300 cells assessed as reduction in cell viability after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB/VJ300";"";"CHEMBL4041503";"27759387";"10.1021/acs.jnatprod.6b00674";"2016";"J Nat Prod";"79";"2709";"2717";"";"";"";"";"";""
"CHEMBL4142205";"F";"Cytotoxicity against human PC3 cells assessed as cell growth inhibition after 48 hrs by MTT assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL4138179";"29133061";"10.1016/j.ejmech.2017.11.004";"2018";"Eur J Med Chem";"143";"1942";"1958";"";"";"";"";"";""
"CHEMBL4122016";"F";"Resistance factor, ratio of IC50 for human K562/VCR cells to IC50 for human K562 cells";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4118137";"29678463";"10.1016/j.bmcl.2018.04.019";"2018";"Bioorg Med Chem Lett";"28";"1817";"1824";"";"";"";"";"";""
"CHEMBL4149475";"F";"Growth inhibition of human KB/S cells after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4145571";"29746134";"10.1021/acs.jnatprod.8b00170";"2018";"J Nat Prod";"81";"1266";"1277";"";"";"";"";"";""
"CHEMBL4049313";"B";"Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay";"Ebolavirus";"28";"28";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"186536";"";"";"HeLa";"";"CHEMBL4043309";"29624387";"10.1021/acs.jmedchem.8b00035";"2018";"J Med Chem";"61";"3582";"3594";"";"";"";"";"";""
"CHEMBL4686074";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in activated gammaH2AX expression at 0.1 uM measured after 24 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4142156";"F";"Cytotoxicity against human NCI-H157 cells after 48 hrs by sulforhodamine B assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H157";"";"CHEMBL4138175";"29133050";"10.1016/j.ejmech.2017.11.001";"2018";"Eur J Med Chem";"143";"1903";"1918";"";"";"";"";"";""
"CHEMBL3748558";"B";"Potency index, ratio of vincristine IC50 to docetaxel IC50 for displacement of [3H]-paclitaxel from biotinylated porcine tubulin";"Sus scrofa";"1";"1";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9823";"";"";"";"";"CHEMBL3745658";"26580420";"10.1021/acs.jmedchem.5b01312";"2015";"J Med Chem";"58";"9309";"9333";"";"";"";"";"";""
"CHEMBL3124373";"F";"Induction of apoptosis in human CCRF-CEM VCR/R cells assessed as cell viability at 2.5 uM after 72 hrs by CellTitre-Blue assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"CCRF-CEM VCR/R";"";"CHEMBL3120073";"24437936";"10.1021/np4008014";"2014";"J Nat Prod";"77";"536";"542";"";"";"";"";"";""
"CHEMBL3283287";"F";"Antitumor activity against mouse P1534(J) cells allografted in mouse assessed as tumor growth inhibition at 0.25 mg/kg/day, ip administered from day 1 to day 9 relative to unreated control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P1534J ";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL3283286";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as survival at 1.8 mg/kg/day after 1 day";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3282240";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as increase in life span at 1.67 mg/kg/day, ip administered on day 1, 5 and 9 measured for 56 days relative to untreated control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3282471";"F";"Antitumor activity against mouse B16 cells allografted in B6D2F1 mouse assessed as mean survival time at 0.216 mg/kg/day, ip administered on day 5, 9 and 13 (Rvb = 20.0 days)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3272325";"412968";"10.1021/jm00199a016";"1978";"J Med Chem";"21";"88";"96";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4184789";"F";"Cytotoxicity against human MOLT4 cells assessed as reduction in cell viability";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLT-4";"";"CHEMBL4184103";"29274817";"10.1016/j.bmcl.2017.12.029";"2018";"Bioorg Med Chem Lett";"28";"410";"414";"";"";"";"";"";""
"CHEMBL3231904";"F";"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/S";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL4686108";"B";"Induction of microtubule disruption in human KB-VIN cells assessed as polymerized fraction at 0.1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 23.1 to 25.5%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4671792";"A";"Cytotoxicity against human PBL assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PBL";"";"CHEMBL4665839";"32986419";"10.1021/acs.jmedchem.0c01315";"2020";"J Med Chem";"63";"12023";"12042";"";"";"";"";"";""
"CHEMBL5161612";"F";"Antiproliferative activity against human HCT-8 cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-8";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL4738989";"F";"Cytotoxicity against human SMMC-7721 cells assessed as cell viability after 24 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4732241";"33636536";"10.1016/j.ejmech.2021.113295";"2021";"Eur J Med Chem";"215";"113295";"113295";"";"";"";"";"";""
"CHEMBL697745";"F";"Cytotoxicity tested against Hela T5 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1131902";"10612603";"10.1016/s0960-894x(99)00610-1";"1999";"Bioorg Med Chem Lett";"9";"3381";"3386";"";"";"";"";"";""
"CHEMBL833733";"F";"Growth inhibitory concentration dissolved in DMSO against human Prostate cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Prostate cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL3527758";"A";"Fraction absorbed in human";"Homo sapiens";"62";"62";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3860266";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at G1 phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 69.83%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL5161635";"F";"Antiproliferative activity against human paclitaxel-resistant A2780/TAX cells assessed as cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL5154799";"35282680";"10.1021/acs.jmedchem.1c01775";"2022";"J Med Chem";"65";"4687";"4708";"";"";"";"";"";""
"CHEMBL5155651";"F";"Resistant index, ratio IC50 for K562/Adr cells over IC50 for K562 cells";"";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"K562/Adr";"";"CHEMBL5154650";"34794817";"10.1016/j.ejmech.2021.113930";"2022";"Eur J Med Chem";"228";"113930";"113930";"";"";"";"";"";""
"CHEMBL3860267";"F";"Cell cycle arrest in human HCC1428 cells assessed as accumulation at S phase at 1 uM after 24 hrs by propidium iodide staining-based flow cytometric method (Rvb = 21.01%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"HCC1428";"";"CHEMBL3860030";"27318123";"10.1016/j.ejmech.2016.06.007";"2016";"Eur J Med Chem";"121";"484";"499";"";"";"";"";"";""
"CHEMBL1964014";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"11487";"11548";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-18";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2032750";"F";"Antiproliferative activity against human SNU398 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SNU-398";"";"CHEMBL2029236";"22320354";"10.1021/jm200848t";"2012";"J Med Chem";"55";"1920";"1925";"";"";"";"";"";""
"CHEMBL3562139";"F";"PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3231905";"F";"Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/S";"";"CHEMBL3227917";"430477";"10.1021/jm00190a008";"1979";"J Med Chem";"22";"391";"400";"standard_type:DOSE standard_relation:= standard_value:0.6 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Acute Graft Versus Host Disease GVHD in Rats | Neoplasms";"";""
"CHEMBL739815";"F";"Compound was evaluated for antitumor activity in P388/VCR-bearing mice at 0.2 mg/Kg as the ratio of median survival time of treated mice to control mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1130845";"9873389";"10.1016/s0960-894x(98)00262-5";"1998";"Bioorg Med Chem Lett";"8";"1555";"1558";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3561990";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ";"";"2189";"2208";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561973";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL821747";"F";"Cytostatic effect on human prostate tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel prostate (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL822048";"F";"Cytotoxic effect on human melanoma tumor cell lines";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Panel melanoma (Carcinoma cell lines)";"";"CHEMBL1135474";"12036377";"10.1021/jm011123c";"2002";"J Med Chem";"45";"2666";"2669";"";"";"";"";"";""
"CHEMBL758459";"F";"Compound was evaluated for in vitro growth inhibition activity against multi drug resistant (MDR) PC-12 cell line.";"Rattus norvegicus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"PC-12";"";"CHEMBL1130905";"9873473";"10.1016/s0960-894x(98)00344-8";"1998";"Bioorg Med Chem Lett";"8";"1997";"2000";"";"";"";"";"";""
"CHEMBL926278";"F";"Cytotoxicity against human KB cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1140639";"17608533";"10.1021/np0701778";"2007";"J Nat Prod";"70";"1380";"1383";"";"";"";"";"";""
"CHEMBL740427";"F";"Percent increase in life span of DBA2 mice after inoculation with L1210 leukemia intravenously at a dose of 2 mg/kg per day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122917";"4020828";"10.1021/jm00146a017";"1985";"J Med Chem";"28";"1079";"1088";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL837113";"F";"Cytotoxic effect dissolved in DMSO against Ovarian cell line at 10E-3 M concentration";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Ovarian carcinoma cell";"";"CHEMBL1141167";"16107161";"10.1021/jm050353e";"2005";"J Med Chem";"48";"5604";"5607";"";"";"";"";"";""
"CHEMBL2066612";"F";"Cytotoxicity against human breast cancer cells after 48 hrs";"Homo sapiens";"23";"52";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL2062525";"22283430";"10.1021/jm2012694";"2012";"J Med Chem";"55";"2078";"2088";"";"";"";"";"";""
"CHEMBL2446772";"F";"Cytotoxicity against human KB-7d cells overexpressing MRP assessed as growth inhibition after 72 hrs by methylene blue staining-based assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB-7d";"";"CHEMBL2440102";"24106982";"10.1021/jm4011115";"2013";"J Med Chem";"56";"8008";"8018";"";"";"";"";"";""
"CHEMBL4686103";"B";"Induction of microtubule disruption in human KB-VIN cells at 1 uM measured after 24 hrs by DAPI staining based deconvolution fluorescence microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL3239658";"F";"Cytotoxicity against human CNS cancer cells after 48 hrs";"Homo sapiens";"18";"46";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL3232816";"24747749";"10.1016/j.ejmech.2014.04.004";"2014";"Eur J Med Chem";"79";"382";"390";"";"";"";"";"";""
"CHEMBL4686093";"F";"Cell cycle arrest in human KB-VIN cells assessed as increase in accumulation at sub-G1 phase at 0.1 uM measured after 48 hrs by propidium iodide staining based flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4686098";"F";"Induction of apoptosis in human KB-VIN cells assessed as increase in activated gammaH2AX expression at 0.1 uM measured after 48 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"KB-VIN";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4686111";"B";"Induction of microtubule disruption in human KB7D cells assessed as polymerized fraction at 0.1 uM measured after 16 hrs by SDS-PAGE analysis (Rvb = 26.4 to 29%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"KB7D";"";"CHEMBL4680226";"32171161";"10.1016/j.ejmech.2020.112158";"2020";"Eur J Med Chem";"192";"112158";"112158";"";"";"";"";"";""
"CHEMBL4412032";"F";"Antiproliferative activity against human taxol-resistant HCT8/T cells after 72 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4411275";"30530194";"10.1016/j.ejmech.2018.11.070";"2019";"Eur J Med Chem";"163";"428";"442";"";"";"";"";"";""
"CHEMBL4431645";"F";"Growth inhibition of human KB/S cells after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4431302";"26918761";"10.1021/acs.jnatprod.5b01117";"2016";"J Nat Prod";"79";"1048";"1055";"";"";"";"";"";""
"CHEMBL4305678";"F";"Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability at 100 uM relative to control";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL4304757";"31112894";"10.1016/j.ejmech.2019.04.025";"2019";"Eur J Med Chem";"176";"343";"377";"";"";"";"";"";""
"CHEMBL3363567";"F";"Antitumor activity against Agrobacterium tumefaciens -induced tumor at 100 ug/ml after 21 days by potato disc bioassay technique";"Agrobacterium tumefaciens";"14";"14";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"358";"";"";"";"";"CHEMBL3352265";"25036793";"10.1016/j.ejmech.2014.07.028";"2014";"Eur J Med Chem";"84";"343";"363";"";"";"";"";"";""
